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Introduction
In December 1997, Jens Christian Skou was awarded the Nobel Prize in Chemistry for “the 
first discovery of an ion-transporting enzyme, Na+,K+-ATPase”. Forty years before, Skou 
published a paper describing “the influence of some cations on an adenosine triphosphatase 
from peripheral nerves”.1 After a suggestion by Robert Post to test for ouabain inhibition 
of the observed activity, it became clear that the enzyme was involved in active transport 
across the cellular membrane.2 Following the first report on an adenosine triphosphatase in 
neuronal tissue of crab, it was quickly shown that there was an active transporter of Na+ and 
K+ present in human red blood cells as well3, leading to many more publications describing 
the presence of Na+,K+-ATPase in the plasma membrane of all animal tissues tested.4,5 Also, 
other ion transporting pumps were identified, including a Ca2+-ATPase in sarcoendoplasmic 
reticulum (SERCA)6, and a H+,K+-ATPase present in stomach and the gastrointestinal tract7, 
both belonging to the same class II family of P-type ATPases as Na+,K+-ATPase. In this thesis, 
the first discovered enzyme of this class, Na+,K+-ATPase, will be discussed.
The role of Na+,K+-ATPase
Na+,K+-ATPase is responsible for a considerable amount of cellular ATP consumption, 
ranging from 25% of the human body in total8 up to 50% in brain tissue.9 An enzyme using 
these amounts of energy is most likely involved in important cellular processes, which is 
confirmed by the presence of Na+,K+-ATPase in a wide variety of animal species.10-12 Today, 
it is known that under physiological conditions the enzyme transports three sodium ions out 
of the cell in exchange for two potassium ions returning into the cell during each transport 
cycle, while consuming one molecule of ATP.13 One of the most prominent features of 
this transport is the net efflux of cations from the cell. This provides a vital compensatory 
mechanism for the high intracellular concentration of K+ and its induced entrance of water.2 
A second role of Na+,K+-ATPase is maintenance of the membrane potential. This involves 
the electrogenic capacity of the enzyme, for example in restoring the membrane potential 
after impulse-induced depolarization in neurons resulting in entry of Na+ and release of K+.9 
In addition to its electrogenic property, Na+,K+-ATPase also generates a steep Na+ gradient 
across the cellular membrane. This gradient provides the driving force for secondary active 
transporter enzymes, for example glucose14,15 and amino acid importers.16 More recently, 
a fourth role has been proposed, in which Na+,K+-ATPase serves as an anchor for enzymes 
that are active in various signaling pathways after activation by endogenous ligands present in 
blood.17,18 Together, these highly important processes rely on Na+,K+-ATPase, underlining its 
importance for cellular function. 
The reaction cycle
As mentioned above, Na+,K+-ATPase exports three sodium ions and imports two potassium 
ions during each reaction cycle, maintaining high intracellular K+ and high extracellular Na+ 
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concentrations. The transport of these cations against their chemical gradient requires energy 
supplied by ATP, which acts as a fuel source. After the discovery of Na+,K+-ATPase, research 
was devoted to the elucidation of the exact mechanism of transport. This transport cycle is 
now well characterized by the so-called Post-Albers scheme.19,20 This scheme (Fig. 1) depicts 
how the enzyme exerts its transport function, by going through a cycle of conformational 
changes induced by binding or release of Na+, K+, and ATP. Na+,K+-ATPase (and other P-type 
ATPases) has three characteristic properties used in the transport cycle: presence of two 
conformational states (E1 and E2) possessing highly different affinities to both Na+ and K+, 
autophosphorylation of a highly conserved aspartic acid by the γ-phosphate from ATP, and 
the ability to form cation occluded states trapping either Na+ or K+ by preventing access from 
either the cytosolic or extracellular sides of the membrane.21
The reaction cycle is divided into four steps, the first step involving the E1 conformation of 
the enzyme. This conformation is characterized by a high affinity for Na+ and ATP, while the 
ion-binding sites are accessible from the cytosolic side only, allowing Na+ binding to take 
place.21 Following high-affinity binding of ATP, the γ-phosphate from ATP is transferred to an 
aspartic acid present in a highly conserved region of the enzyme, inducing a conformational 
change to the E1P state resulting in occlusion of the three sodium ions present in the ion-
binding sites.22,23 Normally, the E1P state spontaneously results in formation of the E2P state, 
a process that can be inhibited by oligomycin.24 In the E2P state, the enzyme has a high K+ and 
low ATP affinity and the ion-binding sites are accessible only from the extracellular side of 
the cell. Due to the low sodium affinity of the E2P state, the enzyme releases these ions to the 
outside of the cell, allowing for two potassium ions to bind to the sites that were occupied by Na+ 
previously. This results in hydrolysis at the phosphorylated aspartic acid site and subsequent 
formation of inorganic phosphate (Pi).20 Now, the enzyme has reached its fourth enzymatic 
conformation, the dephosphorylated E2 state in which the two bound potassium ions become 
occluded, i.e. the extracellular access channel has been shut. Subsequently, ATP binds to the 
enzyme, greatly increasing the conformational change from the E2 to the E1 state, opening the 
intracellular access channel to the ion-binding sites, resulting in release of potassium to the 
intracellular space and completing the reaction cycle.25 While under physiological conditions 
the reaction cycle runs clockwise resulting in consumption of ATP, it is important to mention 
that each step is an equilibrium reaction. This means that when adjusting the biochemical 
conditions, it is possible to allow the reaction cycle to run in the opposite (counter-clockwise) 
direction resulting in formation of ATP.26
Isoforms of Na+,K+-ATPase
In the human body, Na+,K+-ATPase is present in every cell. However, there are differences 
in the types of Na+,K+-ATPase found in specific tissues. In any case, each functional 
Na+,K+-ATPase consists of at least two different subunits: a 110 kDa α-subunit accompanied 
by a 50 kDa β-subunit. Many reports have pointed out the presence of a third subunit dubbed 
as γ-subunit, characterized by the FXYD motif present in the extracellular part27,28, although it 
remains to be established whether this subunit is always present. FXYD proteins play a role in 
modulating Na+,K+-ATPase activity tissue specifically, reflected by identification of multiple 
Na+,K+-ATPase associated FXYD proteins in different tissues.29-31 
The α-subunit is responsible for most of the properties attributed to Na+,K+-ATPase. It 
contains the ion-binding sites and the ATP-binding and phosphorylation site. In the human 
body, four different isoforms of the α-subunit have been detected, each with a different tissue 
expression pattern.32 For example, the α1-isoform is found in every cell of the body and is 
therefore the most ubiquitous isoform33,34, whereas the α4-isoform is specifically expressed in 
testis.35,36 The α2- and α3-isoforms possess an intermediate expression pattern evidenced by 
localization of the α2-isoform in skeletal37, heart38 and vascular smooth muscle39, adipocytes40, 
and brain41, whereas the α3-isoform is found mainly in neurons34,42, but also in ovaries43, 
heart44,45, and white blood cells.46 Interestingly, the α1-, α2-, and α3-isoforms share a high 
degree of similarity (≈ 90%), whereas the α4-isoform shows less homology to these isoforms 
(≈ 80%). 
As is the case with the α-subunit, multiple isoforms of the β-subunit exist. Usually, three 
isoforms are reported42,43, although recently a fourth isoform was described, however, with 
different functionality.47 The β-subunit is not only essential for trafficking and insertion into 
the membrane48,49, but also plays a pivotal role in enzyme activity.50,51 Similar to the α-isoforms, 
the β-isoforms are expressed tissue specifically. The most prominent one, the β1-isoform, is Figure 1 Albers-Post scheme of the reaction cycle of Na+,K+-ATPase.                                                                                        
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expressed throughout the body.34,52 The β2-isoform is found in nervous tissue and skeletal 
muscle53,54, whereas the β3-isoform has been identified in testes, lung, retina, and liver.55,56 
Together, the three different β-isoforms combined with four α-isoforms can produce up to 
12 different Na+,K+-ATPase enzymes (although α1β1 is by far the most prominent), further 
diversified upon association with different FXYD proteins, facilitating a vast array of enzyme 
combinations throughout the body. 
Na+,K+-ATPase related diseases
Since Na+,K+-ATPase is present in every cell of the human body, loss-of-function mutations 
in the corresponding genes are likely to have a significant impact on health. Only recently, 
somatic mutations in the α1-gene have been linked to disease, in this case to aldosterone-
producing adenomas.57 Loss-of-function mutations in the germ line of the α1-gene are 
probably not compatible with life, and this might explain why these have not been reported 
yet. For the α4-isoform, it is not unlikely that mutations could associate with decreased 
male fertility, although this has not yet been investigated. Different neurological diseases 
have been linked to mutations in the α2- and α3-isoforms. The α2-isoform is mutated in 
familial hemiplegic migraine type 2 (FHM2), a rare yet severe subtype of migraine with aura 
associated with hemiparesis.58,59 The α2-isoform present in astrocytes normally provides the 
necessary driving force for reuptake of glutamate from the synaptic cleft following synaptic 
activation, which is affected when Na+,K+-ATPase is dysfunctional as is the case in FHM2.60,61 
Rapid-onset dystonia parkinsonism (RDP), characterized by episodes of bradykinesia and 
postural instability with rapid onset62-64, as well as alternating hemiplegia of childhood (AHC), 
featuring recurrent hemiplegic episodes and distinct other neurological symptoms65-69, have 
been linked to mutations in the α3-gene. How these mutations result in their respective 
phenotypes remains to be established, but it is worth mentioning that only one overlapping 
mutation has been reported70,71, indicating relatively specific effects on protein function for 
both diseases. Also, not all patients suffering from RDP and AHC are shown to have mutations 
in the α3-isoform gene, implying a multifactorial pathogenesis.
Inhibition of Na+,K+-ATPase by natural compounds
As mentioned above, Na+,K+-ATPase plays a role not only as an ion-transporting enzyme, but 
also as a signal transducer. This started with the discovery of naturally occurring inhibitors 
of Na+,K+-ATPase. For many centuries, various civilizations have been using natural poison 
for hunting purposes. African civilizations have been using high doses of compounds derived 
from the shrubs or trees belonging to the Apocynaceae (dogbane) family, and South-American 
hunters obtain similar compounds from toad skin. In lower doses, extracts from the genus 
Digitalis (foxglove, containing compounds belonging to the same family of compounds) have 
been used for treatment of various diseases including congestive heart failure, exemplified 
by William Withering’s 1785 “Account of the Foxglove”.72 Four years before the discovery of 
Na+,K+-ATPase, it was described that these digitalis-like compounds (DLCs), also referred 
to as cardiac glycosides for their effect on heart muscle, inhibit active transport of Na+ and 
K+ in red blood cells.73 Today, it is known that DLCs bind to Na+,K+-ATPase specifically 
and stabilize the enzyme in its E2P state.74,75 By slowing down the reaction cycle, less Na+ 
is transported out of the cell, and less K+ is imported as well. In heart muscle tissue, this 
results in an increase in cellular Na+ concentration and a subsequent increase in activity of the 
Na+/Ca2+ exchanger, leading to an increased intracellular Ca2+ concentration and associated 
increases in contractility, explaining the positive effects of DLCs on heart failure symptoms. 
Inhibition of Na+,K+-ATPase by endogenous compounds
Intriguingly, at the time of the discovery of DLCs it was already postulated that the naturally 
occurring molecules were similar to endogenously produced compounds.76 At the same time, 
while searching for the so-called “third-factor” explaining responses of the body to acute or 
chronic expansion of blood volume, it was shown that an ultrafiltrate from volume-expanded 
dogs was able to inhibit Na+ transport in toad bladder.77 Further studies provided strong 
evidence for a role of DLCs in the pathogenesis of blood volume expansion78-86, even showing 
an antihypertensive effect of antibodies against digoxin in rats.87 This finding led to a search for 
endogenously produced DLCs in the human body, and not surprisingly this search revealed 
that several DLCs are produced in humans as well. These endogenously produced DLCs include 
ouabain88,89, dihydro-ouabain90, marinobufagenin91, telocinobufagenin92, 19-norbufalin93, and 
bufalin.94 However, by the time the first endogenous DLCs were discovered it was clear that 
these compounds were not involved in blood volume regulation as previously hypothesized. 
Since increasing numbers of DLCs were being discovered in the human body, a new role 
emerged for these compounds. The fact that they were found in relatively low amounts in 
blood (pico- to nanomolar range, unable to inhibit Na+,K+-ATPase activity significantly) led 
researchers to investigate whether endogenous DLCs could be involved in cellular signaling. 
In the last ten years, evidence for DLC-mediated cellular signaling has been stacking up.18,95,96 
Several signaling pathways have been described, each originating from binding of DLCs to 
Na+,K+-ATPase. The most studied signaling pathway involves activation of the Ras/Raf/MEK/
ERK1,2 cascade via transactivation of EGFR after DLC binding to Na+,K+-ATPase.97-99 One of 
the proteins in this cascade leading to ERK1,2 activation is Ras, which has also been linked 
to the production of reactive oxygen species in mitochondria of different cell types.18,100,101 
Another route of cellular signaling involves the activation of phospholipase C-γ, leading 
to subsequent formation of IP3, which can bind to its receptor IP3R that controls calcium 
release from the endoplasmic reticulum (ER).102,103 Also, a link was found to signaling via the 
PI3K/PDK/Akt pathway leading to apoptosis104, endocytosis of Na+,K+-ATPase 105, and 
hypertrophic growth in cardiac myocytes.106 An interesting question regarding all these 
signaling pathways involves the role of Src, a protein which is implicated in the Na+,K+-ATPase 
receptor complex. In general, it is thought that Src interacts directly with Na+,K+-ATPase and 
becomes autophosphorylated and subsequently initiates different signaling cascades upon 
stabilization of the enzyme in the E2P conformation upon DLC binding.18,95,96 
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Figure 2 Structure of Na+,K+-ATPase in the E1 conformation109, adapted from Laursen.117
Green represents the β-subunit, the (nonessential) γ-subunit is highlighted by its characteristic FXYD motif. The 
three ion-binding sites are depicted by yellow spheres, whereas the orange sphere indicates the phosphorylation 
site. A, P, and N represent the actuator, phosphorylation, and nucleotide-binding domains, respectively. The half-
channels leading to the ion-binding sites are depicted in gray.
Na+,K+-ATPase crystal structures
Ten years after the Nobel prize was awarded for the discovery of Na+,K+-ATPase, the first 
crystal structure of the enzyme was published.107 This publication set the stage for a new era in 
Na+,K+-ATPase research: it was now possible to study the enzyme in its real-life appearance. 
In the following years, more crystal structures were solved, greatly increasing our knowledge 
on the E2107,108 and E1 conformations109,110 (Fig. 2) of the reaction cycle, including the ouabain-
bound states.111-113 The crystal structures published show clear similarities to other crystallized 
P-type ATPases. 
The α-subunit consists of approximately 1,000 amino acids organized into ten transmembrane 
domains, with the N- and C-terminus located in the cytosol. The cytosolic domains of 
the first six transmembrane domains together form three cytosolic domains essential for 
ATPase activity and are found in all P-type ATPases: the N(ucleotide binding)-domain, the 
P(hosphorylation)-domain and the A(ctuator)-domain.114 These domains work together 
during the reaction cycle: ATP is bound by the N-domain initially in the presence of Mg2+, 
subsequently transferred towards the P-domain allowing for transfer of the γ-phosphoryl to 
a conserved aspartic acid residue located within the P-domain, aided by the A-domain that 
protects the phosphorylated aspartic acid and directs dephosphorylation at the appropriate 
step in the reaction cycle.115 Two of the ion-binding sites are located within the transmembrane 
domains 4-6, which are unwound at the center.107 These two sites (sites I and II) constitute the 
binding sites for the two K+ atoms, reaching these sites via the extracellular DLC binding pocket 
in the E2P conformation116, and leaving the sites in the E1 conformation after deocclusion 
via the cytoplasmic access channel formed by the characteristic kink present in the first 
transmembrane domain, together with the second and fourth transmembrane domains.117 
The third ion-binding site has been subject of debate for many years, but the recent crystal 
structures of the E1 conformation have provided more insight into its exact location.109,110 This 
site (site III, previously site IIIb) has now been located between transmembrane domains 5, 
7, and 8.110 The three Na+ atoms access their binding sites via the N-terminal access channel 
described above, although an alternative access channel leading to the third ion-binding site 
has been discovered recently, playing a role in transfer of a proton that substitutes for Na+ in 
the E2 conformation when sites I and II are occluded with K+.119,120 The sodium ions leave their 
binding sites in transition to the E2P conformation via the binding pocket of DLCs, the same 
channel that is used for entry of K+. This access channel is also the binding site for DLCs in the 
E2P conformation, a state associated with high affinity binding of DLCs, as opposed to the low 
affinity E2 state. A characteristic feature of high affinity DLC binding involves the presence of 
a magnesium ion in ion-binding site II, as was recently discovered.113 
The β-subunit is shown to consist of one transmembrane domain with a large extracellular 
domain, consisting of approximately 300 amino acids in total. It interacts with transmembrane 
domains 7 and 10 of the α-subunit, and the extracellular domain interacts with the extracellular 
loop between α-isoform transmembrane domains 7 and 8, implicated in correct assembly 
of the αβ-heteromer.117 The γ-subunit interacts almost exclusively with transmembrane 
I II
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domain 9, in close proximity to the third ion-binding site, possibly explaining its impact 
on the enzyme’s activity.110 Knowledge of the crystal structures has greatly advanced our 
understanding of Na+,K+-ATPase structure and the related functions.
Aim and outline of this thesis
The research described in this thesis was aimed at increasing our understanding of the role of 
Na+,K+-ATPase in health and disease, based on various biochemical studies. We have studied all 
four α-isoforms present in the human body, either related to physiology or disease. In Chapter 
2, we have looked at the role of the α1-isoform in signaling events based on DLC binding 
to Na+,K+-ATPase, using a biochemical assay representing the proposed Na+,K+-ATPase/Src 
signaling complex. Next, we studied differences in DLC affinity to the α1- and α2-isoforms 
of Na+,K+-ATPase, with a special focus on the role of the (hydrogenated) lactone ring present 
in all DLCs, as described in Chapter 3. The effects of FHM mutations on the α2-isoform were 
studied in Chapters 4 and 5, where we expressed and biochemically characterized mutants 
in order to understand how these mutations could lead to disease. Also, we have investigated 
the effect of mutations of the α3-isoform (Chapter 6) implicated in AHC, providing the first 
biochemical characterization of this unknown disease. Our final experimental studies are 
presented in Chapter 7, where we studied which amino acids are responsible for the difference 
in enzyme activity between the highly active α2- and inactive α4-isoforms. Finally, the results 
are put in a broader context and their significance is discussed in Chapter 8.
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Abstract
Digitalis-like compounds (DLCs), specific inhibitors of Na+,K+-ATPase, are implicated in 
cellular signaling. Exposure of cell cultures to ouabain, a well-known DLC, leads to up- or 
down regulation of various processes and involves activation of Src kinase. Since Na+,K+-
ATPase is the only known target for DLC binding an in vitro experimental setup using highly 
purified Na+,K+-ATPase from pig kidney and commercially available recombinant Src was 
used to investigate the mechanism of coupling between Na+,K+-ATPase and Src. Digoxin was 
used as a representative DLC for inhibition of Na+,K+-ATPase. The activation of Src kinase 
was measured as the degree of its autophosphorylation. It was observed that in addition to 
digoxin, Src activation was dependent on concentrations of other specific ligands of Na+,K+-
ATPase: Na+, K+, vanadate, ATP and ADP. The magnitude of the steady-state ATPase activity 
therefore seemed to affect Src activation. Further experiments with an ATP regenerating 
system showed that the ATP/ADP ratio determined the extent of Src activation. Thus, our 
model system which represents the proposed very proximal part of the Na+,K+-ATPase-
Src signaling cascade, shows that Src kinase activity is regulated by both ATP and ADP 
concentrations and provides no evidence for a direct interaction between Na+,K+-ATPase and 
Src.
Introduction
More than 50 years ago, Skou suggested that an adenosine triphosphatase present in crab 
nerve is involved in the extrusion of sodium.1 Following this hallmark publication, the 
enzyme involved in this process was shown to transport sodium and potassium ions across the 
cellular membrane, using ATP as a fuel source. Ouabain, a digitalis-like compound (DLC)2, 
had already been reported to inhibit active ion transport in red blood cells.3 By combining 
the findings mentioned above Post et al.4 showed that in human red blood cells, Na+ and 
K+ activated transport is fuelled by ATP and inhibited specifically by ouabain. This Na+,K+-
ATPase is now known to be one of the key players in cellular ion homeostasis, present in 
every human cell, and responsible for consumption of approximately 40% of the cellular ATP 
reserve.5 
It was suggested that in some cells, two pools of Na+,K+-ATPase are present on the cell surface: 
one dedicated to transport of Na+ and K+ over the cell membrane, whereas another pool 
resides in caveolae and is implicated in cellular signaling events.6 Several signaling pathways 
have been linked to this pool; the Src-EGFR-RAS-p42/44 MAPK cascade7, PLC-γ and IP3R 
microdomains involved in regulating Ca2+ homeostasis8, and an AMPK-mediated response 
to cellular ATP reduction.9 Recent experiments showed, however, that this strict division into 
ion-pumping and signaling pools of enzyme has to be abandoned. The detailed comparison 
of the properties of the caveolar and noncaveolar fractions of kidney Na+,K+-ATPase revealed 
no difference in either affinities to the specific ligands or molar activities of the enzymes.10 
In recent years the Src-EGFR-RAS-MAPK cascade has been studied extensively, resulting in 
a comprehensive knowledge of the consequences of activation of this cascade.7,11-13 The first 
player, Src, is a well known non-receptor tyrosine kinase, which can be activated by (auto)
phosphorylation of its kinase domain (SH1), more specifically tyrosine 418.14 Phosphorylation 
of another residue, tyrosine 529, results in a decrease in kinase activity. Src has been implicated 
in many different signaling pathways within the cell, and may be activated through different 
receptors including EGFR, PDGFR, ERBB2, and FGFR.14 In addition, Src has been implicated 
in the Na+,K+-ATPase mediated cellular response to endogenous ouabain.7,13,15 These studies 
suggest that Na+,K+-ATPase serves as an anchor for Src and restrains its kinase activity via two 
interactions. The first interaction is a constitutive binding (between the Na+,K+-ATPase CD2 
and Src SH2-SH3 domains). The second, between the Na+,K+-ATPase CD3 and Src kinase/
SH1 domain, is ouabain-dependent and exists only in the absence of the ligand. Ouabain 
binding to Na+,K+-ATPase revokes the latter domain interaction, releases the kinase domain 
and thereby causes activation of Src with downstream regulation of proteins within the Src 
signal transduction cascade.13 
In this paper, an in vitro model resembling the proximal part of the Src-mediated signaling 
cascade is characterized in detail. Recombinant Src protein and purified Na+,K+-ATPase are 
used to form a complex. We observed that also in our hands Na+,K+-ATPase activity prevented 
Src activation. More importantly, any inhibition of Na+,K+-ATPase resulted in activation of 
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Src: we found no difference between the inhibitors digoxin and vanadate. We found also that 
both the decrease in ATP level as well as the resulting increase in ADP level caused by Na+,K+-
ATPase activity were unfavorable for Src activation. Since the concentrations of both ATP and 
ADP, and therefore also the ratio between these two, are heavily dependent on Na+,K+-ATPase 
activity, the activating effects of digoxin and vanadate on Src are of functional (inhibition of 
ATP hydrolysis) but not structural (induction of a certain conformation) origin. This provides 
an alternative hypothesis concerning the role of Src in DLC-induced signaling. 
Materials and methods
Materials
Rabbit polyclonal antibody for detection of activated Src protein (pY418) was purchased 
from Invitrogen (44660G). Protein was detected using a goat anti-rabbit antibody labeled 
with HRP obtained from Abcam (AB6721). Protein presence was detected using a Thermo 
Scientific Supersignal® West Pico Chemiluminescent kit (34080). Pig kidney Na+,K+-ATPase 
was purified according to Klodos et al.16 to a specific activity of 1800 µmol Pi mg-1 h-1. 
Recombinant full length Src protein obtained from Upstate (14-117) can be phosphorylated 
both at residues 418 or 529, rendering the active or inactive protein, respectively.14 Creatine 
kinase and creatine phosphate were obtained from Roche, and ATP and ADP were purchased 
from Sigma-Aldrich. 
In vitro Src phosphorylation
In a final volume of 40 µL, recombinant Src protein (0.5 µL = 1.5 units) was incubated for 
30 min at 37 °C together with 610 ng of Na+,K+-ATPase in its buffer (250 mM sucrose, 20 
mM histidine, 0.9 mM EDTA(II) pH 7.0), in 1 × PBS supplemented with 5.0 mM MgCl2, 
or different when indicated. Phosphorylation was started by addition of 2.0 mM MgATP 
unless described otherwise. An ATP regenerating system, when added, consisted of 100 µg/
mL creatine kinase and 10 mM creatine phosphate present with MgATP. 
After 10 min of incubation at 37 °C, the phosphorylation reaction was stopped by incubation 
of samples with SDS sample buffer for 10 min at 65 °C, and subsequently the samples were 
loaded on a 10% SDS-PAGE gel. Proteins were blotted overnight onto a nitrocellulose 
membrane at 30 V. Then, the membranes were blocked for one hour at room temperature 
with TBS-T + 5% Elk. After washing with TBS-T, incubation of membranes with (1 : 1000) 
anti-pSrc-418 antibody was performed in TBS-T + 1% Elk + 1% BSA for two hours at room 
temperature. After three washes with TBS-T, incubation with (1 : 3000) goat-anti-rabbit 
HRP conjugate antibody was performed in TBS-T + 1% Elk + 1% BSA for one hour at room 
temperature. Afterwards, membranes were washed three times with TBS-T and subsequently 
three times with TBS before imaging was performed. Blots were imaged using a LAS-3000 
scanner and images were subsequently analyzed using Image-J 1.42 software.
ATPase activity studies
In order to determine the extent of ATP hydrolysis under different experimental conditions, 
we tested the conversion of radiolabeled ATP, [γ-32P]ATP (specific activity 100-500 mCi 
mmol-1), which upon hydrolysis is converted into ADP and [32P]Pi. The experimental 
procedure was identical to the in vitro Src phosphorylation experiments, except for the use of 
2.0 mM radiolabeled ATP. After 10 minutes at 37 °C, the reaction was stopped by addition of 
500 µL of 10% (w/v) charcoal in 6% (v/v) trichloroacetic acid. After centrifugation of samples, 
150 out of 540 µL final volume was subsequently analyzed for radioactivity using a liquid 
scintillation counter.17 
Results
Effect of Na+,K+-ATPase on Src activation 
The effect of Na+,K+-ATPase on Src phosphorylation levels was studied by incubating a fixed 
amount of Src with increasing amounts of Na+,K+-ATPase. The level of Src activation was 
visualized on a Western blot (Fig. 1). In the absence of MgATP pSrc-418 was absent as well. 
In contrast, when Src was incubated with MgATP phosphorylation of Src was clearly visible. 
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Figure 1 Na+,K+-ATPase inhibits Src phosphorylation.
Representative Western blot analysis of pSrc-418 formation after incubation of 1.5 units of Src with increasing 
amounts of Na+,K+-ATPase in PBS, supplemented with 5.0 mM MgCl2. After 30 min, MgATP (final concentration 
2.0 mM) or Milli-Q was added for 10 min to initiate Src phosphorylation. ATP hydrolysis for corresponding 
experimental conditions to Src activity levels visible on Western blot are shown in the graph below (mean ± SEM). 
These results were obtained from three experiments using identical methods as described above, except for the use 
of radiolabeled ATP.
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Addition of increasing amounts of Na+,K+-ATPase resulted in a gradual decrease of the 
pSrc-418 signal, indicating that Na+,K+-ATPase prevents Src activation. Presence of 610 
ng Na+,K+-ATPase significantly reduced pSrc-418 levels and therefore was used in further 
experiments, unless indicated otherwise. 
To relate the extent of Src activation to the amount of ATP hydrolysis, we repeated the 
experiment using radiolabeled ATP. The level of ATP hydrolysis under the different 
experimental conditions is shown underneath the corresponding lanes of the Western blot 
image. As expected, the amount of ATP hydrolysed increased with the amount of Na+,K+-
ATPase that was used to inhibit Src activation. In the presence of 610 ng of Na+,K+-ATPase, 
approximately 50% of the 2.0 mM ATP present was hydrolyzed during the time of experiment. 
Digoxin-induced Src activation
The effect of digoxin on Src phosphorylation was tested by incubation of Src with or without 
Na+,K+-ATPase in the absence or presence of digoxin. The results of seven independent 
experiments are shown in figure 2. The signal intensities of Src autophosphorylation are 
related to the control level reached in the presence of ATP alone (100%). Presence of Na+,K+-
ATPase decreased the average signal intensity to approximately 20%, while simultaneous 
presence of Na+,K+-ATPase and digoxin resulted in a signal intensity indistinguishable from 
that in the control situation.
Role of sodium and potassium in Src inhibition by Na+,K+-ATPase
The effect of varying KCl or NaCl on Na+,K+-ATPase mediated inhibition of Src 
phosphorylation is depicted in figure 3. The left part of each panel represents the significant 
inhibition of Src autophosphorylation by 610 ng of Na+,K+-ATPase in PBS buffer essentially 
as described above. This inhibition was reversed by the addition of 10 µM digoxin. The right 
part illustrates how pSrc-418 levels increase as a result of both decreasing NaCl (150, 50, 15, 
5 or 0 mM) (panel A) or KCl concentrations (4.50, 1.50, 0.50, 0.15 or 0 mM) (panel B). This 
modulation of Src activation by either Na+ or K+, ligands of Na+,K+-ATPase, was unexpected. 
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Figure 2 Digoxin stimulates Src phosphorylation.
Western blot showing the average signal intensities (± SEM) for seven independent experiments under different 
experimental conditions. 1.5 units of Src were incubated with or without the presence of (inactive) Na+,K+-ATPase 
in PBS for 30 min, subsequently MgATP (final concentration 2.0 mM) was added for 10 min and the amounts of 
pSrc-418 phosphorylation were quantified and related to pSrc-418 autophosphorylation signal intensities.
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Figure 3 Effects of Na+ and K+.
Representative Western blot analysis of pSrc-418 formation under different buffer conditions. 1.5 units of Src was 
incubated with or without 610 ng of purified Na+,K+-ATPase in PBS or 50 mM Tris-HCl (pH 7.4) with or without 
NaCl or KCl. Panel A shows the effect of decreasing NaCl concentrations (150, 50, 15, 5 and 0 mM) while maintaining 
a constant KCl concentration, whereas panel B shows the result of decreasing KCl concentrations (4.5, 1.5, 0.50, 0.15 
and 0 mM) under a constant NaCl concentration. After 30 min preincubation, the reaction was started by addition of 
2.0 mM MgATP, and was allowed to take place for 10 min. For both experiments (panel A and B), the average amount 
of ATP hydrolysis (mean ± SEM) of three experiments is depicted below the corresponding lane of the Western blot 
image. Again, the methods were essentially the same as described above, except for the use of radiolabeled ATP to 
measure its hydrolysis.
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The process of Src autophosphorylation itself caused only a limited decrease in the amount 
of ATP, whereas 55% of ATP was hydrolyzed when Na+,K+-ATPase was added. Digoxin 
prevented this drop in ATP concentration. When Src and Na+,K+-ATPase were incubated 
in a Tris buffer containing both NaCl and KCl, the ATP hydrolysis increased as expected 
(up to 75%), due to the absence of inhibitory inorganic phosphate. Lowering the NaCl or 
KCl concentrations, while maintaining ionic strength (using NMDG-Cl), decreased the 
level of ATPase consumption in a concentration dependent manner, in agreement with the 
finding described above showing that Na+,K+-ATPase activity is responsible for almost all 
ATP hydrolysis. 
Role of ATP concentrations in Src inhibition
Since both Na+ and K+ are essential for Na+,K+-ATPase induced Src inhibition, we tested if the 
state (active vs. inactive) of Na+,K+-ATPase was important for Src activation. For this purpose 
the classical P-type ATPase inhibitor vanadate was used. Figure 4 shows that vanadate did not 
interfere with Src activity (lanes 1 and 2) in the absence of Na+,K+-ATPase, but did stimulate 
Src phosphorylation in the presence of Na+,K+-ATPase. Similar levels of Src activation were 
obtained by addition of saturating vanadate concentrations or digoxin, i.e. the presence of 
either inhibitor of Na+,K+-ATPase restored Src activity.
The data presented in figure 4 reveal that the extent of ATP hydrolysis correlated inversely 
with the level of Src phosphorylation. This finding suggests that the two enzymes compete for 
the same substrate: ATP. Increasing amounts of vanadate clearly diminished ATP hydrolysis. 
Thus, Na+,K+-ATPase is responsible for most of the ATP conversion, whereas Src is 
responsible for <10% of ATP consumption in the absence of Na+,K+-ATPase (see also Fig. 3). 
Figure 5 confirms that the inactivation of Src in the presence of Na+,K+-ATPase under steady-
state conditions of enzyme activity is due to ATP depletion. In the presence of a low amount 
(305 ng) of Na+,K+-ATPase a significant level of Src activation is observed already at low ATP 
concentrations (0.50-1.0 mM). Increasing the amount of Na+,K+-ATPase present (610 and 1220 
ng) resulted in higher ATP demands in order to reach the same level of Src phosphorylation. 
In contrast, only 0.25 mM ATP was required for Src activation when Na+,K+-ATPase activity 
was inhibited by addition of 10 µM digoxin.
Effect of ADP in Src activation
ADP, the product of the Na+,K+-ATPase reaction cycle, is known to inhibit Src activity.18 
Therefore, the effect of increasing ADP concentrations on the level of Src phosphorylation 
was investigated (Fig. 6). Increasing ADP concentrations attenuated Src phosphorylation. 
The effect of an ATP regenerating system, which converts ADP and Pi into ATP, points in 
the same direction. The presence of Na+,K+-ATPase did not influence these results (Fig. 6B) 
since the regenerating system maintained high ATP concentrations essentially in the absence 
of ADP.
Discussion
Na+,K+-ATPase, in parallel to its transport function, serves as a receptor in the ouabain signaling 
pathway.11,15,19,20 It was shown that exposure of cell cultures to digitalis-like compounds leads 
to up- or down-regulation of various processes (e.g. gene activation, motility, cell-cell contact, 
cell proliferation, apoptosis).21 
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Figure 4 Effect of vanadate.
Representative Western blot analysis of the effect of vanadate on Na+,K+-ATPase induced Src inactivation. 1.5 units 
of Src was incubated with or without 610 ng of purified Na+,K+-ATPase in combination with vanadate or digoxin, 
as indicated. After 30 min preincubation, 2.0 mM MgATP was added for 10 min to allow Src activation. The mean 
(± SEM) amount of ATP hydrolysis of three independent experiments is shown below the corresponding lane of the 
Western blot image. The amount of ATP hydrolysis was determined under similar experimental conditions as used 
for determining Src activity, except for the use of radiolabeled ATP to measure its hydrolysis.
0 0.25 0.50 1.0 2.0 3.0 5.0
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Figure 5 Effect of amount of Na+,K+-ATPase.
Representative Western blot analysis of Src activation after stimulation of fixed amounts of Na+,K+-ATPase (with or 
without digoxin) with increasing concentrations of MgATP, as indicated. After 30 min of incubation of 1.5 units of 
Src with the indicated amounts of Na+,K+-ATPase in the presence or absence of digoxin, MgATP was added for 10 
min at the concentration as indicated.
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DLC binding to Na+,K+-ATPase always inhibits enzyme activity in in vitro experiments. On 
the cellular level, however, the interactions might result in diverse effects. Na+,K+-ATPase 
inhibition can cause changes in ionic composition of the cytoplasm or energetic state of 
the cell. In addition, conformational changes of Na+,K+-ATPase, acting as a receptor and 
physically interacting with its downstream partners, might result in activation of signaling 
pathways. Several studies support the involvement of the non-receptor tyrosine kinase Src 
in DLC induced changes in cellular homeostasis.11-13,19 The suggested mechanism implied 
a direct physical interaction between Src and Na+,K+-ATPase, where signal transduction is 
mediated via a specific conformational state of Na+,K+-ATPase. In short, Src is kept in an 
inactive state by a double intermolecular bond linking the enzyme to Na+,K+-ATPase.13 
Binding of ouabain induces the E2P-ouabain bound conformation of Na+,K+-ATPase, relieving 
one of the two interactions (Src kinase domain-CD3 domain of Na+,K+-ATPase) followed by 
autophosphorylation of tyrosine 418. The phosphorylated Src then initiates diverse signaling 
pathways, eventually leading to changes in cellular homeostasis.13,22 
The attempts to interpret the stimulating effect of ouabain on Src activity as an indication 
of direct interactions between Na+,K+-ATPase and Src were earlier complicated by the 
discrepancies around the vanadate effect on the Na+,K+-ATPase-Src complex. Vanadate was 
first used to show that hydrolytic Na+,K+-ATPase activity does not interfere with Src activity13, 
i.e. that vanadate, in contrast to ouabain, did not relieve the inhibitory effect of Na+,K+-
ATPase on Src activity. In a recent publication22, however, it was hypothesized that cellular 
signaling is activated via the E2 conformations of Na+,K+-ATPase, conformations which are 
stabilized by ouabain binding. Vanadate binding shifts the E1/E2 equilibrium towards the E2 
conformation of Na+,K+-ATPase, and therefore should be expected to stimulate Src activity 
as well. As the experimental conditions for the in vitro experiments in both publications13,22 
are identical, as well as the enzymes used are of similar purity and specific activity, it is hard 
to find an explanation for the lacking vanadate effect observed by Tian et al..13 Moreover, the 
Src-stimulating effect of vanadate was also observed in a study involving intact cells and the 
viral homolog of Src.23 Likewise, recent experiments showed endogenous Src activity in both 
caveolar and noncaveolar preparations of Na+,K+-ATPase and no additional Src activation by 
ouabain.10 
Our results confirm that active Na+,K+-ATPase causes inhibition of Src, while inhibited 
Na+,K+-ATPase was unable to inactivate Src kinase. This suggests another explanation for 
Src activation by binding of DLCs to Na+,K+-ATPase. Exposure of the presumed Na+,K+-
ATPase-Src complex to different experimental conditions revealed that the magnitude of 
Na+,K+-ATPase activity affects the extent of Src phosphorylation. The first observation that 
evoked this association was the fact that Src phosphorylation was enhanced in response 
to diminished NaCl and KCl concentrations, both resulting in attenuated Na+,K+-ATPase 
activity, as was confirmed by ATPase studies (Fig. 3). Then, the Na+,K+-ATPase inhibitor 
vanadate stimulated Src activation in the same way as digoxin did (Fig. 4). Estimation of 
the amount of ATP present after termination of the reaction showed that 50-60% of ATP 
was hydrolyzed by Na+,K+-ATPase in the absence of vanadate, and that the vanadate induced 
decrease in the amount of ATP hydrolysis correlated with the degree of vanadate-dependent 
stimulation of Src phosphorylation (Fig. 4). Direct proof that ATP depletion is one of the 
reasons for Na+,K+-ATPase induced Src inhibition was obtained in experiments where this 
effect was counteracted by increasing ATP concentrations (Fig. 5). Finally, we observed that 
ADP has an inhibitory effect on Src phosphorylation both in the presence and absence of 
Na+,K+-ATPase. Src activity significantly decreased when ATP concentrations were below 2.0 
mM or in the presence of more than 1.0 mM ADP (Fig. 6). In conclusion, the results of our 
in vitro experiments show that the hydrolytic activity of Na+,K+-ATPase determines ATP and 
ADP concentrations and thereby regulates Src activity.
In terms of whole cell physiology our results suggest that coupling between Src and Na+,K+-
ATPase is based on the control of ATP and ADP concentrations, their common ligands. 
Inhibition of Na+,K+-ATPase activity by DLCs will increase the ATP/ADP ratio, activating Src 
phosphorylation. The effect probably involves local changes in the concentrations of ligands, 
since DLC plasma concentrations are in the pico- and nanomolar range24, too low to affect 
the house-keeping function of Na+,K+-ATPase and bulk concentrations of ATP and ADP. 
However, not much is known about DLC concentrations in caveolae, the cellular membrane 
invaginations playing an important role in cell signaling. It is possible that the increase in 
local DLC concentrations in vivo results in significant Na+,K+-ATPase inhibition. 
The role of Na+,K+-ATPase as a regulator of Src kinase suggested above is in many aspects 
similar to its role in maintenance of cellular Ca2+ homeostasis. Inhibition of Na+,K+-ATPase 
+ + + + + + + +
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Figure 6 Effects of ADP and regenerating system.
Representative Western blot analysis of the effect of ADP together with ATP regeneration on Src activation. In short, 
1.5 units of Src was incubated with (panel B) or without (panel A) 610 ng of purified Na+,K+-ATPase in the presence 
of concentrations of MgADP as indicated, with or without the addition of 100 µg/mL creatine kinase in combination 
with 10 mM creatine phosphate, which together form ADP and Pi into ATP.
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activity affects the driving force for the Na+/Ca2+-exchanger, resulting in gain of [Ca2+]CYT 
and changes in contractility of heart muscle as well as in cellular signaling.25 In this study, 
we report evidence that changes in the energetic status of the cell due to varying Na+,K+-
ATPase activity may be involved in cellular signaling. This hypothesis is supported by the 
fact that in some tissues, Na+,K+-ATPase is responsible for almost 50% of ATP conversion. 
Thus, Soltoff and Hedden9 showed that ouabain, by inhibition of Na+,K+-ATPase, increases 
the phosphorylation of AMPK, which subsequently results in phosphorylation of ERK1/2, 
converging on the same signaling pathway that has been reported for Src mediated signaling.
In conclusion, this study suggests another mode of DLC induced signaling than the proposed 
direct interaction between Na+,K+-ATPase and Src. We show that Na+,K+-ATPase activity 
regulates Src phosphorylation indirectly, via modulation of ATP and ADP concentrations. 
Src activation takes place when the ATP concentration is high and ADP concentration is 
low. The fact that vanadate, acting as an ATPase inhibitor, is also able to activate Src via this 
mechanism implies that other ligands are capable of stimulating Src activation by interfering 
with Na+,K+-ATPase activity. 
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Abstract
Digitalis-like compounds (DLCs) comprise a diverse group of molecules characterized by a 
cis-trans-cis ring-fused steroid core linked to a lactone. They have been used in the treatment 
of different medical problems including heart failure, where their inotropic effect on heart 
muscle is attributed to potent Na+,K+-ATPase inhibition. Their application as drugs, however, 
has declined in recent years due to their small safety margin. Since human Na+,K+-ATPase 
is represented by four different isoforms expressed in a tissue-specific manner, one of the 
possibilities to improve the therapeutic index of DLCs is to exploit and amend their isoform 
selectivity. Here, we aimed to reveal the determinants of selectivity of the ubiquitously 
expressed α1-isoform and the more restricted α2-isoform toward several well-known DLCs 
and their hydrogenated forms. Using baculovirus to express various mutants of the α2-
isoform, we were able to link residues Met119 and Ser124 to differences in affinity between 
the α1- and α2-isoforms to ouabain, dihydro-ouabain, digoxin, and dihydro-digoxin. We 
speculate that the interactions between these amino acids and DLCs affect the initial binding 
of these DLCs. Also, we observed isoform selectivity for DLCs containing no sugar groups.
Introduction
In the 18th century, William Withering reported the use of foxglove extracts for various 
medical conditions, specifically concerning edema, known then as dropsy.1 Modern science 
has shown that the most important component of foxglove extract must have been digitoxin, 
a well-known digitalis-like compound (DLC). More recently, endogenously produced DLCs 
were discovered in human plasma, implicating these compounds in various physiological 
processes.2 However, the most prominent property of DLCs is their ability to bind to Na+,K+-
ATPase with high specificity, inhibiting the transport activity of this enzyme.
Na+,K+-ATPase is located in the plasma membrane of almost all animal cells. By recurrent 
transitions between two different conformational states (E1 and E2), Na+ and K+ are transported 
over the plasma membrane using the energy obtained from hydrolysis of ATP. It is estimated 
that this transport process consumes approximately 25-50% of cellular energy, highlighting 
the enzyme’s important role.3 In return, the enzyme maintains the electrochemical gradients 
for Na+ and K+ across the cell membrane, thus providing the driving force for various 
secondary active transporters. Ion transport as well as ATP hydrolysis are performed by the 
α-subunit of Na+,K+-ATPase that is present in four tissue-specifically expressed isoforms. 
Additionally, a β-subunit is necessary for proper insertion of the heteromeric αβ-complex 
into the membrane.
Numerous studies have been dedicated to understand exactly how DLCs bind to Na+,K+-
ATPase. Among the first studies was the work by Lingrel and co-workers, who showed that 
residues Gln118 and Asn129 (human α1-isoform coding) are associated with DLC sensitivity 
based on mutagenesis studies with the corresponding residues from rat isoforms of Na+,K+-
ATPase.4 In the meantime, mutagenesis studies complemented by crystal structures of DLC-
bound Na+,K+-ATPase have provided convincing evidence that the first six transmembrane 
segments of the Na+,K+-ATPase α-subunit constitute a conserved DLC binding pocket.5-11 
Following the localization of the binding site of DLCs, Katz and co-workers subsequently 
investigated the isoform selectivity of DLCs by comparing the binding affinities of various 
DLCs to the α1-, α2-, and α3-isoforms. Using recombinant Na+,K+-ATPase, they concluded 
that isoform selectivity of DLCs is determined by the DLC’s sugar moieties.12 This affirmed 
the conclusions from other studies, which had highlighted the role of the sugar moiety in the 
dissociation rate of ouabain binding.13, 14 
In this study, we set out to study the differences in binding affinities of 13 well-known DLCs 
(Fig. 1) for the human α1- and α2-isoforms of Na+,K+-ATPase, which were expressed in Sf9 
insect cells using baculovirus. Focusing on ouabain, dihydro-ouabain, digoxin, and dihydro-
digoxin, we aimed to reveal specific amino acids responsible for the observed differences and 
could successfully identify two crucial residues present in the first extracellular loop of Na+,K+-
ATPase. Interestingly, a previous study identified an important role for these amino acids in 
the ouabain binding process.15 Here, we provide evidence that these residues are responsible 
for the isoform selectivity of dihydro-DLCs as well. Finally, using the crystal structures of 
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multiple conformational states of Na+,K+-ATPase, including the high-affinity ouabain-bound 
state, we hypothesize how these mutations might affect the affinity of (dihydro-)DLCs.
Materials and Methods
The Gateway system
Mutant and wild type Na+,K+-ATPase were produced using the Gateway cloning system (Life 
Technologies, Breda, The Netherlands). Mutant cDNA was generated by combining two 
α2-isoform based PCR products (A and B) obtained by using either a 5’- or 3’-primer in 
combination with a primer containing the desired mutation(s), resulting in two fragments 
containing complementary mutated flanks. These two fragments were combined in a 
subsequent PCR (C), where only the 5’- and 3’-primers were used to obtain full length cDNA 
containing the desired mutation(s). Subsequently, the cDNA was cloned into an empty entry 
vector containing a kanamycin resistance cassette using BP Clonase II enzyme according to 
the manufacturer’s instructions (Life Technologies, Breda, The Netherlands). Amplification 
of clones was performed by miniprep of colonies visible on a kanamycin selection plate. After 
successful sequence analysis of entry clones, expression clones containing the (mutated) 
α-subunit were obtained by combining an expression clone containing the β1-subunit with 
the entry clone by making use of LR Clonase II enzyme (Life Technologies, Breda, The 
Netherlands), resulting in a plasmid containing both the (mutated) α-subunit and β1-subunit. 
Mock transfection using yellow fluorescent protein (YFP) instead of the α-subunit resulted in 
the generation of a negative control (expressing YFPβ1). 
Generation of recombinant viruses
Expression clones generated using the Gateway system were transformed into competent 
DH10Bac Escherichia coli cells (Life Technologies, Breda, The Netherlands) harboring the 
baculovirus genome (bacmid) and a transposition helper plasmid. Upon transposition 
between the Tn7 sites present in the bacmid and expression clone, recombinant bacmids 
were selected and isolated.16 Subsequent transfection of bacmids into Sf9 insect cells using 
Cellfectin (Life Technologies, Breda, The Netherlands) and incubation for 6 days at 27 °C 
resulted in generation of virus coding for the desired wild type and mutant Na+,K+-ATPase 
isoforms. Using the supernatant of these cells, a fresh batch of Sf9 cells was infected at a 
multiplicity of infection of 0.1. After another 6 days of infection, the supernatant of these cells 
was collected and used for further procedures.
Membrane preparation
Sf9 cells grown at 27 °C in T175 flasks and later in 1000 mL shaking flasks in Xpress medium 
(Sigma, Bornem, Belgium) were infected with recombinant virus at a density of 1.5 ×106 cells 
mL-1 in the presence of 1% (v/v) ethanol, as described before.17 After 3 days of infection, cells 
were harvested by centrifugation at 5,000 ×g for 5 min, and the pellet was resuspended in ice-
cold 250 mM sucrose, 2.0 mM EDTA, and 20 mM HEPES/Tris pH 7.0 buffer. Cell lysis and 
membrane fraction purification were performed by sonication at 80 W for 30 s, followed by 
centrifugation at 10,000 ×g and 4 °C for 30 min and centrifugation of the resulting supernatant 
at 100,000 ×g and 4 °C for 60 min. The pelleted membrane fraction was resuspended in the 
above-mentioned resuspension buffer, homogenized, and stored at -20 °C.
Ouabain competition assay
Approximately 150-200 µg of protein was incubated in 20 mM histidine, 5.0 mM MgCl2, 5.0 
mM H3PO4, 25 nM of radiolabeled ouabain and increasing concentration of nonradiolabeled 
DLCs at room temperature for 2 h. Then, samples were transferred to ice and filtered through 
ME27 cellulose filters (GE Healthcare, Little Chalfont, UK) using ice-cold distilled water, 
retaining only the Na+,K+-ATPase-bound DLCs. The amount of radioactivity on the filters was 
determined by addition of 4 mL of OptiFluor (Canberra Packard, Tilburg, The Netherlands) 
and subsequent liquid scintillation counting.
DLC 1 3 5 11 12 14 19 Other
Ouabain OH L-rhamnose OH OH OH OH
Dihydro-ouabain OH L-rhamnose OH OH OH OH 20-22 hydrogenated
Ouabagenin OH OH OH OH OH OH
Digoxin tri-D-digitoxose OH OH
Dihydro-digoxin tri-D-digitoxose OH OH 20-22 hydrogenated
Digoxigenin OH OH OH
Digitoxin tri-D-digitoxose OH
Digitoxigenin OH OH
Strophantidol OH OH OH OH
Strophantidin OH OH OH O
Convallatoxin L-rhamnose OH OH O
Peruvoside 3-O-methyl glucose OH O
Proscillaridin A L-rhamnose 4-5 double bond OH 6-membered lactone ring
3 5
sugar moiety
lactone ring
steroid core
11
12
14
20 22
19
Figure 1 Characteristics of the DLC structure. 
Each DLC consists of a steroid core, which is linked to a 5- or 6-membered lactone ring. At different positions of the 
steroid core, other chemical groups are attached, as indicated for the DLCs tested in this study. Hydrogenation of the 
lactone results in removal of the double bond between 20 and 22. Crystallization studies have shown convincingly 
that DLCs are docked in their binding pocket with the lactone facing inward, suggesting that this part of the DLC is 
the first to interact with Na+,K+-ATPase.
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In house hydrogenation of digoxin to obtain dihydro-digoxin
Digoxin (50 mg) and PtO2 (10 mg, 6 mol%) were dissolved in 15 mL of ethanol in a Schlenck 
tube. All air was then removed by vacuum, and the solution cooled to 0 ˚C. H2 gas was 
bubbled through the solution, resulting in a color change from brown to black. The solution 
was allowed to warm to room temperature, and H2 bubbling was continued for 16 h. After 
hydrogenation was completed (which was checked by LCQ) the catalyst was removed by 
filtration through a 0.45 µm ultra filter. The solvent was removed by rotary evaporation. The 
product was obtained by recrystallization from EtOH/Et2O in 46% yield as a white solid.
Data analysis
All data was analyzed using GraphPad Prism 5.02 software. Repeated measures ANOVAs were 
performed to check for differences in IC50 values among DLCs (α = 0.05). For determination 
of IC50 values, we performed nonlinear curve fitting using variable slope on averaged (n ≥ 3), 
log-transformed data with a bottom restraint ≥ 0.
Molecular docking
The molecular docking calculations were based on the crystal structure of the Na+,K+-
ATPase E2P-ouabain complex (PDB code 4HYT) and performed in Schrödinger Suite 
2011 (Schrödinger LLC, 2011).8 The receptor was prepared in Protein Preparation Wizard 
according to standard procedures, including addition of hydrogens and assignment of bond 
orders and protonation states. Energy minimization of the receptor was performed with 
the OPLS 2005 force field.18 Ouabain and the two dihydro-ouabain isoforms were build in 
Maestro and minimized with MacroModel v9.5, using the MMFF94s force field with 10,000 
steps of conjugate gradient iterations, or until convergence was reached, according to default 
settings.19 For the molecular docking calculations, the induced-fit docking (IFD) protocol was 
used, allowing side chains and, to some extent, the backbone of the binding site to be flexible 
during the docking calculations.20 The IFD calculations were performed with extra precision 
Glide and the center of the enclosing box was defined by the centroid of the co-crystallized 
ouabain molecule.21 
Results
Screen for differences in DLC binding affinities between α1 and α2 wild type enzymes
We expressed the α1β1- and α2β1-isoforms of Na+,K+-ATPase together with a negative control 
(expressing YFPβ1) using the baculovirus expression system. Purified membrane fractions of 
these enzymes were used to screen for differences in IC50 values between both isoforms for 
13 DLCs. The IC50 values for all the DLCs tested varied from the nano- to micromolar range 
(Table 1). DLCs could be subdivided into three categories: those with (i) similar affinities for 
both isoforms (e.g. ouabain), (ii) lower affinity for the α2-isoform (e.g. dihydro-ouabain), and 
(iii) higher affinity for the α2-isoform (e.g. digoxin). Next, we focused on four DLCs: ouabain, 
dihydro-ouabain, digoxin, and dihydro-digoxin, since hydrogenation of the lactone ring in 
both cases worsened their affinities to Na+,K+-ATPase, which was especially present for the 
α2-isoform. 
Mutagenesis studies focused on the DLC binding pocket
On the basis of differences in the amino acid sequence of the α1- and α2-isoforms in the 
vicinity of the DLC binding pocket, six α2-isoform mutants were designed with one or more 
α2-isoform residues substituted by their α1-isoform counterparts. These mutants included 
α2-G114S-M119T-D121E-S124Q-β1 (mutant A), α2-V306I-G312E-S314T-β1 (mutant B), 
α2-I883L-L885V-T891W-M892I-β1 (mutant C), α2-A135S-β1 (mutant D), α2-L789I-β1 
(mutant E), and α2-Q291H-L292I-β1 (mutant F). As expected, the affinities for ouabain 
were similar to those of the wild type α1- and α2-isoforms for all six mutants (Fig. 2A). 
The binding properties of mutants B-F were comparable to those of the α2-isoform of the 
wild type enzyme for dihydro-ouabain, digoxin, and dihydro-digoxin (Fig. 2B-D), whereas 
mutant A showed the highest degree of similarity to the α1-isoform for these three DLCs, 
a trend that was even statistically significant for dihydro-ouabain. Together, these results 
show that mutant A possesses one or more mutations responsible for the isoform-specific 
differences in affinity toward dihydro-ouabain and, to a lesser extent, also for digoxin and 
Ratio
α1 α2 α2/α1
Ouabain 0.06 ± 0.00 0.07 ± 0.00 1.4 ± 0.1
Dihydro-ouabain 0.08 ± 0.02 0.94 ± 0.16    13 ± 2.2
Ouabagenin 0.20 ± 0.07 0.70 ± 0.08 3.1 ± 0.5
Digoxin 0.63 ± 0.08 0.33 ± 0.03 0.55 ± 0.1  
Dihydro-digoxin 1.73 ± 0.17 2.19 ± 0.14 1.3 ± 0.1
Digoxigenin 0.04 ± 0.02 0.28 ± 0.09   8.8 ± 1.6
Digitoxin 0.50 ± 0.08 0.24 ± 0.04 0.48 ± 0.0  
Digitoxigenin 0.03 ± 0.01 0.19 ± 0.07   6.3 ± 1.6
Strophantidol 0.10 ± 0.02 0.40 ± 0.07 4.0 ± 0.2
Strophantidin 0.05 ± 0.02 0.25 ± 0.04   5.7 ± 0.9
Convallatoxin 0.04 ± 0.01 0.04 ± 0.00 1.1 ± 0.3
Peruvoside 0.14 ± 0.03 0.14 ± 0.05 1.0 ± 0.3
Proscillaridin A 0.11 ± 0.02 0.19 ± 0.05 1.8 ± 0.2
DLC  IC50 ± SEM (µM) 
*
*
*
*
*
*
*
*
*
*
Increasing concentrations of DLCs were incubated with 25 nM radiolabeled ouabain for 2 h before washing 
outcompeted radiolabeled ouabain away. The amount of radioactivity retained on the filters for different 
concentrations of competing DLC was used for nonlinear curve fitting to determine IC50 values. IC50 values represent 
the average (± SEM) of at least three independent experiments. Ratio’s were determined from each experiment 
individually and subsequently averaged, allowing for small differences compared with hand-calculated ratio’s. 
* = P < 0.05 versus 1.0.
Table 1 Screen for DLC binding affinities to α1- and α2-isoforms of Na+,K+-ATPase.
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dihydro-digoxin. The mutated residues were all located in the loop between transmembrane 
helices αM1 and αM2, highlighting this area for further studies.
Single mutations G114S, M119T, D121E and S124Q
The individual effects of the amino acid residues substituted in mutant A were tested by 
investigating four single mutants: α2-G114S-β1, α2-M119T-β1, α2-D121E-β1, and α2-
S124Q-β1. None of the single mutations significantly changed the affinity for ouabain (Fig. 
3A) compared to that of the α2-isoform of the wild type enzyme. However, experiments with 
the other three DLCs revealed that mutations M119T and S124Q (dihydro-ouabain), M119T 
(digoxin), and S124Q (dihydro-digoxin) significantly changed the affinities compared with 
those for the α2-isoform of the wild type enzyme, although the effect was not as strong as that 
observed with mutant A. Thus, Met119 and Ser124 seemed to affect DLC binding for dihydro-
ouabain and dihydro-digoxin as well as digoxin itself. 
Met119 and Ser124 mutations
On the basis of the change in affinity from α2-isoform to α1-isoform levels upon replacing 
either Met119 or Ser124 with their corresponding α1-isoform residues, the final round of 
mutagenesis studies was aimed at investigating the role of the amino acid side chains. To 
this end, we generated the following mutants: α2-M119A-β1, α2-M119D-β1, α2-M119F-β1, 
α2-M119K-β1, α2-M119L-β1, α2-M119N-β1, α2-M119S-β1, α2-S124A-β1, α2-S124E-β1, α2-
S124K-β1, α2-S124L-β1, α2-S124N-β1, and α2-S124T-β1. Again, the apparent affinities of 
ouabain, dihydro-ouabain, digoxin, and dihydro-digoxin were tested. 
As expected, none of the Met119 mutations improved the affinity for ouabain (Fig. 4A). In 
contrast, replacing methionine with aspartic acid (M119D) decreased the ouabain affinity 
for this mutant significantly. For dihydro-ouabain (Fig. 4B), only introduction of serine 
(M119S) significantly increased the affinity, reflecting its structural resemblance to threonine, 
which is present in the α1-isoform. Digoxin (Fig. 4C) showed a decreased affinity for several 
mutations: M119D, M119K, M119N, and M119S. A significant decrease in dihydro-digoxin 
affinity was induced by the M119D mutation (Fig. 4D). 
Finally, the apparent DLC affinities upon substitution of Ser124 were tested. As expected, no 
significant changes in affinity for ouabain (Fig. 5A) and digoxin (Fig. 5C) were observed, 
except for a minor decrease in affinity of S124K for ouabain. However, for dihydro-ouabain 
(Fig. 5B), replacing Ser124 with alanine (S124A), glutamic acid (S124E), lysine (S124K), or 
leucine (S124L) significantly increased the affinity, whereas replacing serine with threonine 
(S124T) did not. Finally, alanine (S124A), lysine (S124K) and leucine (S124L) showed 
nonsignificant increases in affinity for dihydro-digoxin (Fig. 5D).
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Figure 2 Overview of competition assays and relative IC50 values for mutants A–F. 
In essence, radiolabeled ouabain was incubated for 2 h with increasing concentrations of ouabain (A), dihydro-
ouabain (B), digoxin (C), and dihydro-digoxin (D). The amount of radioactivity retained on the filters following 
filtration, reflecting the amount of enzyme-bound ouabain, was determined using liquid scintillation analysis. Values 
represent mean ± SEM of at least three experiments performed on at least two independently produced protein 
batches. * P < 0.05 versus α2 wild type, ** P < 0.01 versus α2 wild type, *** P < 0.001 versus α2 wild type.
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Figure 3 Overview of competition assays and relative IC50 values for single mutants G114S, 
M119T, D121E and S124Q. 
Radiolabeled ouabain was incubated for 2 h with increasing concentrations of ouabain (A), dihydro-ouabain (B), 
digoxin (C), and dihydro-digoxin (D). The amount of radioactivity retained on the filters following filtration, 
reflecting the amount of enzyme-bound ouabain, was determined using liquid scintillation analysis. Values represent 
mean ± SEM of three experiments performed on independently produced protein batches. * P < 0.05 versus α2 wild 
type, ** P < 0.01 versus α2 wild type, *** P < 0.001 versus α2 wild type.
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Figure 4 Overview of competition assays and relative IC50 values for various mutations of 
Met119. 
Radiolabeled ouabain was incubated for 2 h with increasing concentrations of ouabain (A), dihydro-ouabain (B), 
digoxin (C), and dihydro-digoxin (D). The amount of radioactivity retained on the filters following filtration, 
reflecting the amount of enzyme-bound ouabain, was determined using liquid scintillation analysis. Values represent 
mean ± SEM of three experiments performed on independently produced protein batches. * P < 0.05 versus α2 wild 
type, ** P < 0.01 versus α2 wild type, *** P < 0.001 versus α2 wild type.
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Computational prediction of the binding mode of dihydro-ouabain 
As described above, ouabain and dihydro-ouabain showed a significant difference in isoform 
selectivity. This is in spite of the fact that (i) the structural differences between the two DLCs 
are confined to the degree of saturation of the lactone ring and (ii) the lactone moiety of 
ouabain is located more than 15 Å away from Met119 and Ser124 in the crystal structure of 
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Figure 5 Overview of competition assays and relative IC50 values for various mutations of 
Ser124. 
Radiolabeled ouabain was incubated for 2 h with increasing concentrations of ouabain (A), dihydro-ouabain (B), 
digoxin (C), and dihydro-digoxin (D). The amount of radioactivity retained on the filters following filtration, 
reflecting the amount of enzyme-bound ouabain, was determined using liquid scintillation analysis. Values represent 
mean ± SEM of three experiments performed on independently produced protein batches. * P < 0.05 versus α2 wild 
type, ** P < 0.01 versus α2 wild type, *** P < 0.001 versus α2 wild type.
T119
T119
Q124 T119
Q124
R883
Q124
Figure 6 DLC binding site, showing the computational predicted binding mode of both 
dihydro-ouabain isoforms (depicted in blue and magenta sticks, respectively). 
The crystal structure of the high affinity E2P-ouabain complex (7) is depicted by a green cartoon, with the co-
crystallized ouabain molecule represented by green sticks. To demonstrate the large conformational rearrangements 
that αM1 and αM2 are undergoing during the catalytic cycle, crystal structures of the [K2]E2·Pi and [Na3]E1P-
ADP conformational states9, 29, 30 have been superimposed onto the E2P-ouabain complex. Residues identified via 
mutagenesis are shown in sticks, and are distant from the DLCs upon high affinity binding. Arg883 is predicted to 
form a hydrogen-bond with Gln124 in the [K2]E2·Pi state. 
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the high affinity E2P-ouabain complex.8 To gain insight into whether hydrogenation of the 
lactone prevents dihydro-ouabain from obtaining a binding mode similar to that previously 
described for ouabain, an induced-fit docking approach was applied to computationally 
predict the binding mode of dihydro-ouabain (Fig.6).8, 11, 20 Initial redocking of ouabain 
into the binding site of the high affinity E2P-ouabain complex confirmed that the docking 
approach applied was able to predict the binding mode of ouabain as being similar to the one 
obtained in the crystal structure.8 Moreover, the molecular docking calculations predicted 
the binding mode of dihydro-ouabain to be similar to that of ouabain, i.e. the steroid core 
was superimposable with that of ouabain, with the concave apolar α-surface interacting with 
bulky hydrophobic side chains of αM4-αM6 and the hydrophilic groups on the β-surface 
taking part in an extensive hydrogen bonding network with polar side chains of the αM1-
αM2 loop (flexible in the IFD calculations); the lactone is located in a hydrophobic funnel 
formed by αM4-αM6, with a putative Mg2+ bound in cation binding site II, whereas the sugar 
moiety is located in a wide hydrophilic cavity exposed to the extracellular environment. No 
spatial clashes were found between the lactone of dihydro-ouabain and the receptor. However, 
the docking scores obtained for ouabain were slightly better than those obtained for the two 
dihydro-ouabain isoforms.
Discussion
This study was designed to elucidate the mechanism of Na+,K+-ATPase isoform-specific 
selectivity toward DLCs. We have determined the apparent affinities of the wild type α1- and 
α2-isoforms and various mutants of the α2-isoform for a selection of DLCs and conclude 
that residues Met119 and Ser124, present in the first extracellular loop of Na+,K+-ATPase, are 
responsible for the low affinity of hydrogenated DLCs for the α2-isoform. 
The screen of Na+,K+-ATPase isoform affinities toward different DLCs (Table 1) revealed three 
groups of ligands: (i) ouabain, dihydro-digoxin, convallatoxin, peruvoside and proscillaridin 
A were bound with similar affinities by both isoforms (0.5 < ratio α2/α1 < 2.0) , whereas (ii) 
digoxin and digitoxin showed a preference for the α2-isoform (0.5 ≥ ratio α2/α1), and (iii) 
dihydro-ouabain, ouabagenin, digoxigenin, digitoxigenin, strophanthidol, and strophanthidin 
bound to the α1-isoform preferably (ratio α2/α1 > 2). On the basis of the absence or presence 
of differences in affinities of closely related DLCs, it is possible to rule out the effect of various 
hydroxyl groups: for example, the hydroxyl group at position 12 did not affect the affinity 
for either isoform (digoxin and digoxigenin versus digitoxin and digitoxigenin, respectively). 
Also, substitution of the hydroxyl group at position 19 by a ketone did not affect the affinities 
as well (strophanthidol versus strophanthidin). In addition, the hydroxyl groups at positions 
1 and 11 did not influence DLC affinity (ouabagenin versus strophanthidol). With respect 
to the α1-isoform, the lowest affinities were detected for digoxin, dihydro-digoxin, and 
digitoxin, implying that the presence of three sugar groups decreases the affinity for this 
isoform. Although different from recent studies, these findings are in line with the earlier 
work of Forbush and co-workers, who showed that digitoxigenin bound to the α1-isoform 
of Na+,K+-ATPase to a lower extent than did digitoxin and ouabain.12, 22-24 In contrast to the 
α1-isoform, the presence of three sugar moieties (digoxigenin and digitoxigenin versus 
digoxin and digitoxin) did not result in a decreased affinity for the α2-isoform. In fact, the 
α2-isoform possessed the lowest affinities for DLCs containing a hydrogenated lactone moiety 
(dihydro-ouabain and dihydro-digoxin). Lastly, the isoform selectivity was decreased in the 
presence of sugar moieties: ouabain, digoxin, digitoxin, and convallatoxin possessed 3-14 
times lower isoform selectivity than their aglycones ouabagenin, digoxigenin, digitoxigenin, 
and strophanthidin, respectively. The most recent study concerning isoform preference of 
DLCs was performed with human Na+,K+-ATPase isoforms expressed in Pichia pastoris, and 
the authors concluded that this selectivity was mediated via the sugar group because aglycones 
showed no preference for either of the isoforms.12 Although the results obtained in this 
study confirm the preference of digoxin and digitoxin for the α2-isoform, we also observed 
significant selectivity for several aglycones, including digoxigenin and digitoxigenin. This 
inconsistency might be explained by different experimental conditions used in the present 
study, including the baculovirus expression system, the degree of β-subunit glycosylation, 
the enzymatic conformations induced in the competition experiments (vanadate-induced 
versus Mg2+ and Pi-induced phosphorylated enzyme), and the time and temperature used for 
incubation of membranes.25 
On the basis of the isoform selectivity screen described above, four DLCs were selected 
for further studies: ouabain, digoxin, and their hydrogenated forms, dihydro-ouabain 
and dihydro-digoxin. Hydrogenation of the lactone ring in these ligands has different 
consequences. Whereas the α1-isoform bound dihydro-ouabain and ouabain with comparable 
affinities, the dihydro-digoxin affinity was 2.5-fold lower compared with that of digoxin. The 
affinities observed for the α2-isoform were decreased significantly by hydrogenation in both 
cases. From a series of mutagenesis studies (Figs. 2 and 3), two residues located in the first 
extracellular loop of the α2-isoform were shown to influence isoform selectivity of dihydro-
ouabain, dihydro-digoxin, and digoxin: it appears that Met119 is responsible for the decreased 
affinity for dihydro-ouabain as well as the higher digoxin affinity observed for the α2-isoform 
compared with that for the α1-isoform, whereas Ser124 is responsible for the decreased affinity 
of the α2-isoform for dihydro-ouabain and dihydro-digoxin. 
Met119 and Ser124 are located in the first extracellular loop, which is highly important for DLC 
binding as evidenced by mutagenesis studies as well as crystal structures, although the recent 
high-affinity ouabain bound crystal structure predicts that neither residue interacts directly 
with ouabain.6, 8, 26-28 Instead, the residue corresponding to Met119 (Thr119) is located at the 
entry site of the DLC binding pocket, lining the sugar binding cavity, whereas the amino 
acid corresponding to Ser124 (Gln124) faces the lipid bilayer. However, careful analysis of 
various available crystal structures representing the [Na3]E1P-ADP, E2P-ouabain, and [K2]
E2·Pi states shows that the αM1-αM2 and αM3-αM4 extracellular segments undergo large 
conformational changes during the Na+,K+-ATPase reaction cycle (Fig. 6).8, 9, 29, 30 Located 
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within the first extracellular loop, Met119 and Ser124 are involved in various hydrogen bonding 
networks involving the extracellular loops αM7-αM8 and αM9-αM10. Also, both residues 
are located close to Glu122, which forms a hydrogen bond to the steroid core of ouabain in the 
high affinity structure. 
Met119 and Ser124 have been shown to play an important role in the ouabain binding kinetics of 
the α1- and α2-isoforms in Xenopus laevis.15 The authors showed that the ouabain association 
and dissociation rates of the α2-isoform were decreased in parallel upon substitution of 
Met119 and Ser124 with their α1-isoform corresponding amino acids. On the basis of the 
crystal structure, Met119 and Ser124 are not predicted to interact directly with ouabain in 
the high affinity E2P-ouabain complex, yet docking of dihydro-ouabain and ouabain in 
the DLC binding site is highly similar as evidenced by molecular docking studies (Fig. 6). 
Therefore, we hypothesize that the mutations described here mainly affect the ligand-receptor 
interaction during the association state of ligand binding. Still, it is worth mentioning that 
electrophysiological studies have provided evidence that dihydro-ouabain has an increased 
dissociation rate when compared with that of ouabain, implicating the residues identified 
here in the dissociation process.31, 32 
Met119 plays a two-sided role in DLC selectivity: the presence of an amino acid containing 
a hydrophobic side chain is shown here to benefit digoxin affinity, whereas the presence of 
a hydroxyl group appears to benefit dihydro-ouabain affinity. It should be mentioned that 
introduction of aspartic acid at this position significantly decreased the Kd of ouabain for this 
mutant (data not shown). Hydrogenation of the lactone ring decreased the affinity for the 
α2-isoform compared with that for the α1-isoform. Introduction of a hydroxyl group 
(replacing Met119 with serine or threonine) decreased this effect significantly. It is likely that 
the hydroxyl group at position 119 interacts with the lactone ring during the prebinding state, 
resulting in an increased affinity. 
Ser124 plays a less ambiguous role than Met119. The presence of an amino acid possessing a 
hydroxyl group decreased the dihydro-ouabain and dihydro-digoxin affinities (opposite to 
introduction of these amino acids for Met119), whereas substitution with either hydrophobic, 
charged, or other polar amino acids increased the affinities for both hydrogenated DLCs. 
Although this residue is facing outward from the first extracellular loop in the high affinity E2P-
ouabain state, in the [K2]E2·Pi state the crystal structure predicts the formation of a hydrogen 
bond with Arg883 (located in the αM7-αM8 loop), which might be affected upon introduction 
of a serine, possessing a shorter side chain that possibly affects this interaction. Ser124 is the 
first residue of the transmembrane segment αM2 and might interact with residues of the first 
extracellular loop via multiple hydrogen bonds, resulting in a more rigid structure, thereby 
affecting DLC affinity. Finally, because Ser124 affects the apparent affinity of both hydrogenated 
DLCs tested here, it is possible that the effect observed involves a direct interaction with the 
lactone ring upon preliminary association of hydrogenated DLCs. In this respect, it is worth 
mentioning the work by Yoda and co-workers, who suggested that DLC binding involves two 
subsequent steps: first, an initial binding step, followed by conformational rearrangement of 
the enzyme, allowing for DLC binding in the binding cavity.14 It is possible that the residues 
identified here mediate the gating of the binding pocket.
Except for the presence of a reduced lactone ring, dihydro-ouabain is structurally identical to 
ouabain. However, the reduction of the lactone ring affects its spatial orientation, polarity, and 
electrostatic properties. Thus, for ouabain, the highly strained, five-membered unsaturated 
lactone ring facilitates charge relocation reducing the ring strain, which causes an increased 
partially negatively charged carbonyl group. In the case of dihydro-ouabain, saturation of 
the lactone ring causes a change in the hybridization state of C20 and C22, going from sp2- 
to sp3-hybridization, leading to a reduced planarity and relaxation of the ring strain in the 
lactone ring. The reduced ring strain and loss of conjugation at the ring result in a reduced 
partial negative charge at the carbonyl group of the lactone and thereby decreases its ability 
to form long-range electrostatic interactions. Also, the saturation of the ring leads to loss of 
planarity around C20 and loss of the ability to form electrostatic π-interactions. Our docking 
calculations predict that the orientation of dihydro-ouabain is similar to that of ouabain, with 
its modified lactone moiety pointing toward the cation binding site, an apparent contrast 
to a previous study which, based on lanthanide-based resonance energy transfer (LRET), 
hypothesized an alternative docking sequence with the lactone ring facing the extracellular 
side, which has been addressed in the high-affinity crystal structure paper.8, 33 Also, no spatial 
clashes between the lactone ring of dihydro-ouabain and the cavity are predicted. On the 
basis of previous studies pointing toward a Mg2+ bound in cation binding site II as a key 
determinant for high affinity ouabain binding, a hypothesis for the general loss of affinity 
following hydrogenation of the lactone ring is that the polarization of the lactone leads to a 
reduced ability to form long-range electrostatic interactions with a putative Mg2+ in cation 
binding site II.8, 34 
In conclusion, we performed a screen for isoform selectivity of various DLCs and identified 
two amino acids in the first extracellular loop of Na+,K+-ATPase that determine the selectivity 
of hydrogenated DLCs for the α1- and α2-isoforms. It is most likely that this interaction 
affects the initial binding steps in the ligand-receptor interaction. 
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Abstract
Sporadic hemiplegic migraine type 2 (SHM2) and familial hemiplegic migraine type 
2 (FHM2) are rare forms of hemiplegic migraine caused by mutations in the Na+,K+-
ATPase α2-encoding gene. Today, more than 70 different mutations have been linked to 
SHM2/FHM2, randomly dispersed over the gene. For many of these mutations, functional 
studies have not been performed. Here, we report the functional characterization of nine 
SHM2/FHM2 linked mutants that were produced in Spodoptera frugiperda (Sf)9 insect cells. 
We determined ouabain binding characteristics, apparent Na+ and K+ affinities, and maximum 
ATPase activity. Whereas membranes containing T345A, R834Q or R879W possessed 
ATPase activity significantly higher than control membranes, P796S, M829R, R834X, 
del 935-940 ins Ile, R937P and D999H membranes showed significant loss of ATPase activity 
compared to wild type enzyme. Further analysis revealed that T345A and R879W showed 
no changes for any of the parameters tested, whereas mutant R834Q possessed significantly 
decreased Na+ and increased K+ apparent affinities as well as decreased ATPase activity and 
ouabain binding. We hypothesize that the majority of the mutations studied here influence 
interdomain interactions by affecting formation of hydrogen bond networks or interference 
with the C-terminal ion pathway necessary for catalytic activity of Na+,K+-ATPase, resulting 
in decreased functionality of astrocytes at the synaptic cleft expressing these mutants.
Introduction
Na+,K+-ATPase is a cation-transporting membrane protein involved in active transport of 
sodium and potassium ions against their concentration gradients across the cell membrane. 
For every molecule of ATP consumed, three sodium ions are exported from the cell in 
exchange for import of two potassium ions. Na+,K+-ATPase serves many roles, including 
cell-volume homeostasis as well as maintenance of the membrane potential. In addition, the 
generated Na+ and K+ gradients drive various secondary active transporters. Since transport 
of Na+ and K+ across the cell membrane takes place against such steep concentration gradients, 
the enzyme consumes high amounts of energy: approximately 25-50% of cellular ATP is 
consumed by Na+,K+-ATPase.1,2 
Na+,K+-ATPase consists of at least two different subunits: an α-subunit (110 kDa), 
containing ten transmembrane α-helices (αM1-αM10) and two large cytosolic loops 
(αM2-αM3 and αM4-αM5), together with a highly glycosylated single transmembrane domain 
spanning β-subunit (50 kDa). In some tissues, a third subunit containing a characteristic 
FXYD motif is present as well (γ-subunit).3 In the human genome, four α-subunit encoding 
genes have been described. The proteins encoded by these genes share a sequence homology 
of approximately 80-90% and are expressed tissue specifically.4 For example, the α1-isoform is 
expressed ubiquitously5, whereas the α4-isoform is detected only in the testis.6 The α3-isoform 
is present in both the central and peripheral nervous systems7,8, whereas the α2-isoform is 
expressed in different tissues including heart, skeletal, and vascular smooth muscle, bone, 
adipocytes, and astrocytes.9 
Genetic studies have linked over 70 mutations in the ATP1A2 gene (chromosome 1q23) 
encoding the α2-isoform of Na+,K+-ATPase to sporadic/familial hemiplegic migraine 
type 2 (SHM2/FHM2), shown in figure 1.10 Sporadic (only one affected family member) 
and familial (two or more affected family members) hemiplegic migraine are autosomal-
dominant monogenic subtypes of migraine with aura (MA), characterized by neurological 
aura symptoms preceding the migraine attack. In addition to the mutations present in the 
α2-isoform of Na+,K+-ATPase, two other genes have been linked to FHM: CACNA1A has 
been linked to SHM1/FHM1 whereas SCN1A has been associated with FHM3 (no sporadic 
mutations reported).11 Together, SHM and FHM show a prevalence of approximately 
0.005%.12,13
The exact pathophysiology of SHM2/FHM2 remains to be elucidated, but it is assumed that 
α2-isoform Na+,K+-ATPase mutations result in altered enzyme functionality at the synaptic 
cleft, where astrocytes expressing the α2-isoform are present as supporting cells. The 
Na+,K+-ATPase present at the plasma membrane of these cells presumably plays a role in 
uptake of K+ from the synaptic cleft following nerve excitation, resulting in a favorable driving 
force for the re-uptake of glutamate by the co-localized glutamate transporter.14 Changes in 
the enzymatic properties of Na+,K+-ATPase might therefore have an indirect effect on signal 
transmission via the synaptic cleft, leading to hemiplegic migraine attacks.
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Over 70 SHM2/FHM2 causing mutations in the ATP1A2 gene have been reported, randomly 
dispersed over the gene.15 For many of these mutations the effects on enzyme functionality 
have not been reported yet, whereas investigation of the biochemical effects of each of 
these mutations on protein functionality is an essential step towards understanding the 
pathogenesis of SHM2/FHM2 mutations. Using Spodoptera frugiperda (Sf)9 insect cells lacking 
endogenous Na+,K+-ATPase, we set out to characterize the enzymatic effects of nine SHM2/
FHM2 mutations (all except T345A) located within the carboxy-terminal transmembrane 
segment: T345A, P796S, M829R, R834Q, R834X (truncated protein), R879W, del 935-940 ins 
Ile, R937P and D999H. The carboxy-terminal segment is present only in PII- and PIIIa-type 
ATPases of the P-type ATPase family.16 It plays a vital role in the catalytic activity of Na+,K+-
ATPase as was illustrated by the discovery of an essential C-terminal half-channel forming a 
gateway to the third ion-binding site, allowing protons to access the third ion-binding site as 
required for K+ occlusion.17 Interestingly, various SHM2/FHM2 mutations have been mapped 
to this half-channel, leading us to investigate extensively the biochemical effects of mutations 
located within this region of Na+,K+-ATPase.
R879W
P796S
D999H
del 935-940 ins Ile
T345A
R937P
R834X/R834Q
M829R
Figure 1 Mutant localization.
Homology model of the α2-isoform of Na+,K+-ATPase (based on PDB file 2ZXE38) showing the residues that are 
associated with SHM2/FHM2 mutations in literature highlighted in green, whereas the mutations described in the 
present study are highlighted in yellow. The α-subunit is shown in blue, whereas red represents the β-subunit: these 
two subunits together constitute a functional Na+,K+-ATPase.
Materials and methods
The Gateway system
The cDNA for the α2-isoform was obtained by purchasing a vector (Thermo Scientific 
MHS1011-9199751) containing the cDNA obtained from a human teratocarcinoma cell line 
(cDNA: NM_000702). The desired mutations were obtained by performing two PCRs (A and 
B) on human Na+,K+-ATPase α2-encoding wild type cDNA using either a 5’- or 3’-primer 
together with a mutagenesis primer (Biolegio, Nijmegen, the Netherlands) containing the 
desired mutation. This resulted in generation of two fragments that were subsequently 
combined in a PCR (C) using only the 5’-and 3’-primers, allowing for annealing of the two 
fragments. Using Gateway cloning (Life Technologies, Breda, the Netherlands), the mutated 
Na+,K+-ATPase α2-encoding gene was then transferred to an entry vector containing a 
kanamycin resistance cassette using BP Clonase II enzyme according to the manufacturer’s 
instructions. After successful transformation of entry clones into Escherichia coli DH5α cells 
and overnight selection on kanamycin LB-agar plates, colonies were inoculated in LB medium 
containing kanamycin, grown overnight and subsequently isolated using the Genelute™ mini-
prep isolation kit (Sigma-Aldrich). Then, full-length sequencing of the different constructs 
was performed to check for successful mutagenesis. Subsequently, expression clones were 
obtained by inserting the α2-encoding gene carrying the mutation in the Gateway Reading 
Frame Cassette B behind a polyhedrin promoter in an ampicillin resistant pFastBac Dual 
transfer vector containing the β1-subunit behind the p10 promoter using LR Clonase II enzyme 
(Life Technologies, Breda, the Netherlands). After successful transformation of expression 
clones into E. coli DH5α cells and overnight selection on ampicillin LB-agar plates, colonies 
were inoculated in LB medium containing ampicillin, grown overnight and subsequently 
isolated using the Genelute™ mini-prep isolation kit (Sigma-Aldrich). Throughout the cloning 
procedures, YFP was used as a negative control, resulting in the generation of an expression 
clone encoding YFPβ1. 
Generation of recombinant baculoviruses
The expression clones generated using the Gateway system were transformed to competent 
DH10Bac E. coli cells (Life Technologies, Breda, the Netherlands) harboring the baculovirus 
genome (bacmid) and a transposition helper plasmid, conferring resistance against 
kanamycin, gentamycin, and tetracycline. Upon transposition between the Tn7 sites present 
in both the bacmid and expression clones18, recombinant bacmids were selected on LB-agar 
plates containing kanamycin, gentamycin, and tetracycline. Subsequently, resistance-selected 
bacmids were transfected to S. frugiperda (Sf)9 insect cells grown in Grace medium (Sigma, 
Bornem, Belgium) at 27 °C in 175 cm2 monolayers using Cellfectin reagent (Life Technologies, 
Breda, the Netherlands). After a 6-day period, recombinant baculoviruses were harvested and 
used to infect fresh Sf9 cells at a multiplicity of infection of 0.1.19 After another 6 days of 
culture of infected Sf9 cells, amplified baculoviruses were harvested.20 
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Protein production using recombinant virus
Sf9 cells grown at 27 °C in 175 cm2 monolayers and later in 500 mL shaking flasks in Xpress 
medium (Sigma, Bornem, Belgium) were infected at a density of 1.5 ·106 cells·mL-1 in the 
presence of 1% (v/v) ethanol as described before.21 After three days of infection, the cells were 
harvested by centrifugation at 2,000 ×g for 5 min. Then, the pelleted cells were resuspended at 
0 °C in a 0.25 M sucrose, 2 mM EDTA and 20 mM Hepes/Tris (pH 7.0) buffer. Sonication was 
performed for 30 s at 80 W prior to centrifugation at 10,000 ×g at 4 °C for 30 min, followed 
by centrifugation of the resulting supernatant at 100,000 ×g at 4 °C for 60 min. The pelleted 
membranes were resuspended using the buffer mentioned above, homogenized and stored at 
-20 °C and the protein concentration was determined using the modified Lowry method.22 
Western blotting
Approximately 10 µg of membranes was treated with SDS-PAGE solubilization buffer 
overnight at room temperature before loading on a 10% polyacrylamide gel, as described 
previously.23 After separation, the proteins were transferred overnight to a nitrocellulose 
membrane at 30 V. The alpha- and beta-subunits were detected using either the C356-M09 
(α-subunit) or the C385-M77 (β-subunit) antibodies, respectively.21,23 
Ouabain binding experiments
Ouabain binding was determined by incubation of approximately 150-200 µg of membranes in 
the presence of 20 mM histidine, 5 mM MgCl2, 5 mM H3PO4 pH 7.0 and 25 nM of radiolabeled 
ouabain (Perkin-Elmer, Waltham, MA, USA) in a final volume of 60 µL at room temperature 
for 2 h. After incubation for 15 min on ice, the amount of bound ouabain was determined 
by washing the samples over a 0.8 µm ME27 filter using distilled H2O, retaining the enzyme-
bound ouabain to the filters. The amount of radioactivity on the filters was then determined in 
a liquid scintillation counter after addition of 4 mL OptiFluor (Canberra Packard, Tilburg, the 
Netherlands).24 Correction for endogenous ouabain binding was performed by subtracting 
the amount of ouabain bound in YFPβ1 samples.
ATPase activity studies
ATPase activity was determined in the Na+ or K+ affinity studies by incubating 20 µL of 
membranes in a final volume of 100 µL containing 50 mM Tris-Ac pH 7.0, 0.1 mM EGTA, 1.2 
mM MgCl2, 1.0 mM Tris-N3, and 100 µM of radiolabeled ATP in the presence of 50 mM NaCl 
or 5.0 mM KCl and increasing concentrations of KCl or NaCl, respectively. After incubation 
of the samples for 30 min at 37 °C, the reaction was stopped by addition of 500 µL 10% 
(w/v) charcoal in 6% (v/v) trichloroacetic acid and, after 10 min at 0 °C, the mixture was 
centrifuged for 30 s (10,000 ×g). Subsequently, 150 µL of the clear supernatant was mixed 
with 4 mL OptiFluor before analysis using a liquid scintillation counter to determine the 
amount of formed Pi (inorganic phosphate), a measure of ATPase activity.25 Na+,K+-ATPase 
specific activity was determined by subtracting the amount of Pi formed in the presence of 
1.0 mM ouabain. [γ-32P]ATP (3000 Ci mmol-1) was obtained from Perkin-Elmer (Waltham, 
MA, USA).
Data analysis
All data were analyzed using Graphpad Prism 5.02. Repeated measures ANOVA was used 
to test for differences in apparent Na+ and K+ affinities and maximum ATPase activity 
levels compared with α2-wild type enzyme, with α=0.05. Ouabain binding characteristics 
(maximum ouabain binding (EOmax)) and Kd) were tested for differences compared to wild 
type enzyme using Students t-test. With regard to the Na+ and K+ affinities the Origin 6.1 
(Microcal, Northampton, MA) software was used to perform non-linear regression analysis. 
The Na+0.5 and K+0.5 values (defined as the concentrations of Na+ and K+ resulting in half-
maximal activation) were calculated via the Hill equation using the averaged data and SEM 
values, and the Hill coefficients (nH) obtained for wild type Na+,K+-ATPase were also used 
for calculation of the mutant half-maximum Na+ and K+ concentrations. Maximum ATPase 
activity was determined in the presence of 50 mM NaCl, 5.0 mM KCl, 1.2 mM MgCl2 and 0.1 
mM ATP at pH 7.0.
Structural analysis
Homology models based on different crystal structures of the α1β1 Na+,K+-ATPase 
(enzyme obtained from pig and shark) and sarcoendoplasmic reticulum Ca2+-ATPase 
(SERCA) were used as templates to investigate the possible interactions between residues of 
interest using the YASARA software. The following PDB entries were used (corresponding 
enzyme conformation): 2C9M (E1Na+), 1T5S (E1Na+-ATP), 1T5T (E1Na+-P-ADP), 3BA6 
(E1Na+P:ADP), 3B9B (E2P), 3B9R (E2K+-P-ATP), 2ZXE (E2K+·Pi), and 2C88 (E2K+ ATP). The 
homology models were built using the YASARA software and the WHAT IF Twinset using 
default parameters. YASARA-calculated Z-scores were used for validation and selection of 
the best model and ranged from -1.990 (3B9R), -1.788 (3B9B), -1.762 (2C9M), -1.699 (1T5T), 
-1.644 (3BA6), -1.557 (2C88), -1.548 (1T5S) to -0.454 (2ZXE). Minimization was performed 
using an automatic YASARA protocol and default settings.26
Results
General characterization of ATP1A2 migraine mutants 
We selected 9 ATP1A2 SHM2/FHM2 causing mutations identified in the C-terminal part of 
the α2-subunit of Na+,K+-ATPase to investigate the effects of these mutations on the enzyme’s 
apparent Na+, K+, and ouabain affinities, as well as maximum ATPase activity and ouabain 
binding. Baculovirus infected Sf9 insect cells were used to obtain membrane fragments 
containing the desired mutants. Figure 2 shows that the amount of protein detected was 
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equal for all mutants compared to wild type enzyme, indicating similar expression levels. As 
expected, the α-subunit could not be detected in membranes from cells infected with YFP 
(neg. control). 
Subsequently, we investigated protein functionality as reflected by ouabain binding. 
Ouabain is a well-known and highly specific ligand of Na+,K+-ATPase that binds in a pocket 
constituted by the first six transmembrane spanning domains and specific residues present 
in several extracellular loops connecting these transmembrane domains.26 Therefore, binding 
of ouabain implies that the first six transmembrane domains of Na+,K+-ATPase are properly 
folded. Figure 3 shows the amount of ouabain binding under equilibrium after incubation 
with 25 nM radiolabeled ouabain. Wild type, T345A, R879W, R834Q, and R937P membranes 
showed significantly higher ouabain binding levels compared with control membranes 
expressing YFP. 
Next, we tested the ATPase activity of all mutants by incubation of membranes in the presence 
of 50 mM NaCl, 5.0 mM KCl, 100 µM ATP and 1.2 mM MgCl2 for 30 min. Table 1 shows 
that mutants T345A, R834Q and R879W possessed significantly higher ATPase activity 
than YFP control membranes. We observed that two mutants (R879W and R834Q) showed 
decreased levels of maximum ATP conversion compared with wild type enzyme: R834Q 
showed a statistically significant decrease of 78% (P = 0.03) and mutant R879W showed a 
near-significant decrease in ATPase activity of 49%. 
Based on the presence of ATPase activity as described above, we tested mutants 
T345A, R879W and R834Q with regard to their ouabain binding characteristics (Fig. 4, 
Table 2) and determined the maximum ouabain binding (EOmax) as well as ouabain affinities 
for the different mutants. EOmax values ranged from 4.8 pmol/mg for wild type enzyme to 
6.3 pmol/mg for T345A, whereas mutants R879W and R834Q showed lower maximum 
ouabain levels of 2.7 and 0.5 pmol/mg, the latter being significantly decreased when compared 
Figure 2 Expression of mutants.
Western blot showing equal protein expression for all mutants tested in this study. For each mutant, 10 µg of Sf9 
membranes was incubated overnight in solubilization buffer and used for SDS-PAGE using 10% acrylamide gels 
followed by transfer to a nitrocellulose membrane and subsequent detection with antibodies against the α-subunit 
(C356-M09) and β-subunit (C385-M77). Note that the lower band for mutant R834X (insertion stop codon) reflects 
a truncated protein, as expected.
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Figure 3 Ouabain binding screen.
Binding was determined using scintillation counting after two hours of incubation with 25 nM ouabain at room 
temperature. Compared to the negative control membranes expressing YFPβ1, wild type and mutants T345A, 
R834Q, R879W, and R937P showed significantly increased levels of ouabain binding at equilibrium. * = p < 0.05 
versus neg. control.
wild type 1.05 ± 0.27
T345A 1.34 ± 0.38
P796S -0.02 ± 0.03*
M829R 0.00 ± 0.01*
R834Q 0.23 ± 0.05*
R834X -0.03 ± 0.02*
R879W 0.54 ± 0.08
del 935-940 ins Ile -0.05 ± 0.01*
R937P -0.04 ± 0.01*
D999H -0.02 ± 0.01*
µmol Pi mg
-1 hour-1
Max. ATPase
Results were obtained by averaging the amount of ATP consumed at 37 °C for 30 min in a medium consisting of 50 
mM NaCl, 5.0 mM KCl and 100 µM ATP, corrected for non-specific ATPase activity by incubation of membranes 
with 1.0 mM ouabain and subsequently background-corrected by subtracting the activity observed for YFPβ1 
expressing control membranes. * = p < 0.05 versus wild type.
Table 1 Maximum ATPase activity.
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with wild type enzyme. The ouabain affinities were identical for wild type and T345A 
(Kd = 21 ± 11 and 21 ± 6 nM), whereas R879W and R834Q showed non-significant increases 
in ouabain affinities compared with wild type enzyme (Kd = 12 ± 3 and 12 ± 4 nM). 
Apparent Na+ and K+ affinities and turnover numbers
6 out of 9 mutants possessed no significant ATPase activity (table 1), providing a hypothesis 
for their pathogenicity: loss of catalytic activity. However, the lack of ATPase activity also 
excluded these mutants from further biochemical characterization using ATPase related 
studies. As a result, we could only determine the Na+ and K+ affinities for the remaining three 
mutants: T345A, R834Q, and R879W (Fig. 5, Table 2). 
The apparent Na+ affinity was studied by investigating the amounts of radioactive ATP 
hydrolyzed under increasing concentrations of NaCl in the presence of 5.0 mM KCl, 100 µM 
ATP and 1.2 mM MgCl2. The results of these experiments can be observed in figure 5A and 
table 2. We observed no significant changes for mutants T345A and R879W compared with 
wild type, whereas mutant R834Q showed a significant two-fold decrease in apparent Na+ 
affinity compared with wild type (P = 0.0007). 
The apparent K+ affinity was determined from the amounts of radioactive ATP hydrolyzed 
under increasing KCl concentrations in the presence of 50 mM NaCl, 100 µM ATP and 1.2 
mM MgCl2. The results of these experiments are shown in figure 5B and table 2. There were 
no significant changes in apparent affinities for T345A and R879W compared with wild 
type enzyme, whereas mutant R834Q showed a significant two-fold increase in apparent K+ 
affinity (P = 0.013). This finding is a mirror image of the result observed for the Na+ affinity 
of the same mutant, which showed a two-fold decrease in affinity. 
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Figure 4 Ouabain binding characteristics.
Membranes were incubated with different concentrations of radiolabeled ouabain at room temperature for 
2 h, followed by filtration over ME-27 filters. Radioactivity retained on the filters, containing the enzyme-ouabain 
complex, was subsequently quantified using liquid scintillation analysis.
By dividing the maximum ATPase activity by the maximum ouabain binding (Table 2), we 
calculated the turnover number, which is a measure for the specific activity. We did not find 
any statistically significant differences for the mutants described here (data not shown).
In silico studies based on homology models
Finally, we performed in silico mutagenesis studies using homology models based on 
crystal structures of the α1β1-isoform of Na+,K+-ATPase as well as the highly similar 
sarcoendoplasmic reticulum Ca2+-ATPase (SERCA). For the three mutants showing 
ATPase activity, no interactions involving Tyr345 and Arg879 or their substitutes (alanine and 
tryptophan, respectively) were predicted, however a hydrogen bond network was predicted 
between residue Arg834 and residues Glu285 and Glu363 in the E2K+·Pi conformation, Asp767 in 
the E2P conformation, and Asp839 in the E2K+ ATP conformation (Fig. 6). Regarding the six 
  

	








	

















 

!



















  

	








	

















 

!



















Figure 5 Affinities for Na+ and K+.
Average (n ≥ 3) background corrected Na+ (A) and K+ (B) ATPase activities for wild type, T345A, R834Q and 
R879W enzymes. ATPase activities were determined by measuring the amount of radioactive ATP hydrolyzed after 
incubation of membranes for 30 min at 37 °C under different concentrations of either NaCl (A) or KCl (B).
wild type 1.05 ± 0.3 5.9 ± 0.2 1.10 ± 0.1 4.80 ± 1.2 21.0 ± 10.4
T345A 1.34 ± 0.4 6.2 ± 0.2 1.30 ± 0.1 6.30 ± 2.1 21.0 ± 6.3
R834Q 0.23 ± 0.1* 11.6 ± 0.4* 0.50 ± 0.1* 0.50 ± 0.0 11.8 ± 4.0
R879W 0.54 ± 0.1 6.5 ± 0.3 1.00 ± 0.0 2.70 ± 0.4 11.9 ± 3.0
nH = 2.03 nH = 1.93 nH =1.00
Affinity
µmol Pi mg
-1 hour -1 mM mM pmol mg-1 nM
Max. ATPase Na+0.5 K+0.5 Max. binding
ATPase activity Ouabain binding
Table 2 Overview of results.
Characteristics of ATPase activity and ouabain binding for wild type, T345A, R834Q and R879W enzymes. ATPase 
experiments using radiolabeled ATP were performed to determine apparent Na+ and K+ affinities and maximum 
ATPase values, whereas radiolabeled ouabain was used to determine apparent ouabain affinity and maximum 
binding level. nH = Hill coefficient, * = p < 0.05 versus wild type.
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mutants showing a complete loss of ATPase activity: a hydrogen bond was predicted between 
serine when introduced at position 796 (P796S) and Arg884, a residue predicted to interact 
with Gln907 as well. Also, introduction of arginine at residue 829 (M829R) led to formation of 
two hydrogen bonds with Val756.
Discussion
We investigated the biochemical characteristics of nine mutations/deletions in the α2-isoform 
of Na+,K+-ATPase linked to sporadic/familial hemiplegic migraine type 2 (SHM2/FHM2) in 
order to increase our knowledge on the pathogenesis of each of these mutations. All mutants 
could be expressed in Sf9 insect cells. However, further experiments revealed that six mutants 
could not be studied in detail due to significant loss of ATPase activity. Three mutants 
(T345A, R834Q, and R879W) were characterized biochemically, showing significant effects 
on apparent Na+- and K+-affinities for mutant R834Q. Below, we will describe the findings 
for each mutant and provide hypotheses on how each mutation might lead to the observed 
effects.
T345A was linked to FHM2 in a study describing a Finnish family of which 10 individuals 
were experiencing FHM attacks, whereas two individuals carried the mutation but most likely 
did not yet reach the age of onset-of-disease.27 We did not detect significant changes for any 
of the parameters tested, although we observed a slightly higher maximum ATPase activity, 
which was accompanied by a parallel increase in EOmax. Although we were not able to identify 
any interactions of the highly conserved Tyr345, Van der Waals’ interactions with Val362 were 
hypothesized before.28,29 Previously, a decreased K+ affinity and unchanged turnover number 
were reported for T345A rat cDNA expressed in HeLa cells30, whereas a study in COS-1 cells 
showed a reduction in ouabain affinity, an unchanged K+ affinity, and a decreased turnover 
number, which were linked to a reduced maximum phosphorylation rate.28 In contrast to these 
E2K
+Pi E2K
+ATP E2P
Figure 6 Interactions involving Arg834.
Conformation-dependent hydrogen bond interactions between Arg834 and various other amino acids that take 
place during the Na+,K+-ATPase reaction cycle. Arg834 is predicted to interact with Glu285 and Glu363 in the E2K+·Pi 
conformation (homology model based on 2ZXE), Asp767 in the E2P conformation (homology model based on 3B9B), 
and Asp839 in the E2K+ ATP conformation (homology model based on 2C88).
studies, we used a non-mammalian expression system with two important benefits over the 
two expression systems mentioned above: the absence of background Na+,K+-ATPase as well 
as equimolar expression of the α- and β-subunits. The differences between these expression 
systems might provide explanations for the differences between these studies and our results. 
The R834Q mutation was discovered in a French family containing eleven individuals 
suffering from FHM.31 We identified a significantly decreased apparent Na+ affinity, increased 
apparent K+ affinity, and decreased maximum ATPase activity and maximum ouabain binding 
compared to wild type enzyme. An increase in apparent K+ affinity has been reported before28, 
but we are the first to report a decrease in apparent Na+ affinity for this mutation. Based on the 
lower maximum ATPase activity, re-uptake of K+ from the synaptic cleft might be decreased, 
although an increased apparent K+ affinity could diminish this effect. As predicted by the 
homology models used in this study, Arg834 is involved in interactions with other residues 
present in the cytosolic domains of Na+,K+-ATPase, serving an important role in interactions 
between different domains during the catalytic cycle as pointed out before.32 Being located 
in the cytosolic loop between the sixth and seventh transmembrane domains (αM6-αM7), 
Arg834 is also part of the C-terminal half-channel, serving as a gateway to the third ion-binding 
site by allowing protons to access this site as required for K+ occlusion.17 We hypothesize 
that substitution of Arg834 with a glutamine (resulting in removal of a positive charge at this 
residue) disturbs hydrogen bond interaction networks shown in figure 6, thereby affecting 
the structure and/or accessibility of the C-terminal half-channel, interfering indirectly with 
apparent Na+ and K+ affinities and the transitions between different conformations. 
Mutation R879W was found in a screen for mutations in patients suffering from sporadic 
hemiplegic migraine (SHM) and was identified together with another mutation of the same 
non-conserved residue, R879Q.33 Although no mutations were detected in 92 controls, 
both ATP1A2 mutations were also found in non-affected family members, questioning the 
dominance in SHM. Our data seem to confirm this lack of causality, as they show a non-
significant increase in ouabain affinity as well as a non-significant decrease in apparent 
maximum ATPase activity compared to wild type enzyme. Based on analysis of different 
homology models, we were not able to identify any hydrogen bond interacting residues for 
Arg879, in line with the low conservation of this residue among different isoforms. Previously, 
we reported on another mutation at the same position (R879Q), which showed only minor 
changes in the enzyme’s biochemical properties, leading us to conclude that this mutation 
might not be pathogenic.19 Here, we conclude the same for R879W, strengthening our 
hypothesis that there is no link to SHM for mutations involving Arg879. 
Mutation P796S was linked to FHM2 in a Portuguese family by a cell assay that showed no 
survival of HeLa cells transfected with the mutated Na+,K+-ATPase, inferring pathogenicity 
for this mutation.29 Introduction of serine resulted in prediction of a hydrogen bond with 
Arg884, which in turn is involved in a hydrogen bond with Gln907, located in the C-terminal 
half of the extracellular loop between αM7 and αM8, implicated in interactions between the 
α- and β-subunits.34 Possibly, substitution of proline with serine results in affected interactions 
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between both subunits leading to a complete loss of ATPase activity as observed here, or 
might result in improper insertion of the enzyme into the membrane due to loss of these 
interactions.
M829R was identified in a study describing multiple new mutations linked to FHM231 and 
subsequently reported to result a minor increase in apparent K+ affinity in oocytes.32 Our 
study shows a complete loss of ATPase activity for this mutant, implying an even more severe 
effect of this mutation. Again, the difference in experimental results might be related to the 
insect cells used here, which are cultured at 27 °C instead of 18 °C used for oocytes. Based 
on analysis of the first crystal structure of Na+,K+-ATPase35, the highly conserved Met829 
has been implicated in important interactions stabilizing the interdomain interface region 
between αM6 and αM7 during the catalytic cycle.32 Therefore, it is likely that replacement of 
methionine with arginine results in disturbance of these essential hydrogen bond networks, 
leading to loss of ATPase activity as shown here.
The mutations R834X36, del 935-940 ins Ile31, R937P31 and D999H37, all showing complete 
loss of ATPase activity, affect one or more residues involved in the structure of the C-terminal 
pathway. This half-channel controls the access of protons from the cytosol to the third 
proposed ion-binding site and plugs this channel upon occlusion of the third ion binding site 
(IIIb) by either Na+ (E1 state) or H+ (E2 state).17 Disruption of this half-channel could therefore 
easily lead to loss of ATPase activity resulting from the absence of Na+ and K+ occlusion, in 
particular for the mutations affecting multiple residues of the C-terminal segment including 
R834X (insertion stop codon) and del 935-940 ins Ile. Arg937 was found to play a role in 
controlling the C-terminal tyrosine residues essential for ATPase activity by forming hydrogen 
bonds and cation-π interactions.17 The same study also described Asp999 as one of the residues 
facing inwards into the proposed channel, highlighting the importance of this residue for 
ATPase activity as well. We hypothesize that mutation of this residue into a positively charged 
histidine disturbs C-terminal function, interfering with the affinity and occlusion of Na+ 
and/or H+, thereby indirectly affecting ATPase function. 
In conclusion, we found a statistically significant decrease in maximum ATPase activity and 
apparent K+ affinity together with an increase in apparent Na+ affinity for mutation R834Q. 
Mutants T345A and R879W did not show any significant changes for the parameters studied 
here. Mutants P796S, M829R, R834X, del 935-940 ins Ile, R937P and D999H could not be 
tested due to a lack of ATPase activity, but this might explain how these mutations, as well as 
R834Q, lead to development of SHM2/FHM2 by affecting transport of K+ and Na+ between 
the synaptic cleft and supporting cells expressing the α2-isoform of Na+,K+-ATPase. Lack 
of transport of Na+ and K+ is believed to affect the secondary active transport of glutamate 
eventually leading to decreased recovery from neural excitation associated with development 
of SHM2/FHM2 attacks.
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Abstract
Familial hemiplegic migraine (FHM) is a monogenic variant of migraine with aura. One 
of the three known causative genes, ATP1A2, which encodes the α2-isoform of Na+,K+-
ATPase, causes FHM type 2 (FHM2). Over 50 FHM2 mutations have been reported, but 
most have not been characterized functionally. Here we study the molecular mechanism of 
Na+,K+-ATPase α2-subunit missense mutations. Mutants E700K and P786L inactivate 
or strongly reduce enzyme activity. Glutamic acid 700 is located in the phosphorylation 
(P)-domain and the mutation most likely disrupts the salt bridge with lysine 35, thereby 
destabilizing the interaction with the actuator (A)-domain. Mutants G900R and E902K 
are present in the extracellular loop at the interface of the α- and β-subunits. Both mutants 
likely hamper the interaction between these subunits and thereby decrease enzyme activity. 
Mutants E174K, R548C and R548H reduce the Na+ and increase the K+ affinity. Glutamic acid 
174 is present in the A-domain and might form a salt bridge with lysine 432 in the nucleotide 
binding (N)-domain, whereas arginine 548, which is located in the N-domain, forms a salt 
bridge with glutamine 219 in the A-domain. In the catalytic cycle, the interactions of the 
A- and N-domains affect the K+ and Na+ affinities, as observed with these mutants. Functional 
consequences were not observed for ATP1A2 mutations found in two sporadic hemiplegic 
migraine cases (Y9N and R879Q) and in migraine without aura (R51H and C702Y).
Introduction
Migraine is a disabling common brain disorder typically characterized by attacks of severe 
headache and associated with autonomic and neurological symptoms.1 Auras that consist of 
transient mainly visual and sensory symptoms can precede headaches in one-third of patients 
(hence migraine with aura). Auras are likely caused by cortical spreading depression (CSD) 
events, which are slowly propagating cortical waves of neuronal and glial depolarization.2 
Familial hemiplegic migraine (FHM) is a rare monogenic variant of migraine with aura with 
some degree of hemiparesis during the aura.1 Of the three known FHM genes, two encode 
α1-subunits of voltage-gated CaV2.1 calcium channels (CACNA1A; FHM1) or voltage-
gated NaV1.1 sodium channels (SCN1A; FHM3).3-5 ATP1A2 (FHM2) encodes the catalytic 
α2-subunit of the sodium potassium pump.6 This pump transfers Na+ out and K+ into the 
cell, using ATP as energy source. The sodium pump is present in all human cells, but the 
α2-isoform is mainly restricted to brain and muscle. In the adult brain the α2-isoform is 
located in glial cells where it generates the Na+ gradient that is essential for the re-uptake of the 
excitatory transmitter glutamate. Moreover, it also removes excess K+ from the intracellular 
space.7
Since the discovery of the first FHM2 mutation in 20036, over 50 ATP1A2 mutations have 
been published, but only a minority have been functionally studied in detail.7 ATP1A2 
mutations have been reported to be associated also with non-FHM phenotypes such as basilar 
migraine, alternating hemiplegia of childhood, and common migraine with or without aura.7 
For most of the mutations, however, functional evidence supporting that these mutations are 
causal is lacking. Here we set out to investigate ATP1A2 mutations associated with FHM and 
non-FHM phenotypes in an attempt to find functional evidence for an association with a 
broader spectrum of migraine-related phenotypes. In addition, we investigated whether some 
of the mutations may be involved in specific domain interactions within the sodium potassium 
pump. Our functional analyses reinforce the association between ATP1A2 mutations and 
sporadic and familial hemiplegic migraine, but do not provide robust functional evidence for 
a relationship with other types of migraine.
Materials and methods
The Gateway system
The wild type and mutants of the Na+,K+-ATPase α2-isoform were cloned by Gateway-
adapted PCR procedures according to the manufacturer’s instructions (Invitrogen, Breda, 
The Netherlands). A destination vector was generated by subcloning the cDNA of the 
human Na+,K+-ATPase β1-subunit in the pFastbacdual vector (Life Technologies, Breda, 
The Netherlands) after the p10 promotor and the α2-subunit in the Gateway Reading Frame 
Cassette B (Invitrogen) that was introduced after the polyhedrin promoter. The (mutated) 
entry vectors were recombined with this vector by using Gateway LR Clonase II Enzyme 
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Mix (Invitrogen). Site-directed mutagenesis was performed using the Single Base mutation 
system, DpnI method (Stratagene, La Jolla, CA). The mutagenic primer (Biolegio, Nijmegen, 
The Netherlands) introduced the desired mutation in the α-subunit. After selection the 
mutants were checked by Sanger direct sequence analysis. 
Generation of recombinant viruses
The pFastbacdual transfer vector containing the different (mutant) cDNAs was transformed 
to competent DH10bac Escherichia coli cells (Life Technologies) harboring the baculovirus 
genome (bacmid) and a transposition helper vector. Upon transposition between the Tn7 
sites in the transfer vector and the bacmid, recombinant bacmids were selected and isolated.8 
Subsequently, insect Sf9 cells were transfected with recombinant bacmids using Cellfectin 
reagent (Life Technologies). After a three-day incubation period, recombinant baculoviruses 
were isolated and used to infect Sf9 cells at a multiplicity of infection of 0.1. Four days after 
infection, the amplified viruses were harvested.
Preparation of Sf9 membranes
Sf9 cells were grown at 27 °C in 175 cm2 monolayers and later in 500 mL shaking flasks 
cultures. For production of Na+,K+-ATPase, 1.5 ·106 cells mL-1 were infected at a multiplicity 
of infection of 1-3 in the presence of 1% (v/v) ethanol, and 0.1% (w/v) Pluronic F-68 (Sigma, 
Bornem, Belgium) in Xpress medium (Biowittaker, Walkersville, MD) as described before.9 
After 3 days, the Sf9 cells were harvested by centrifugation at 2,000 ×g for 5 min. The cells 
were resuspended at 0 °C in 0.25 M sucrose, 2 mM EDTA, and 25 mM Hepes/Tris (pH 7.0), 
and sonicated for 30 s at 60W (Branson Power Company, Denbury, CT). After centrifugation 
for 30 min at 10,000 ×g the supernatant was collected and centrifuged again for 60 min at 
100,000 ×g at 4 °C. The pelleted membranes were resuspended in the above-mentioned buffer 
and stored at -20 °C and the protein concentration was determined with the modified Lowry 
method.
Western blotting
Protein samples from the membrane fraction were solubilized in SDS-PAGE sample buffer 
and separated on SDS-gels containing 10% acrylamide as described previously.10 For 
immunoblotting, the separated proteins were transferred to Immobilon polyvinylidenefluoride 
membranes (Millipore Corporation, Bedford, MA). The α-subunit of Na+,K+-ATPase was 
detected with the polyclonal antibody C356-M09.10
Na+,K+-ATPase assay
The ouabain sensitive ATPase activity was determined using a radiochemical method.11 
For this purpose, 0.6-5 μg of Sf9 membranes were added to 100 µL of medium, which 
contained 10-200 µM [γ-32P]-ATP (specific activity 20-100 mCi mmol-1), 1.2 mM MgCl2, 
0.2 mM EGTA, 0.1 mM EDTA, 1.0 mM Tris-N3, 25 mM Tris-HCl (pH 7.0) and various 
concentrations of KCl and NaCl in the presence and absence of 0.1 mM ouabain. After 
incubation for 30 min at 37 °C, the reaction was stopped by adding 500 µL 10% (w/v) charcoal 
in 6% (v/v) trichloroacetic acid and after 10 min at 0 °C the mixture was centrifuged for 10 s 
(10,000 ×g). To 0.15 mL of the clear supernatant, containing the liberated inorganic phosphate (32Pi), 
3 mL OptiFluor (Canberra Packard, Tilburg, The Netherlands) was added and the mixture 
was analyzed by liquid scintillation analysis. In general, blanks were prepared by incubating 
in the absence of membranes. The Na+,K+-ATPase activity is presented as the difference of the 
activity in the absence and presence of ouabain.
Ouabain binding capacity
Ouabain binding was determined as described before.12 Sf9 membranes (100 μg) were 
incubated at 21 °C in 20 mM histidine (pH 7.0), 5.0 mM MgCl2, and 5.0 mM Pi in a volume 
of 50 µL. 10 µL of [3H]-ouabain (specific activity 30 Ci mmol-1, Perkin Elmer) was added 
and the mixture was incubated for 2 h at 21 °C. The protein was collected by filtration over a 
0.8 µm membrane filter (Schleicher and Schuell, Dassel, Germany). After washing twice with 
2 mL water (4 °C), the filters were analyzed by liquid scintillation analysis. Data are corrected 
for the levels of nonspecific ouabain binding obtained with mock-infected membranes.
Chemicals
Cellfectin, competent DH10bac Escherichia coli cells and all enzymes used for DNA cloning 
were purchased from Invitrogen (Breda, The Netherlands). [γ-32P]ATP (3000 Ci mmol-1 was 
obtained from Perkin-Elmer (Waltham, MA, USA). 
Analysis of data
All data are presented as mean values for three individual enzyme preparations with standard 
error of the mean. Differences were tested for significance by means of the Student’s t-test. IC50 
and K0.5 values were determined by analyzing the plots using the Non-Linear Curve Fitting 
program (Hill equation function) of Origin 6.1 (Microcal, Northampton, MA).
The Na+0.5 and K+0.5 values were calculated via the Hill equation in Origin, on the averaged 
data with standard error of the mean. The Hill coefficient value obtained for the wild type 
Na+,K+-ATPase (1.73 for Na+ and 1.3 for K+) was also used for the mutants studied. The 
maximal ATPase activity (Vmax) is the activity in the presence of 50 mM NaCl, 5 mM KCl, 
1 mM MgCl2 and 0.1 mM ATP at pH 7.0.
Molecular modeling 
The consequences of the mutations studied can be interpreted by studying the location and 
interactions of the specific amino acid in the sodium pump structures. The role of the amino 
acids can be understood better when its role during the catalytic cycle is visualized. Therefore, 
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we made homology models of the human sodium pump in different conformations using 
SERCA and pig and shark Na+,K+-ATPase as a template. E1Na+ (2C9M), E1Na+·ATP (1T5S), 
E1Na+·P·ADP (1T5T), E1Na+P:ADP (3BA6), E2P (3N23), E2K+·P ATP (3B9R), E2K+·Pi (2ZXE), 
E2K+ ATP (2C88). The homology model was built with the YASARA and WHAT IF Twinset 
using default parameters. YASARA calculated “Z-scores” where used for validation and 
selection of the best model. Minimization was done with the standard forcefield in YASARA.9
Results
Functional expression of ATP1A2 migraine mutants in insect cells
We selected 11 ATP1A2 mutations that were located in different domains of the α2-subunit 
of the Na+,K+-ATPase enzyme. All mutations had been identified in clinical genetic studies 
and postulated as disease-causing. A PCR-based mutagenesis method was used to introduce 
the respective mutations in the human ATP1A2 cDNA. The (mutant) Na+,K+-ATPase α2- 
and β1-subunits were cloned into recombinant baculoviruses and expressed in Sf9 insect 
cells. The membrane fractions of cells expressing the recombinant ATPase proteins were 
isolated. Western blot analysis revealed similar expression levels for mutant and wild type 
Na+,K+-ATPase protein (Fig. 1).
The immunological detection of proteins on Western blots does, however, not indicate 
whether the expressed proteins are functionally active. To investigate functionality of 
the mutant proteins, we performed several functional assays. For instance, binding of the 
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Figure 1 Expression of wild type and mutant Na+,K+-ATPase.
A: Western blot of the different Na+,K+-ATPase membrane preparations (10 μg) isolated from infected Sf9 cells. The 
presence of Na+,K+-ATPase α-subunit was detected with antibody C356-M09.10 B: Ouabain binding to wild type and 
mutant Na+,K+-ATPase. The assay was performed at 21 °C in 20 mM histidine buffer (pH 7.0), 5.0 mM MgCl2, 5 mM 
Pi and 12 nM 3H-ouabain. Average with SEM for 3 different expression experiments.
Na+,K+-ATPase inhibitor ouabain in a pocket of the enzyme close to the cation binding sites 
indicates that the protein is able to adopt a conformation that binds ouabain.9,13,14 The ouabain 
equilibrium saturation was analyzed and the affinity for ouabain was similar for all mutants. 
However, the maximum binding (EOmax) varied between the different mutants (Table 1). 
The maximum binding of the wild type and Y9N, R51H, E174K, R548C, and R548H varied 
between 2.5 and 3.6 pmol/mg and the binding of C702Y and R879Q varied between 1.6 and 
1.8 pmol/mg. In contrast, the maximum binding of E700K, G900R, and E902K was greatly 
reduced (approximately 0.8 pmol/mg), whereas P786L was not able to bind ouabain at all. This 
indicates that although none of the mutations affected the expression levels, four mutations 
(i.e. E700K, P786L, G900R, and E902K) seriously influence functional expression.
Kinetic alterations 
One of the most important properties of Na+,K+-ATPase that could be influenced by 
mutations is substrate affinity. In previous studies by Segall et al.15,16 three mutations (T345A, 
R689Q, and M731T) showed an affected K+ and vanadate affinity. In addition, Tavraz et 
al.17,18 showed that some mutants possessed altered K+ affinities. To investigate whether 
the 11 mutants exhibit kinetic alterations, we determined Na+, K+, and ATP affinities for 
the wild type and mutant enzymes. The Na+,K+-ATPase activity was determined in the 
presence of 100 μM ATP, 5 mM KCl and varying concentrations of NaCl. The apparent 
affinities for Na+ are depicted in Table 1 and were not significantly different for Y9N, R51H, 
C702Y, R879Q, G900R and E902K when compared to wild type enzyme. The ATPase 
activity of E700K and P786L was not sufficient to obtain reliable ATPase activities under 
different circumstances. E174K, R548C, and R548H, however, had a reduced apparent Na+ 
affinity (15.7, 17.0, and 13.8 mM, respectively) compared to wild type enzyme (7.1 mM). 
wild type 3.15 ± 0.40 18.6 ± 2.9 0.55 ± 0.10 7.1 ± 0.47 1.35 ± 0.15 25.0 ± 4.2 3032 ± 637
Y9N 2.67 ± 0.45 16.5 ± 2.0 0.50 ± 0.12 8.1 ± 0.97 1.54 ± 0.14 23.3 ± 6.1 3110 ± 362
R51H 3.58 ± 0.87 18.5 ± 3.4 0.65 ± 0.13 7.6 ± 0.73 1.33 ± 0.14 26.0 ± 2.3 3229 ± 652
E174K 2.66 ± 0.65 19.7 ± 4.5 0.27 ± 0.07 15.7 ± 2.38 * 0.86 ± 0.18 29.8 ± 5.5 1755 ± 270
R548C 2.87 ± 0.41 21.6 ± 1.8 0.12 ± 0.04 ** 17.0 ± 2.22 ** 0.81 ± 0.13 * 31.3 ± 6.9 713 ± 200 *
R548H 2.46 ± 0.11 21.5 ± 1.9 0.17 ± 0.02 * 13.8 ± 0.59 *** 0.45 ± 0.05 ** 23.0 ± 10.2 1160 ± 168 *
E700K 0.75 ± 0.06 *** 19.4 ± 1.9 0.06 ± 0.01 ** n.d. n.d. n.d. 1449 ± 318
C702Y 1.61 ± 0.25 * 14.8 ± 1.4 0.26 ± 0.04 * 6.2 ± 1.07 1.17 ± 0.15 36.9 ± 8.3 2827 ± 405
P786L n.d. n.d. -0.01 ± 0.00 ** n.d. n.d. n.d. n.d.
R879Q 1.77 ± 0.26 * 16.4 ± 2.0 0.35 ± 0.08 8.5 ± 0.76 1.43 ± 0.14 35.2 ± 5.9 3593 ± 948
G900R 0.75 ± 0.15 ** 11.8 ± 1.1 0.16 ± 0.04 * 7.8 ± 2.18 1.26 ± 0.16 29.7 ± 5.7 3854 ± 875
E902K 0.76 ± 0.08 ** 12.6 ± 2.5 0.18 ± 0.04 * 10.8 ± 1.58 1.23 ± 0.15 42.6 ± 4.6 * 4873 ± 1657
Max. ouabain
pmol mg-1
Ouabain affinity Na+ affinity Turnover
nM μmol mg-1 hour-1 mM mM
K+ affinity ATP affinity
µM (min-1)
ATPase activity
Summary of the catalytic properties of wild type and mutant Na+,K+-ATPase. The values presented are the mean ± 
SEM of  3-4 enzyme preparations. The values of the mutant enzyme preparations are compared to those of the wild 
type. n.d. = not detected, * = p < 0.05 versus wild type, ** = p < 0.01 versus wild type, *** = p < 0.001 versus wild type.
Table 1 Overview of results for all mutants.
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In figure 2 the apparent affinities for Na+ of the R548C mutant and wild type are shown. In 
the presence of 100 μM ATP, 50 mM NaCl and varying concentrations of KCl, the activity 
of Na+,K+-ATPase was determined. The apparent K+ affinity of Y9N, R51H, E174K, C702Y, 
R879Q, G900R and E902K was not significantly changed compared to the wild type enzyme 
(Table 1). R548C and R548H, however, had an increased apparent K+ affinity (0.81 and 
0.45 mM, respectively) compared to wild type enzyme (1.35 mM).
The apparent ATP affinity in the presence of 50 mM NaCl and 5 mM KCl was similar for all 
mutants and the wild type enzyme (Table 1). We determined the maximal ATPase activity at 
0.1 mM ATP, 50 mM NaCl and 5 mM KCl (Table 1). Mutants Y9N and R51H had a similar 
Vmax as wild type enzyme. E174K, C702Y, and R879Q had a somewhat reduced Vmax (47-64%), 
whereas the activities of R548C, R548H, E900R, and E902K were greatly reduced (22-33%). 
The P786L was completely inactive and the activity of E700K was only 11% of that of wild 
type enzyme.
The catalytic turnover determined as the ratio of Vmax/EOmax is plotted in figure 3 and the 
calculated values are shown in Table 1. Most mutants had a similar turnover number as wild 
type enzyme. The catalytic turnovers of E174K and E700K seem to be lower, but were not 
significantly decreased when compared to wild type. In contrast, the turnover numbers of 
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Figure 2 The properties of the wild type Na+,K+-ATPase and the R548C mutant. 
Na+ dependence (A), K+ dependence (B), and ATP dependence (Scatchard plot) (C) are shown in the ATPase activity 
assay. In panel D the ouabain binding affinity and capacity are shown in a Scatchard plot. The assay conditions were 
as described in the materials and methods section.
R548C and R548H were significantly reduced. Although their ouabain binding level was 
comparable to that of wild type, their Na+,K+-ATPase activity was largely reduced.
Discussion
Familial hemiplegic migraine type 2 (FHM2) is caused by mutations in ATP1A2 that 
encodes the α2-subunit of Na+,K+-ATPase. Here we studied the catalytic function of 11 
Na+,K+-ATPase mutants that were not functionally characterized (in detail) before. For several 
of these mutants, we predicted that the domain interactions of the α2-subunit were disrupted, 
which suggested a novel pathogenic mechanism for Na+,K+-ATPase dysfunction in relation to 
migraine. The identified functional consequences of the ATP1A2 mutants will be discussed 
below grouped by domain. 
Within the A-domain we investigated mutant E174K. The negative charge at residue 174 is 
highly conserved in PIIc-type ATPases. In a previous study the E174K mutation had been 
characterized to some extent, and showed no difference from the wild type α2-subunit, 
suggesting perhaps a more subtle effect on protein function than revealed by the activity 
assay used.19 Our functional studies show a slightly reduced catalytic turnover, a clearly 
reduced apparent Na+ affinity, and an increased apparent K+ affinity compared to that of 
wild type enzyme. In the A-domain Glu174 is predicted to be exposed to the cytosol in most 
conformations. However, in the E1P conformation Glu174 is predicted to be in close proximity 
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Figure 3 Relationship between Na+,K+-ATPase activity and ouabain binding.
The maximal ouabain binding (pmol per mg protein) and the ATPase activities (µmol ATP hydrolyzed per mg 
protein per h) were plotted for each mutant and wild type enzyme. The dotted line indicates a catalytic turnover 
number that is equal to that of the wild type enzyme.
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to Lys432 in the N-domain (Fig. 4). In this conformation a salt bridge between both residues 
might stabilize the E1P sodium binding conformation. Substitution of the negatively charged 
Glu with the positively charged Lys will likely disrupt this stabilizing interaction and could 
thereby be responsible for the reduced apparent Na+ affinity by decreasing its association rate 
or increasing its dissociation rate.
Several of the studied ATP1A2 mutations are located in the N-domain. For this study 
we focused on mutants R548C and R548H. Arginine 548 is strongly conserved in P-type 
ATPases. It most likely forms a salt bridge with Glu221 that stabilizes the interaction between 
the A- and N-domains in the E2P conformation (Fig. 5).20 However, when ATP is bound, 
Arg548 probably forms a salt bridge to the β-phosphate of ATP. Indeed, the substitution 
of Arg548 with Gln was shown to abolish high-affinity ATP binding and Na+,K+-ATPase 
activity21, whereas substitution with Lys was shown not to affect ATP binding, but reduced 
ATPase activity to 30% of the wild type enzyme.21 Nucleotides might disrupt the Arg548-Glu221 
K432
E174
E1P
E174
K432
Figure 4 Interaction between E174 and K432 visualized in Na+,K+-ATPase in the E1P 
conformation (homology model based on 3BA6) and E2K+·Pi state (2ZXE). 
View is from outside to inside. Cyan is transmembrane domain; blue is phosphorylation domain, red is nucleotide-
binding domain; green is actuator domain.
salt bridge, aiding dissociation of the A- and N-domains and accelerating K+ release.20 In the 
E1 conformation the A- and N-domains are far apart and the salt bridge between Arg548 and 
Glu221 is absent (Fig. 5). In our functional studies we observed that both R548C and R548H 
had a reduced catalytic turnover number, a slightly reduced Na+ affinity and an increased K+ 
affinity. Interestingly, the replacement of arginine by cysteine removes the salt bridge between 
the N- and A-domains, due to which binding of K+ might be facilitated. In R548H similar 
effects were observed, suggesting that also in this case a salt bridge cannot be formed.
Within the Na+,K+-ATPase P-domain we analyzed mutant E700K. Our functional studies 
showed no detectable changes in apparent Na+, K+, or ATP affinities. However, the 
number of active E700K transporter molecules is significantly decreased compared to 
wild type, supporting a causal relation with disease. Glu700 is highly conserved in P-type 
IIc ATPases and located at the surface of the P-domain, where it might be involved in the 
formation of a salt bridge with Lys35 of the A-domain in the E2K·Pi conformation (Fig. 6). 
E1
E221
R548
E221
Figure 5 Interaction between R548 and E221 visualized in the crystal structure of Na+,K+-
ATPase in the E1 conformation (homology model based on 2C9M) and E2K+·Pi state (2ZXE). 
Cyan is transmembrane domain; blue is phosphorylation domain, red is nucleotide-binding domain; green is 
actuator domain.
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Recently, it was shown that E700K exhibits a reduced rate of E2P dephosphorylation and a 
reduced vanadate affinity.22 These observations are in agreement with our observed reduced 
activity. Moreover, the disruption of the salt bridge might destabilize the E2P conformation 
and thereby inhibit the E1P to E2P transition. In contrast to Schack et al.22, we did not observe 
an increased ouabain affinity. 
The P786L mutation is located within the transmembrane (αM) domain, more specifically 
αM5. P786L previously did not show survival of cells in our specialized assay.23 Our present 
functional studies showed no ouabain binding or ATPase activity for this mutant. In the 
sarcoplasmic reticulum Ca2+-ATPase substitution of the corresponding amino acid Cys774 
with alanine caused inhibition of Ca2+ transport and ATPase activity.24 This cysteine has been 
proposed to play a central role in proton transfer.25 Homology modeling studies suggested 
K35
E700
E1
K35
Figure 6 Possible interaction between E700 and K35 visualized in the crystal structure of 
Na+,K+-ATPase in the E1 conformation (homology model based on 2C9M) and E2K+·Pi state 
(2ZXE).
K35 is located at the N-terminal region of Na+,K+-ATPase, due to which the modeling is rather hypothetical. View is 
from outside to inside. Cyan is transmembrane domain; blue is phosphorylation domain, red is nucleotide-binding 
domain; green is actuator domain.
that Pro786 in αM5 might be necessary for the Na+ ions to reach their binding site. This 
might be the reason why αM5 possesses the sequence PEITP, similar to αM4 (PEGLP).26 The 
prolines and polar amino acids in αM5 are also responsible for the very inefficient signal 
anchor sequence.27 Its correct membrane insertion is probably mediated by posttranslational 
hairpin formation with αM6, which is favored by a proline pair in the connecting loop. The 
proline mutant had decreased apparent Na+ and K+ affinity and a reduced turnover, whereas 
we did not observe any ATPase activity. The discrepancy is most likely due to the expression 
of Xenopus laevis Na+,K+-ATPase in Xenopus laevis oocytes at 18 °C27, whereas we expressed 
human Na+,K+-ATPase in insect cells at 27 °C. Previously, it was demonstrated that folding 
defects of mutant proteins can be revealed in a temperature-dependent fashion.17
Several studied ATP1A2 mutations are located in the extracellular loop between transmembrane 
segments 7 and 8: R879Q28, R879W28, W887R6, G900R29, E902K30, and R908Q.23 This part of the 
Na+,K+-ATPase α-subunit has been implicated in binding of the Na+,K+-ATPase β-subunit.31,32 
We did not observe any effect on ligand affinity for the G900R and E902K mutants, although 
we observed a drastic reduction in the amount of functional ATPase molecules for these 
mutants. The overall effect for the patient will likely be that the amount of functional 
Na+,K+-ATPase molecules is reduced, which may hamper the restoring of ions and might 
enhance cortical spreading depression. The affected glycine 900 is conserved and part of the 
amino acid sequence SYGQ, which is directly involved in interactions between the α-and 
β-subunits of Na+,K+-ATPase.32 Glycine does not carry a side chain and therefore is important 
for the position of neighboring amino acids. The crystal structures of Na+,K+-ATPase indeed 
show that in this region several hydrogen bonds between both subunits are likely.20,33 For 
instance, Tyr899 binds to Lys250 and Gln901 binds to the backbone atoms of Ile185 (Fig. 7).20,33 
Glutamic acid 902 is also well conserved (Asn or Glu) and forms a hydrogen bond with Arg183 
of the β-subunit. Replacement of Gly900 or Glu902 will likely disrupt hydrogen bridges and affect 
E902
G900
Q901
Y899
S898
K250
R182
L184
Figure 7 Interaction between Na+,K+-ATPase α- and β-subunits visualized in the crystal 
structure of Na+,K+-ATPase in the E2K+·Pi state (2ZXE). 
Cyan is transmembrane domain of the α-subunit; magenta is β-subunit. 
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the interaction between the α-and β-subunits of the Na+,K+-ATPase enzyme. Due to these 
mutations, the formation of an α-β enzyme complex is predicted to be hampered. However, if 
the α- and β-subunits were able to form a functional complex, its functional properties were 
not affected.
The R879Q mutant showed Na+, K+, ATP, and ouabain affinities that are similar to that of 
the wild type enzyme. Moreover, the number of active R879Q transporter molecules was not 
significantly decreased compared to the wild type. This non-conserved arginine is located 
in the first half of the extracellular αM7-αM8 loop, that most likely is not involved in direct 
binding of the β-subunit.31 Y9N and R51H are both located in the Na+,K+-ATPase N-terminus 
and did not show any functional differences. Functional studies also showed no difference in 
apparent Na+, K+, or ATP affinities of C702Y compared to wild type enzyme. Moreover, the 
number of active C702Y transporter molecules was, at best, only slightly decreased compared 
to wild type enzyme. A cysteine-less Na+,K+-ATPase α1-subunit in which all 23 cysteines 
were replaced by serine residues still possessed the same catalytic turnover number and only 
minor changes in Na+ and K+ affinities were observed.34 The number of active cysteine-less 
Na+,K+-ATPase molecules was still 30% of that of the wild type. Thus, the Na+,K+-ATPase 
α1-subunit seems to contain no cysteine residues that are essential for its function which is 
in line with our finding that the single C702Y mutation did not affect Na+,K+-ATPase α2β1 
function. This observation, therefore, casts considerable doubt on whether this mutant caused 
disease in the patient. 
Our functional studies provide important experimental evidence as to which ATP1A2 
mutations are likely disease-causing or not. For the three typical FHM2 families with 
mutations R548C, E700K and E902K that were absent in healthy relatives and large subsets of 
control chromosomes30,35,36, we could clearly show catalytic dysfunction of the Na+,K+-ATPase 
enzyme. The same is true for mutation G900R, that was observed in a family with patients 
having FHM, epileptic seizures or both29, indicating that the mutation may underlie both 
phenotypes. We showed that the functional consequences of G900R are comparable with 
those of E902K. Another substitution of Arg548 (R548H) was found in an Italian family that 
was reported suffering from basilar migraine and absent from a large group of controls.37 
Both Arg548 mutations resulted in similar functional effects and are likely disease-causing. 
The difference between FHM and basilar migraine could be due to the minor difference 
in apparent K+ affinities, yet undiscovered differences in genetic background, or perhaps 
diagnosing an atypical case of FHM as basilar migraine. 
The ATP1A2 P786L variant was identified in a family with sporadic hemiplegic migraine 
(SHM) without additional associated neurologic symptoms like cerebellar ataxia or epilepsy.23 
The P786L mutation had occurred de novo as it was not present in the proband’s parents 
and false paternity was excluded. P786L completely disrupted the catalytic activity of 
Na+,K+-ATPase. 
E174K was found in a family in which several members suffered from migraine with aura, 
whereas the mutation was not observed in 520 control chromosomes.19 The high degree 
of conservation of this negative charge and the finding that the kinetic properties of 
Na+,K+-ATPase are affected provide some evidence that E174K may be involved in causing 
the migraine phenotype and is not merely a rare non-causal polymorphism. Still, as the 
mutation was also present in the unaffected maternal grandfather, the functional effects of 
E174K appear not sufficient to cause the migraine phenotype. 
In contrast to the disease-causing ATP1A2 mutants described above, we observed no or only 
very minimal catalytic effects for mutants R879Q, C702Y, Y9N and R51H. Of them, R879Q 
was identified in a Danish nationwide search of SHM patients.28 It was not detected in the 92 
controls and was found in several unaffected family members.28 C702Y occurred in a family 
with occipitotemporal epilepsy and migraine without aura and was present in four unaffected 
individuals and absent in 170 control individuals.29 Y9N was identified in two SHM patients 
and the healthy mother of one of the probands.28,38 Moreover, Y9N has been observed in 
the unaffected mother of a carrier with the R583Q mutation.28 Finally, a Portuguese three-
generation family with migraine without aura harbored the R51H variant.39 R51H was 
not present in 346 control chromosomes and seemed to co-segregate reasonably well with 
migraine without aura in the proband’s nuclear family. Cell survival assays39 and the present 
study, however, fail to provide any evidence for a functional consequence of this variant. The 
absence of functional abnormalities in this study suggests that R879Q, C702Y, Y9N and R51H 
for the moment should be regarded rare missense variants without a clear pathogenic effect.
In conclusion, in this study, we analyzed 11 mutations in the Na+,K+-ATPase α2-subunit 
that have been reported in patients with various migraine phenotypes. Four FHM 
mutations (R548C, E700K, G900R, E902K) and one SHM mutation (P786L) clearly affected 
Na+,K+-ATPase pump function and must be regarded disease-causing. Most of them probably 
hamper the interactions between Na+,K+-ATPase domains during the catalytic cycle. Of 
the non-hemiplegic migraine mutations, E174K (migraine with aura) and R548H (basilar 
migraine) affected Na+,K+-ATPase pump function as well. No functional effects were, however, 
observed for SHM mutations Y9N, P786L, and R879Q and for R51H and C702Y that were 
found in patients with migraine with or without aura. Our current results strengthen the role 
of ATP1A2 mutations in FHM2 and SHM.
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Abstract
De novo mutations in ATP1A3, the gene encoding the α3-subunit of Na+,K+-ATPase, are 
associated with the neurodevelopmental disorder Alternating Hemiplegia of Childhood 
(AHC). The aim of this study was to determine the functional consequences of six ATP1A3 
mutations (S137Y, D220N, I274N, D801N, E815K, and G947R) associated with AHC. Wild 
type and mutant Na+,K+-ATPases were expressed in Sf9 insect cells using the baculovirus 
expression system. Ouabain binding, ATPase activity, and phosphorylation were absent in 
mutants I274N, E815K and G947R. Mutants S137Y and D801N were able to bind ouabain, 
although these mutants lacked ATPase activity, phosphorylation, and the K+/ouabain 
antagonism indicative of modifications in the cation binding site. Mutant D220N showed 
similar ouabain binding, ATPase activity, and phosphorylation to wild type Na+,K+-ATPase. 
Functional impairment of Na+,K+-ATPase in mutants S137Y, I274N, D801N, E815K, and 
G947R might explain why patients having these mutations suffer from AHC. Moreover, 
mutant D801N is able to bind ouabain, whereas mutant E815K shows a complete loss of 
function, possibly explaining the different phenotypes for these mutations.
Introduction
Alternating hemiplegia of childhood (AHC) is a rare, severe neurodevelopmental disorder, 
reported for the first time in 1971 by Verret and Steele.1 The incidence of AHC has been 
estimated at 1 in 1,000,000 births, with disease usually ensuing within the first six months.2 
AHC is characterized by episodes of hemiplegia on alternating sides of the body3, which can 
last from a few minutes up to several days. Other symptoms that can occur during AHC 
episodes include pallor, abnormal eye movements, movement disorders, dystonia and severe 
cognitive impairment.4 Patient studies have reported different provoking factors: water 
exposure, extreme temperatures, physical activity, bright light, and stress.5 Falling asleep 
leads to disappearance of all symptoms, although they may return after waking up. The 
exact mechanism of disease is unknown, although treatment with Flunarizine (a Ca2+ influx 
inhibitor specific for vascular smooth muscle and neurons) has been reported to reduce 
symptoms.6,7 However, the effectiveness and long-term effects of this treatment are unknown.5 
AHC was recently linked to de novo mutations in ATP1A3, the gene encoding the 
Na+,K+-ATPase α3-subunit.8,9 Most mutations are located in or near the ten transmembrane 
domains of Na+,K+-ATPase. Interestingly, two mutations (D801N and E815K) found in 66% 
of the AHC patients show differences with regard to disease severity, where E815K has been 
associated with a more severe phenotype.10 Previously, ATP1A3 mutations were identified in 
patients suffering from rapid-onset dystonia parkinsonism (RDP).11 Until now, there has been 
only one mutation that is reported in AHC and RDP cases (D923N), indicating minor overlap 
between both diseases.12-14
Na+,K+-ATPase plays a major role in maintaining the electrochemical gradient across the 
plasma membrane. The α-subunit is the catalytic component of this transport protein, 
which together with the β-subunit forms a functional transporter enzyme, in some tissues 
accompanied by a third or gamma-subunit. In humans, four different isoforms of the 
α-subunit exist. Three of these isoforms are expressed in the human brain: α1 in multiple cell 
types due to its ubiquitous expression, including neurons and glial cells, α2 predominantly in 
astrocytes, and α3 in peripheral and central nervous system neurons.15,16 When catalytically 
active, Na+,K+-ATPase transports three sodium ions out of the cell and two potassium ions 
into the cell, a process fueled by hydrolysis of one molecule ATP.15 During this catalytic cycle, 
Na+,K+-ATPase is present in the E1 or the E2 conformation, depending on the association 
of either Na+ or K+ to the ion binding sites (Fig. 1A). The presence of both ATP and Na+ is 
necessary for phosphorylation of the protein in the E1 state, which leads to a conformational 
change into the Na+-bound phosphorylated conformation (E1P-ADP). During transition 
to the E2P state, Na+ is released out of the cell, followed by binding of K+, which initiates 
dephosphorylation of the protein and transition into the K+-bound E2 state.17 Binding of ATP 
drives the protein back into the E1 state, completing the catalytic cycle.
The effect of ATP1A3 mutations on protein functionality is hardly studied. Moreover, whether 
different phenotypes can be linked to specific mutations is not known. In this study, we 
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Figure 1 Na+,K+-ATPase ion-transport scheme and structure.
(A) Albert-Post scheme of the reaction cycle of Na+,K+-ATPase: transport of Na+ and K+ across the cell membrane 
is accomplished by a series of conformational changes of Na+,K+-ATPase based on binding of either Na+ or K+, 
leading to phosphorylation or dephosphorylation, changing the affinity of the enzyme for its ligands. During each 
reaction cycle, three Na+ ions are transported out of the cell, in return transporting two K+ ions into the cell. This 
process requires the hydrolysis of ATP, to drive the transition into the high energy E1P and E2P states. Binding of 
DLCs, well-known inhibitors of Na+,K+-ATPase function, is only possible in the E2P or E2 state. (B) Crystal structure 
of the Na+,K+-ATPase heteromer in the E2 state (PDB: 3KDP32), with the location of the six mutations studied here 
highlighted by spheres. Note how five mutations are located in or near transmembrane regions, whereas mutant 
D220N is located in the large cytosolic loop between transmembrane domains two and three. The six residues are 
conserved between the α1- and α3-isoforms, making the α1-isoform crystal structure suitable for representation. 
Blue is α-subunit, red is β-subunit, green is γ-subunit, and yellow is used to highlight the mutations studied here. 
Figure was created using YASARA software.
determined the functional consequences of six de novo ATP1A3 mutations (S137Y, D220N, 
I274N, D801N, E815K, and G947R, see Fig. 1B) in order to relate protein functionality to 
AHC phenotypes.
Materials and methods
The Gateway system
The desired mutations were obtained by first performing two PCRs (A and B) on human 
Na+,K+-ATPase alpha 3 wild type cDNA using either a 5’- or 3’-primer in combination 
with a primer containing the desired mutation, resulting in two different fragments 
that were subsequently combined for a final PCR (C) using only the 5’- and 3’-primers, 
allowing annealing of the two fragments (A and B) containing the desired mutation. Next, 
the obtained mutant Na+,K+-ATPase α3-isoform was cloned into an entry vector using BP 
Clonase II enzyme according to the manufacturer’s instructions (Invitrogen). After successful 
transformation of entry clones into DH5α cells and overnight selection, colonies were grown 
overnight in liquid medium and subsequently isolated using the Genelute™ mini prep isolation 
kit (Sigma-Aldrich). Following a restriction analysis, full length sequencing of the different 
constructs was performed to check for successful mutagenesis. Subsequently, the entry clones 
were combined with an empty destination vector already containing the β1-encoding gene 
(ATP1B1) using LR Clonase II (Invitrogen), resulting in an expression clone containing the 
desired mutation. As a negative control, an expression clone containing YFP in combination 
with the β1-subunit was used for mock transfection.
Generation of recombinant viruses
The expression clones, generated using the Gateway system, were transformed to competent 
DH10Bac Escherichia coli cells (Life Technologies, Breda, the Netherlands) harboring the 
baculovirus genome (bacmid) and a transposition helper plasmid. Upon transposition 
between the Tn7 sites present in both the bacmid and expression clone, recombinant 
bacmids were selected and isolated.18 Subsequently, the obtained bacmids were transfected 
to Spodoptera frugiperda (Sf)9 insect cells using Cellfectin reagent (Life Technologies, Breda, 
the Netherlands). After a 6-day period, recombinant baculoviruses were harvested and used 
to infect fresh Sf9 cells at a multiplicity of infection of 0.1. After another 6 days of culture of 
infected Sf9 cells, amplified baculoviruses were harvested.19 
Protein production
Sf9 cells grown at 27 °C in T175 and later in 500 mL shaking flasks in Xpress medium 
(Sigma, Bornem, Belgium) were infected at a density of 1.5 ·106 cells mL-1 in the presence of 
1% (v/v) ethanol, as described before.20 After three days of infection, cells were harvested by 
centrifugation at 2,000 ×g for 5 min. Then, the pelleted cells were resuspended at 0 °C in a 
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250 mM saccharose, 2.0 mM EDTA and 20 mM HEPES/Tris at pH 7.0 buffer. Sonication was 
performed for 30 s at 80 W prior to centrifugation at 10,000 ×g at 4 °C for 30 min, followed 
by centrifugation of the resulting supernatant at 100,000 ×g at 4 °C for 1 h. The pelleted 
membranes were resuspended in the buffer mentioned above, homogenized, and stored at 
-20 °C before use in biochemical studies. 
Western blotting
Approximately 20 µg of membranes were treated with SDS-PAGE solubilization buffer 
overnight at room temperature before loading on a 10% polyacrylamide gel, as described 
previously.21 After separation, the proteins were transferred to a polyvinylidene fluoride 
membrane and subsequently blocked in 5% Elk in TBS-T. Then, α- and β-subunits were 
detected using either the G36 (anti-α) or C385-M77 (anti-β) antibodies, respectively.20,21 
ATPase activity studies
To determine the ATPase activity in Na+ or K+ affinity studies, 20 µL of membranes was 
incubated in a final volume of 100 µL containing 50 mM Tris-Ac at pH 7.0, 0.1 mM EGTA, 
1.25 mM MgCl2, 1.0 mM Tris-N3, 100 µM of radiolabeled ATP, and 50 mM NaCl or 5.0 mM 
KCl and increasing concentrations of either KCl or NaCl. After incubation of the samples 
for 30 min at 37 °C, the reaction was stopped by addition of 500 µL 10% (w/v) charcoal in 
6% (v/v) trichloroacetic acid and after 10 min at 0 °C the mixture was centrifuged for 30 s. 
Subsequently, 150 µL of the clear supernatant was mixed with 4 mL OptiFluor before analysis 
using a liquid scintillation counter to determine the amount of inorganic phosphate (Pi) 
formed, a measure for ATPase activity.22 The Na+,K+-ATPase specific activity was determined 
by subtracting the amount of Pi formed in the presence of 1.0 mM ouabain. Maximum ATPase 
values were determined by measuring the activity in the presence of 50 mM NaCl, 5.0 mM 
KCl, 1.25 mM MgCl2 and 0.1 mM ATP at pH 7.0.
Phosphorylation assay
Sf9 membranes were incubated in 60 µL medium, containing 50 mM Tris-acetic acid 
(pH 7.0), 1.25 mM MgCl2, 100 mM NaCl and in the presence or absence of 10 mM KCl. 
After 30 min preincubation, 10 µL of 0.6 µM [γ-32P]ATP was added and incubated for 10 
s at 0 °C. The reaction was stopped by adding 5% TCA and (phosphorylated) protein was 
collected by filtration through a 0.8 µm membrane filter. After repeated washing with ice-
cold water the filters were added to 4 mL OptiFluor and analyzed by liquid scintillation 
analysis.22 Phosphorylation was calculated by subtracting the amount of phosphate detected 
(phosphorylated protein) in the presence of KCl from the amount obtained in the absence of 
KCl.
Ouabain binding experiments
Ouabain binding was determined by incubation of approximately 150-200 µg of membranes 
in the presence of 20 mM histidine, 5.0 mM MgCl2, 5.0 mM H3PO4 at pH 7.0, (varying 
concentrations of KCl) and 25 nM of radiolabeled ouabain (Perkin-Elmer, Waltham, MA, 
USA) in a final volume of 60 µL at room temperature for 2 h. After incubation for 15 min on 
ice, the amount of bound ouabain was determined by washing the samples through a 0.8 µm 
ME27 filter using H2O, retaining the enzyme-bound ouabain. The radioactivity retained on 
the filters was determined in a liquid scintillation counter after addition of 4 mL OptiFluor 
(Canberra Packard, Tilburg, the Netherlands).23 
Data analysis
All data were analyzed using Graphpad Prism 5.02. Statistical analysis (ANOVA, with Dunnet’s 
post test comparing to mock values, n ≥ 3 for all experiments and α=0.05) was performed to 
test for differences in maximum ouabain binding, apparent ouabain affinity, apparent Na+ 
and K+ affinities, maximum phosphorylation levels and maximum ATPase activity levels 
compared to mock. The Na+0.5 and K+0.5 values were calculated via the Hill equation using the 
averaged data and SEM values. The Hill coefficient obtained for wild type Na+,K+-ATPase was 
used also for calculation of the half-maximum Na+ and K+ concentrations of mutants. 
Analysis of crystal structures
Three different crystal structures representing α1β1 Na+,K+-ATPase in the E1P-ADP (4HQJ24), 
E2P-ouabain (4HYT25), and E2K+·Pi (2ZXE26) conformations were used to identify possible 
interactions involving the mutations characterized in the present study. YASARA software 
(www.YASARA.org) was used to visualize these crystal structures and identify hydrogen (H-) 
bond interaction networks.
Results
Analysis of expression
Six single mutations associated with AHC (S137Y, D220N, I274N, D801N, E815K, and 
G947R, see Fig. 1B) were introduced in the α3-subunit of Na+,K+-ATPase. Wild type and 
mutant Na+,K+-ATPase were expressed in Sf9 insect cells using the baculovirus expression 
system. The membrane fractions of these Sf9 cells were isolated and used for biochemical 
characterization. Similar expression levels for wild type and mutant enzymes were detected by 
Western blot analysis using antibodies against the α- and β-subunits (Fig. 2). 
Mutant D220N is catalytically active
The Na+,K+-ATPase activity of both wild type and mutants was determined in the presence 
of 100 µM ATP, 5.0 mM KCl and 50 mM NaCl. Five mutants did not show ATPase activity 
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different from mock (Fig. 3). Significantly higher ATPase activities were observed for wild 
type enzyme and mutant D220N (p < 0.05). The activities of wild type enzyme (1.2 ± 0.1 µmol 
Pi mg-1 h-1) and mutant D220N (0.98 ± 0.05 µmol Pi mg-1 h-1) were not significantly different. 
The absence of ATPase activity for the other mutants indicated that these mutations result in 
a catalytically inactive enzyme. 
Figure 3 ATPase activity of mutant and wild type Na+,K+-ATPase. 
Enzymes were incubated at 37 °C in the presence of 1.3 mM MgCl2, 0.1 mM EGTA, 2.0 mM Tris-N3, 50 mM Tris-
acetic acid (pH 7.0), 100 µM radiolabeled ATP, 5.0 mM KCl and 50 mM NaCl for 30 min. Na+,K+-ATPase activity 
was corrected for background by subtracting mock values. Values are presented as mean ± SEM with N ≥ 3. * p < 0.05 
versus mock, ANOVA with Dunnett’s post test.
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Figure 4 Effect of Na+, K+ and ATP on the ATPase activity of wild type and mutant Na+,K+-
ATPase.
Enzymes were incubated at 37 °C in the presence of 1.3 mM MgCl2, 0.1 mM EGTA, 2.0 mM Tris-N3, 50 mM Tris-
acetic acid (pH 7.0), 50 mM or varying concentrations of NaCl (A), 5.0 mM or varying concentrations of KCl (B), 
and 100 µM or varying concentrations of ATP (C) for 30 min. Values are presented as mock corrected mean ± SEM 
with N ≥ 3.
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Figure 2 Expression levels of mutants. 
Western blot of Na+,K+-ATPase α- and β-subunits for six different Sf9 membrane preparations. Membranes (20 µg) 
were run on a 10% SDS-PAGE gel and transferred to a PVDF membrane. The presence of α- and β-subunits was 
detected using antibodies G36 and C385-M77, respectively.20,21
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Na+, K+, and ATP affinities for mutant D220N and wild type enzyme are similar
Next, we determined the effect of Na+, K+ and ATP on the ATPase activity. Since mutant 
D220N was the only protein that showed ATPase activity, these experiments were performed 
only for this mutant. The Na+ affinity was determined by measuring ATPase activity at 
increasing concentrations NaCl in the presence of 0.1 mM ATP and 5.0 mM KCl. ATPase 
activity increased with increasing Na+ concentration (Fig. 4A), and no significant differences 
in apparent Na+ affinity were observed between wild type and the mutant D220N (K0.5 of 
11 ± 1 mM and 12 ± 1 mM, respectively).
The K+ affinity was determined by measuring ATPase activity at increasing concentrations 
KCl in the presence of 0.1 mM ATP and 50 mM NaCl. As shown in figure 4B, there were no 
significant differences in apparent K+ affinity between wild type (K0.5 = 0.62 ± 0.1 mM ) and 
mutant D220N (K0.5 = 0.56 ± 0.1 mM).
The ATP affinity was determined by measuring ATPase activity at increasing ATP 
concentrations in the presence of 50 mM NaCl and 5.0 mM KCl. Figure 4C shows no 
differences in apparent ATP affinity (K0.5 of 55 ± 19 µM (wild type) and 86 ± 27 µM (D220N)).
Phosphorylation capacity
One of the features of the Na+,K+-ATPase reaction cycle is phosphorylation of the protein, 
forming an acid-stable intermediate. Both Na+ and ATP are necessary for the conformational 
change of the protein from the E2 state to the phosphorylated E2P state. In the absence 
Figure 5 ATP phosphorylation level of wild type and mutant Na+,K+-ATPase. 
Membranes expressing Na+,K+-ATPase were pre-incubated with 50 mM Tris-acetic acid (pH 7.0) 100 mM NaCl and 
1.25 mM MgCl2 at 0 °C for 30 min. Then, 0.1 µM radiolabeled ATP was added for 10 seconds before the reaction was 
stopped. Values are presented as mean ± SEM with N ≥3. * p < 0.05 versus mock, ANOVA with Dunnett’s post test.
of K+ and high levels of Na+, the enzyme will accumulate in this conformation (Fig. 1A). 
The phosphorylation capacity of all mutants was determined by measuring the amount of 
phosphoenzyme (EP) in the presence of 100 mM NaCl and 0.1 µM ATP, background-corrected 
for the amount of EP present when 10 mM KCl was added (allowing dephosphorylation to 
take place as well). Phosphorylation of mutants S137Y, I274N, D801N, E815K, and G947R 
was absent (Fig. 5). Mutant D220N showed a phosphorylation level of 1.8 pmol EP mg-1, 
similar to wild type enzyme (1.8 pmol EP mg-1). 
Mutants S137Y, D220N and D801N bind ouabain
The conformational change from E2 to E2P-ouabain via E2P (backdoor phosphorylation) could 
be determined in the presence of 5 mM Pi and increasing concentrations of [3H]-ouabain. 
Ouabain binding was observed for wild type Na+,K+-ATPase and three mutants: S137Y, 
D220N, D801N (Fig. 6A). The other three mutants (I274N, E815K and G947R) showed no 
ouabain binding. Mutant D801N showed an increase in maximum ouabain binding compared 
to wild type enzyme (6.6 pmol mg-1 versus 1.5 pmol mg-1). Mutant S137Y showed a decreased 
EOmax (1.0 pmol mg-1), whereas mutant D220N exhibited ouabain binding capacity equal to 
wild type enzyme (1.5 pmol mg-1). Calculated ouabain affinities (Kd) of mutants and wild type 
enzyme were not significantly different. 
K+/ouabain antagonism is absent in S137Y and D801N
As described above, three mutants (S137Y, D220N and D801N) were able to bind ouabain 
(Fig. 6A), whereas only one of them (D220N) showed ATPase activity (Fig. 3). In order to 
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Figure 6 Ouabain binding experiments.
(A) Ouabain-binding capacity of wild type and mutant Na+,K+-ATPase. Membranes were incubated at room 
temperature in the presence of 50 mM histidine pH 7.0, 10 mM MgCl2, 5 mM H3PO4, 25 nM radiolabeled ouabain 
and different concentrations of non-radiolabeled ouabain. Values are presented as mean ± SEM with N ≥ 3. Three 
mutants (I274N, E815K and G947R) did not bind ouabain and are not shown. (B) The effect of K+ on ouabain binding. 
Membranes were incubated at room temperature in the presence of 50 mM histidine at pH 7.0, 10 mM MgCl2, 5.0 
mM H3PO4, 25 nM radiolabeled ouabain and increasing concentrations of KCl for 2 h. Values are presented as mean 
± SEM with N ≥ 3, corrected for values obtained in the absence of KCl.
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determine whether the K+-binding was affected, we studied the well-known antagonism 
between K+ and ouabain (Fig. 1A). We measured the relative ouabain binding at increasing 
concentrations of KCl in the presence of 25 nM ouabain: a decrease in ouabain binding 
was seen for wild type and mutant D220N upon increasing KCl concentrations (Fig. 6B). 
The inhibitory effect of KCl on ouabain binding was not observed for S137Y and D801N, 
indicating that K+ is not able to bind to these mutants. 
In silico analysis of mutants
In silico analysis of three crystal structures representing α1β1 Na+,K+-ATPase in various 
conformations (E1P-ADP, E2P-ouabain, and E2K+·Pi) resulted in identification of various 
H-bond interactions involving the residues corresponding to Ser137 and Glu815. In the E2P-
ouabain crystal structure, Ser137 was predicted to form a hydrogen bond with Gln85, whereas 
Glu815 was involved in a network of H-bonds involving residues Asn761, Lys928, Asn937, and 
Asn941 in multiple crystal structures. Finally, Gly947 was observed to have limited space due to 
the close proximity of Val807 and Pro808 as observed for the E2P-ouabain conformation.
Discussion
Alternating hemiplegia of childhood (AHC) is a rare, severe neurodevelopmental 
disorder caused by de novo mutations in the ATP1A3 gene, coding for the α3-isoform of 
Na+,K+-ATPase. In this study we examined the functional consequences of six single mutations 
in ATP1A3 associated with AHC. The amino acids affected in all six mutations are highly 
conserved in Na+,K+-ATPase, suggesting an important impact of the mutations on enzyme 
function.27 Here, we discuss the relationship between functional activities of the mutants and 
the AHC phenotype. A summary of the experimental findings obtained for the mutants and 
wild type Na+,K+-ATPase is shown in table 1.
D220N possesses biochemical characteristics similar to wild type enzyme
In general, AHC mutations are located near or inside one of the transmembrane domains. 
One exception to this rule appears to be D220N, located in the cytosolic loop between 
transmembrane domains 2 and 3 (Fig. 1B). We could not identify any statistically significant 
differences between D220N and the wild type enzyme. Protein expression, ATPase activity, 
apparent Na+, K+, and ATP affinities, phosphorylation, ouabain binding, as well as the ouabain/
K+ antagonism were all similar to those of wild type enzyme. These results imply that this 
mutation is possibly not pathogenic, although we have not investigated protein localization. 
Further studies are required to explain the severe phenotype reported for this mutation.8
Catalytic activity
All six ATP1A3 mutants were expressed at protein levels comparable to that of wild type 
enzyme. However, no significant ATPase activity or phosphorylation level was detected for 
S137Y, I274N, D801N, E815K and G947R. Moreover, I274N, E815K, and G947R could not 
bind ouabain, which indicates that these mutations result in a severely affected protein with 
a complete loss of function.
Whereas almost all AHC-linked mutations are de novo, I274N was reported in a family 
with several members suffering from a form of alternating hemiplegia.8 Kirshenbaum et al. 
modeled the structure of Na+,K+-ATPase with I274N, which showed a loss of interaction 
between Glu776 with its interacting K+ atom and also a disturbance of the side-chain interaction 
between Thr272 and Ile274.12 These changes might seriously impact protein functionality, 
thereby explaining the lack of ATPase activity. 
The absence of ATPase activity in mutant E815K was reported previously in a study using 
COS-7 cells.8 In three crystal structures, representing the E1P-ADP, E2P-ouabain and E2K+·Pi 
conformations (4HQJ24, 4HYT25 and 2ZXE26, respectively), we could identify an extensive 
interaction network between the side chains of Glu815 with Asn761, Lys928, Asn937 and Asn941, 
which is possibly affected by replacement of the negatively charged glutamic acid by a 
positively charged lysine. 
Mutant G947R is located in transmembrane domain 9. Being located in an α-helix, a change 
from glycine to arginine might strongly disturb the helix structure. Based on a crystal 
structure representing the E2P-ouabain conformation (4HYT25), we found that the side chain 
of arginine at this position has limited space, as residues Val807 and Pro808 (in transmembrane 
domain 6) are located near Gly947. Also, Gly947 is located close to Glu951, important in regulating 
the C-terminal ion pathway.28 In addition, a recently published crystal structure of the Na+-
bound state suggested that G947R affects the IIIa ion binding site of Na+,K+-ATPase, which is 
important for the release of Na+ ions following transition from the E1P-ADP state to the E2P 
state.24
ATPase activity Na+ K0.5 K
+ K0.5 ATP K0.5 Max. binding Ouabain Kd K+/ouabain antagonism
µmol Pi mg
-1 hour-1 mM mM µM pmol mg nM IC50 (mM) EP mg
-1 -1
wild type  0.94 ± 0.11 11 ± 1 0.62 ± 0.1 55 ± 19 1.55 ± 0.20 17 ± 5 2.7 ± 1.1  1.42 ± 0.10
S137Y -0.12 ± 0.07 - - - 1.01 ± 0.17 37 ± 10 >>  0.07 ± 0.05
D220N  0.71 ± 0.05 12 ± 1 0.56 ± 0.1 86 ± 27 1.53 ± 0.16 27 ± 5 2.9 ± 1.2  1.43 ± 0.06
I274N  0.07 ± 0.03 - - - not converged - -  0.21 ± 0.06
D801N -0.03 ± 0.06 - - - 6.62 ± 2.58 54 ± 31 >> -0.03 ± 0.04
E815K -0.07 ± 0.02 - - - not converged - -  0.05 ± 0.08
G947R -0.09 ± 0.06 - - - -0.02 ± 0.01 - -  0.07 ± 0.11
ATPase activity studies
Phosphorylation
Ouabain binding studies
Data represent mean ± SEM of three enzyme preparations corrected for background values. * = p < 0.05 versus 
mock, - = not tested, >> = exceeding tested range.
Table 1 Summary of catalytic properties of wild type and mutant Na+,K+-ATPase. 
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Ouabain and K+ binding
S137Y and D801N failed to show ATPase activity, whereas significant ouabain binding was 
present. We conclude that these two mutations result in correctly folded protein, capable of 
binding ouabain, yet with an impaired reaction cycle. It appeared that they can transit into the 
ouabain binding E2P conformation, indicating that the conformation that is affected involves 
the Na+ binding E1 state. The absence of phosphorylated protein also points in this direction, 
as ATP phosphorylation occurs via the E1 state of the enzyme. 
The ouabain binding capacity of these mutants allows us to evaluate the K+ binding capacity. It 
is known that ouabain and K+ act as antagonists, and a change in K+ affinity should therefore 
be reflected by a shift in the K+/ouabain competition curve. Although the amount of ouabain 
bound enzyme was decreased for wild type and D220N upon addition of K+, we could not 
observe this phenomenon for S137Y and D801N. This indicates that the latter mutations 
decrease the affinity for K+, which together with the absence of phosphorylation suggest that 
S137Y and D801N affect cation binding in general.
Whereas this study reports on the biochemical effects of the S137Y mutation, low ATPase 
activity for S137F was reported before in COS-7 cells.8 Ser137 is located within the second 
transmembrane domain where it forms an H-bond with Gln85 as based on our in silico 
analysis of the recently published E2P-ouabain structure.25 Gln85 is located just before the 
characteristic αM1 kink, important in the N-terminal ion pathway of the enzyme29, through 
which the cations pass. Replacing the serine with a tyrosine might have a strong impact on 
the interaction between serine and glutamine, due to the bulky aromatic ring in the side chain 
of tyrosine.
Mutant D801N belongs to the most frequent mutations in AHC cases.8,9 This mutation has 
been reported to reduce ATPase activity in COS-7 cells8, in accordance with our results. In 
addition, we have previously shown a lack of phosphorylation for the corresponding residue 
(Asp804) in rat α1-isoform Na+,K+-ATPase.30 Contrary to our results, Pedersen et al. described 
phosphorylation of mutant D804N after Na+ stimulation in yeast cells.31 Structural modeling 
of the D801N mutation predicted a direct effect on binding of potassium ions8,12, reflecting the 
highly important role of Asp801 in coordination of ion binding sites I and II in K+-occlusion32 
and Na+-coordination24,33, and also binding of a Mg2+ ion in site II in the high resolution 
ouabain bound structure.25 We speculate that replacing aspartic acid with asparagine at this 
position increases the preference of the enzyme for the E2P-DLC conformation by decreasing 
the preference for the E2P conformation. For the rat Na+,K+-ATPase α1-isoform it was already 
known that Asp804 (corresponding to Asp801 in human) plays a major role in the cation binding 
pocket.31,34 
Mechanism of disease
Unfortunately, the exact mechanism of disease for ATP1A3 mutations remains to be 
understood. It is known that the α3-subunit of Na+,K+-ATPase is found mainly in the central 
and peripheral nervous system, and therefore it is not surprising that these mutations have 
a neurological effect. The first study to look at the functional consequences of AHC at the 
cellular level was published recently35, reporting a structural and functional granule defect 
in platelets and fibroblasts of AHC patients. Furthermore, increased cathepsin B-dependent 
apoptosis in fibroblasts was observed, linking lysosomal defects to decreased ATPase activity. 
It is highly challenging to correlate changes in biochemical characteristics to the frequency 
and duration of attacks in patients suffering from AHC. However, due to the high frequency 
of D801N and E815K, responsible for most AHC cases, it was possible to show that E815K 
causes a more severe phenotype than D801N.10 Although both enzymes are catalytically 
inactive, we found that D801N is able to bind ouabain, whereas E815K is not. Possibly, the lack 
of ouabain binding might link E815K to its severe phenotype. Previous studies have shown 
that ouabain and other digitalis-like compounds are produced endogenously, both in adrenal 
cells as well as in the hypothalamus.36 The role of Na+,K+-ATPase as a signal transducer might 
provide an explanation for the less severe phenotype observed for D801N compared with 
E815K. A possible role of endogenous ouabain in AHC should be the subject of future studies. 
Conclusion
Our study is the first to show in detail the biochemical properties of six AHC causing mutations, 
and reveals that mutations in ATP1A3 affect the functionality of Na+,K+-ATPase, which might 
explain why they are associated with AHC. However, no differences in protein function were 
observed for mutant D220N compared to wild type Na+,K+-ATPase. Mutants I274N, E815K, 
and G947R did not result in functional protein as reflected by a complete loss of ouabain 
binding and ATPase activity, rendering them unsuitable for further studies. Mutants S137Y 
and D801N could bind ouabain, but showed no ATPase activity, no phosphorylation, and an 
impaired K+ binding. The presence of ouabain binding might provide an explanation for the 
less severe phenotype observed for D801N as compared to E815K. 
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Abstract
Na+,K+-ATPase plays an important role in the maintenance of membrane potential and ion-
gradients across the cellular membrane. It serves this role at the expense of ATP consumption: 
for every molecule that is hydrolyzed, three sodium and two potassium cations are transported 
out of and into the cell, respectively. A functional enzyme consists of at least two subunits: 
a catalytic α-subunit and a β-subunit that is necessary for proper trafficking of the enzyme 
to the cellular membrane. In the human body, four isoforms of the Na+,K+-ATPase catalytic 
subunit exist, each with a specific tissue expression pattern. Previous unpublished studies by 
our lab have revealed that upon expression of all four α-isoforms in Spodoptera frugiperda 
(Sf)9 cells, maximum ATPase activity was lowest for the α4-isoform, and highest for the 
α2-isoform. Interestingly, it has been suggested that the α4-isoform gene originated from the 
α2-isoform gene. Therefore, we aimed to elucidate the structural features determining the 
difference in maximum ATPase activity between the isoforms. By designing and producing 
various chimeras consisting of residues of both isoforms, we found that Ile679 and Pro692 in 
the α4-isoform are responsible for the low activity, as compared to the corresponding Met670 
and Thr683 in the α2-isoform. The two amino acids identified are located in the P-domain 
of Na+,K+-ATPase, which harbors a Rossmann-fold: a structural motif characteristic for 
nucleotide binding proteins. By using homology modeling, in silico analysis of the identified 
residues revealed that hydrogen-bonds predicted for the α2-isoform are not present in the 
α4-isoform. The physiological role of the α4-isoform probably has emerged from that of the 
α2-isoform, associated with a decreased need for enzyme activity.
Introduction
Na+,K+-ATPase plays an essential role in cellular life: ATP-mediated transport results in 
transfer of Na+ and K+ over the plasma membrane against steep concentration gradients. 
These gradients are the driving force for secondary active transporters and help maintain 
the membrane potential.1 Na+,K+-ATPase consists of at least two subunits: a large catalytic 
α-subunit and a β-subunit that together constitute a functional protein. The human genome 
encodes four α-isoforms, which are expressed tissue specifically. The α1-isoform is expressed 
in all human cell types, whereas the α2- and α3-isoforms are found in a limited number of 
tissues, including muscle cells, astrocytes, leukocytes and neurons. The α4-isoform is restricted 
to germ cells in the testis, playing an essential role in sperm motility and hyperactivation, 
hence, mice lacking this isoform show complete loss of fertility.2-4
In general, the similarity of all four α-isoforms of Na+,K+-ATPase is high. Interestingly, the 
α4-isoform shows the lowest degree of similarity (~78%) with the other three, which are 
even more closely related to each other (~87%). The lower similarity of the α4-isoform might 
reflect a different physiological role as opposed to the other isoforms. Analysis of evolutionary 
patterns of the various isoforms indicated that the α4-isoform possesses the highest similarity 
to the α2-isoform.5 Unpublished studies by our laboratory have shown that expression of all 
four human α-isoforms together with the β1-subunit in insect cells resulted in the highest 
ATPase activity for α2β1-isoform, whereas the α4β1-associated ATPase activity was almost 
negligible.
The goal of this study was to understand how the difference in ATPase activity between 
these two isoforms emerged. Using baculovirus-mediated expression of a large number of 
chimeras and single mutants of the α2- and α4-isoforms in insect cells lacking endogenous 
Na+,K+-ATPase, we were able to identify two α4-specific amino acids that are responsible for 
the difference in ATPase activity between these two isoforms.
Methods
The Gateway system
The cDNA for the α2- and α4-isoforms was obtained by purchasing vectors (Thermo 
Scientific MHS1011-9199751 and MHS1010-98075446) containing the cDNA obtained from 
a human teratocarcinoma cell line or human testis (cDNA: NM_000702 and NM_14469). 
The desired chimeras were obtained by performing PCRs on human wild type α2- and 
α4-isoform encoding cDNA using either a 5’- or 3’-primer together with a chimera/mutation 
specific primer (Biolegio, Nijmegen, the Netherlands) annealing at the transition(s)/mutation 
site. Using Gateway cloning (Life Technologies, Breda, the Netherlands), the chimera/single 
mutant cDNA was then transferred to an entry vector containing a kanamycin resistance 
cassette using BP Clonase II enzyme according to the manufacturer’s instructions. After 
successful transformation of entry clones into Escherichia coli DH5α cells and overnight 
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selection, colonies were inoculated in selective LB medium, grown overnight and plasmid 
was subsequently isolated using the Genelute™ mini-prep isolation kit (Sigma-Aldrich). Then, 
full-length sequencing of the different constructs was performed to check for successful 
mutagenesis. Subsequently, expression clones were obtained by inserting the chimera/single 
mutant gene carrying the mutation in the Gateway Reading Frame Cassette B behind a 
polyhedrin promoter in an ampicillin resistant pFastBac Dual transfer vector containing the 
β1-subunit behind the p10 promoter using LR Clonase II enzyme (Life Technologies, Breda, 
the Netherlands). After successful transformation of expression clones into Escherichia coli 
DH5α cells and overnight selection on ampicillin selection plates, colonies were inoculated 
in LB medium containing ampicillin, grown overnight and subsequently isolated using the 
Genelute™ mini-prep isolation kit (Sigma-Aldrich). Throughout the cloning procedures, YFP 
was used as a negative control, resulting in an expression clone encoding YFPβ1. 
Generation of recombinant baculoviruses
The expression clones generated using the Gateway system were transformed to competent 
DH10Bac Escherichia coli cells (Life Technologies, Breda, the Netherlands) harboring the 
baculovirus genome (bacmid) and a transposition helper plasmid, conferring resistance 
against kanamycin, gentamycin, and tetracycline. Upon transposition between the Tn7 sites 
present in both the bacmid and expression clone6, recombinant bacmids were selected on 
LB-agar plates containing kanamycin, gentamycin, and tetracycline. Subsequently, resistance-
selected bacmids were transfected to Spodoptera frugiperda (Sf)9 insect cells grown in Grace 
medium (Sigma, Bornem, Belgium) at 27 °C in 175 cm2 monolayers using Cellfectin reagent 
(Life Technologies, Breda, the Netherlands). After 6 days, recombinant baculoviruses were 
harvested and used directly to infect fresh Sf9 cells at a multiplicity of infection of 0.1.7 After 
another 6 days of culture of infected Sf9 cells, the amplified baculoviruses were harvested.8 
Protein production using recombinant virus
Sf9 cells grown at 27 °C in 175 cm2 monolayers and later in 500 mL shaking flasks in Xpress 
medium (Sigma, Bornem, Belgium) were infected at a density of 1.5 ·106 cells mL-1 in the 
presence of 1% (v/v) ethanol, as described before.9 After three days of infection, the cells 
were harvested by centrifugation at 2,000 ×g for 5 min. Subsequently, the pelleted cells were 
resuspended at 0 °C in a 0.25 M sucrose, 2 mM EDTA and 20 mM Hepes/Tris (pH 7.0) buffer. 
Sonication was performed for 30 s at 80 W prior to centrifugation at 10,000 ×g at 4 °C for 30 
min, followed by centrifugation of the resulting supernatant at 100,000 ×g at 4 °C for 60 min. 
The pelleted membranes were resuspended using the buffer mentioned above, homogenized 
and stored at -20 °C and the protein concentration was determined using the modified Lowry 
method.10 Of all proteins described in this study we produced two independent batches for 
analysis.
Western blotting
Approximately 10 µg of membranes was treated with SDS-PAGE solubilization buffer 
overnight at room temperature before loading on a 10% polyacrylamide gel, as described 
previously.11 After separation, the proteins were transferred overnight to a polyvinylidene 
difluoride (PVDF) membrane using dry blotting (iBlot, Life Technologies). Both subunits 
were detected using the polyclonal antibodies C356-M09 (α-subunit) and C385-M77 
(β-subunit) antibodies.9,11 
ATPase activity studies
Maximal ATPase activity was estimated from Na+-affinity studies by incubating 20 µL of 
membranes in a final volume of 100 µL containing 50 mM Tris-Ac pH 7.0, 0.1 mM EGTA, 
1.2 mM MgCl2, 1.0 mM Tris-N3, 5.0 mM KCl, and 100 µM of radiolabeled ATP in the 
presence of increasing concentrations of NaCl. After incubation of the samples for 30 min 
at 37 °C, the reaction was stopped by addition of 500 µL 10% (w/v) charcoal in 6% (v/v) 
trichloroacetic acid and after 10 minutes at 0 °C, the mixture was centrifuged for 30 s 
(10,000 ×g). Subsequently, 150 µL of the clear supernatant was mixed with 4 mL OptiFluor 
before analysis using a liquid scintillation counter to determine the amount of formed Pi 
(inorganic phosphate), a measure of ATPase activity.12 Na+,K+-ATPase specific activity was 
determined by subtracting the amount of Pi formed in the presence of 1.0 mM ouabain. 
[γ-32P]ATP (3000 Ci mmol-1) was obtained from Perkin-Elmer (Waltham, MA, USA).
Data analysis
All data was analyzed using Graphpad Prism 5.02. Maximum ATPase activity was determined 
using non-linear curve fitting of log-transformed sodium concentrations. The ATPase activity 
of the α2-isoform was set at 100% and all other chimeras and single mutants were related 
to this value. Since all experiments were performed on two independent batches of protein, 
average ATPase activities are shown in the figures. Sequence alignments were performed 
using the web-based ClustalW2 program. 
Generation of homology models
Crystal structures of the α1-isoform of Na+,K+-ATPase and sarcoendoplasmic reticulum 
Ca2+-ATPase (SERCA) were used as templates for four homology models representing the 
α4-isoform in the E1Na+ (2C9M13), E1P-ADP (3WGU14), E2P (4HYT15), and E2K+·Pi (2ZXE16) 
conformations. These homology models were built using YASARA software and the WHAT 
IF Twinset using default parameters. Minimization was performed using an automatic 
YASARA protocol and default settings.17 
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Results
To identify the amino acids responsible for the observed difference in ATPase activities 
between the wild type α2- and α4-isoforms of Na+,K+-ATPase, we performed a series of 
chimera and single mutagenesis studies (Table 1). We were able to identify two residues in 
the P-domain of Na+,K+-ATPase that confer a tenfold increase in ATPase activity upon the 
α4-isoform following substitution by the corresponding α2-isoform residues. 
The first series of experiments confirmed the difference in ATPase activity between both wild 
type proteins observed previously by our lab, with an eightfold difference in ATPase activity 
for the chimeras produced (Fig. 1). Replacement of the C-terminal part of the α2-isoform 
with the corresponding α4-isoform derived residues resulted in an increase in ATPase activity 
(chimera 4), whereas extension of the α4-isoform sequence towards αM4 decreased the activity 
dramatically (chimera 5). Introduction of the large cytosolic loop connecting αM4 and αM5 
in the α4-isoform by the corresponding residues from the α2-isoform (chimera 10) increased 
ATPase activity to 1.6 µmol Pi mg-1 hour-1 (171% of wild type α2), while protein expression 
was unchanged (Fig. 1). Hence, the amino acids responsible for the observed difference in 
ATPase activity between both isoforms are located in the loop connecting transmembrane 
domains αM4 and αM5.
Based on the high ATPase activity observed for chimera 10, five chimeras were designed 
(11-15) possessing αM4-αM5 loops that were partially substituted with α4-isoform residues 
(Fig. 2). Chimeras 12, 13, and 14 showed clearly increased (12 and 14) or mildly decreased 
ATPase activities, indicating that the amino acids replaced by α4-isoform residues are not 
Chimera Composition on amino acid level
Chim. 4 α2 1 – 750, α4 760 – 1029
Chim. 6 α2 1 – 348, α4 359 – 1029
Chim. 10 α4 1 – 358, α2 349 – 750, α4 760 – 1029
Chim. 11 α4 1 – 430, α2 421 – 750, α4 760 – 1029
Chim. 12 α4 1 – 358, α2 349 – 420, α4 431 – 481, α2 472 – 750, α4 760 – 1029
Chim. 13 α4 1 – 358, α2 349 – 471, α4 482 – 550, α2 541 – 750, α4 760 – 1029
Chim. 14 α4 1 – 358, α2 349 – 540, α4 551 – 643, α2 635 – 750, α4 760 – 1029
Chim. 15 α4 1 – 358, α2 349 – 634, α4 644 – 1029
Chim. 16 α4 1 – 358, α2 349 – 420, α4 431 – 643, α2 635 – 750, α4 760 – 1029
Chim. 17 α4 1 – 643, α2 635 – 750, α4 760 – 1029
Chim. 18 α4 1 – 358, α2 349 – 407, α4 418 – 643, α2 635 – 750, α4 760 – 1029
Chim. 19 α4 1 – 417, α2 408 – 420, α4 431 – 643, α2 635 – 750, α4 760 – 1029
Chim. 20 α4 1 – 358, α2 349 – 420, α4 431 – 660, α2 652 – 750, α4 760 – 1029
Chim. 21 α4 1 – 358, α2 349 – 420, α4 431 – 643, α2 635 – 651, α4 661 – 675, α2 667 – 750, α4 760 – 1029
Chim. 22 α4 1 – 358, α2 349 – 420, α4 431 – 643, α2 635 – 666, α4 676 – 1029
Chim. 23 α4 with I679M, Q680T, K682E, Q686E, Q689K, P692T, L714Q, and V717I
Table 1 Design of chimeras used in this study.
Amino acid constitution of a selection of the chimeras designed and expressed for this study. 
responsible for the high activity associated with α2-isoform enzyme. Clearly, chimeras 11 
and 15 possessed lower ATPase activities compared with wild-type α2-enzyme: 0.4 and 0.1 
µmol Pi mg-1 hour-1, respectively. Together, these results indicated that the amino acids responsible 
for the observed differences between both isoforms are located either in the N-terminal 
and/or the C-terminal segments of the αM4-αM5 loop.
In order to investigate the role of both the N-terminal and C-terminal segments of the 
αM4-αM5 loop, another series of chimeras was designed (Fig. 3). Since chimeras 
16-19 showed high ATPase activity, the role of the N-terminal part was considered of minor 
importance compared to the C-terminal part. Chimeras 20 and 21 possessed increased 
ATPase activities, further pinpointing the high activity-associated amino acids to the very last 
segment of the αM4-αM5, confirmed by a marked decrease in ATPase activity observed upon 
0.0 0.5 1.0 1.5 2.0 2.5 3.0
Max. ATPase activity
(µmol Pi mg
-1 hour-1)
1 2 3 4 5 6 7 8 9 10
Figure 2 Overview of results obtained for the second series of chimeras produced, focused on 
the cytosolic loop between transmembrane regions αM4 and αM5.
From left to right: graphical representation of chimera design, representative Western blot showing expression levels, 
maximum ATPase activity obtained from Na+-affinity studies, maximum ATPase activity relative to α2-isoform wild 
type enzyme. Maximum ATPase activity represents the average of two independently produced batches of protein. 
Figure 1 Overview of results obtained for a selection of the initial screen of chimeras.
From left to right: graphical representation of chimera design, representative Western blot showing expression levels, 
maximum ATPase activity obtained from Na+-affinity studies, and maximum ATPase activity relative to α2-isoform 
wild type enzyme. Maximum ATPase activity represents the average of two independently produced batches of 
protein. 
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7identified were not unique for the α4-isoform: Ile679, Gln686, and Gln689 were found in at least two human isoforms. Next, a sequence alignment was performed to study the amino acid 
sequence of the α4-isoform across therian mammals, which are the only organisms possessing 
this isoform. As figure 6 shows, the two amino acids identified above were likely introduced 
into the α4-isoform upon the emergence of the Hominidae family: man, chimpanzee, and 
orangutan share Ile679 and Pro692, whereas various other mammals (ranging from elephant, 
bat, mouse, guinea pig, green monkey, crab-eating macaque, and olive baboon) express 
different amino acids at these positions.
Finally, we constructed homology models representing the α2- and α4-isoforms in the four 
basic conformations (E1, E1P, E2, and E2) of Na+,K+-ATPase to identify possible intramolecular 
interactions, which might explain the effect observed upon replacement of Ile679 and Pro692 
with methionine and threonine, respectively. Model calculations revealed for both isoforms 
introduction of α4-derived residues to this segment with chimera 22 (0.4 µmol Pi mg-1 hour-1). 
Because chimera 22 possessed only eight amino acid substitutions compared with wild type 
α4-isoform, we concluded that one or more of these eight mutations present in the very last 
segment of the αM4-αM5 loop was responsible for the observed difference in activity.
Introduction of the α2-derived equivalents of all these eight amino acids into wild type 
α4-isoform increased maximal ATPase activity approximately tenfold, as shown in figure 4 
(Chimera 23: 2.1 µmol Pi mg-1 hour-1 versus α4 wild type: 0.2 µmol Pi mg-1 hour-1). This clearly 
confirmed that the very last segment of the αM4-αM5 loop is involved in the difference in 
ATPase activity between both isoforms. To identify the role of each of these amino acids, single 
mutation studies were performed, which indicated that four amino acids were associated 
with the increased ATPase activity observed for chimera 23: α4-I679M (0.6 µmol Pi mg-1 
hour-1), α4-Q680T (0.2 µmol Pi mg-1 hour-1), α4-K682E (0.2 µmol Pi mg-1 hour-1), and 
α4-P692T (0.4 µmol Pi mg-1 hour-1). Combination of the two mutations that conferred highest 
ATPase activity (I679M and P692T) resulted in an increase of activity to 112% of α2-isoform 
wild type enzyme (1.7 µmol Pi mg-1 hour-1), indicating that residues Ile679 and Pro692 together 
account for most of the loss of activity of the α4-isoform. Mutations Q680T and K682E were 
considered not of importance, since their additional introduction into the Ile679 and Pro692 
double mutant only slightly increased ATPase activity.
Now that the relevant amino acids were identified, sequence analyses were performed to 
understand the association of the mutants with the low ATPase activity of the α4-isoform. 
A comparison of the eight amino acids present in chimera 23 across the human isoforms 
(Fig. 5) showed that several of the identified amino acids are exclusively present in the 
α4-isoform, including Gln680, Lys682, Pro692, Leu714, and Val717. The other three amino acids 
0.0 0.5 1.0 1.5 2.0 2.5 3.0
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(µmol Pi mg
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Figure 4 Overview of results obtained for the final series of chimeras, aimed at identifying 
the specific amino acids responsible for differences in ATPase activity located within the 
C-terminal segment of the P-domain of Na+,K+-ATPase.
From left to right: graphical representation of chimera design, representative Western blot showing expression levels, 
maximum ATPase activity obtained from Na+-affinity studies, maximum ATPase activity relative to α2-isoform wild 
type enzyme. Maximum ATPase activity represents the average of two independently produced batches of protein.
α1-isoform   SQVNPRDAKACVVHGSDLKDMTSEQLDDILKYHTEIVFARTSPQQKLIIVEGCQRQGAIV 712 
α2-isoform   SQVNPREAKACVVHGSDLKDMTSEQLDEILKNHTEIVFARTSPQQKLIIVEGCQRQGAIV 709 
α3-isoform   SQVNPRDAKACVIHGTDLKDFTSEQIDEILQNHTEIVFARTSPQQKLIIVEGCQRQGAIV 702 
α4-isoform   SKVDASAAKAIVVHGAELKDIQSKQLDQILQNHPEIVFARTSPQQKLIIVEGCQRLGAVV 718 
Figure 5 Sequence alignment of all four human α-isoforms.
Grey-marked residues highlight the eight residues that were selected from the chimera studies, with bold residues 
marking the residue positions that confer the low ATPase activity to the α4-isoform.
0.0 0.5 1.0 1.5 2.0 2.5 3.0
Max. ATPase activity
(µmol Pi mg
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1 2 3 4 5 6 7 8 9 10
Figure 3 Overview of results obtained for the third series of chimeras produced, focused on 
the P-domain of the cytosolic loop of Na+,K+-ATPase. 
From left to right: graphical representation of chimera design, representative Western blot showing expression levels, 
maximum ATPase activity obtained from Na+-affinity studies, maximum ATPase activity relative to α2-isoform wild 
type enzyme. Maximum ATPase activity represents the average of two independently produced batches of protein.
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that the identified residues are flanking an α-helix, which joins two β-sheets belonging to 
the Rossmann fold present in the P-domain. Interestingly, in the E1 conformations of both 
isoforms the proximal β-sheet linked by the helix mentioned above is absent, whereas a 
hydrogen bond is predicted between the backbone of Pro692 and a loop that is organized 
into a β-sheet in the other three conformations for the α4-isoform, as shown in figure 7. 
For the α2-isoform, the same hydrogen bond was predicted for all conformations, except the 
E1 conformation.
Discussion
In this study we investigated the difference in ATPase activity between the α2- and α4-isoforms 
of Na+,K+-ATPase. For this purpose, we designed and produced various chimeras and single 
mutants, which were tested in an ATPase activity assay. We identified residues Ile679 and Pro692 
of the α4-isoform to be associated with the very low ATPase activity observed for this isoform. 
Proof for their involvement was obtained by the marked increase in ATPase activity observed 
upon replacement of these two residues with their α2-isoform derived counterparts. 
The α4-isoform was discovered last of the four isoforms and was found to be expressed in 
testis tissue only.3 Biochemical characterization of rat and human α4β1 and α4β3 (testis 
expresses both β-isoforms) enzymes expressed in insect cells showed that these two isoforms 
possess similar Na+, K+, and ouabain affinities, whilst the β-subunit does not significantly 
affect the affinities for any of the parameters tested.18,19 The latter study also showed that there 
are distinct differences between the α4- and α1-isoforms (testis expresses both isoforms): the 
α4-isoform possesses increased Na+- and decreased K+-affinities, respectively, whereas the 
ouabain affinity was significantly increased compared with the α1-isoform. In fact, the latter is 
hypothesized to play a housekeeping role and the α4-isoform is specifically involved in sperm 
motility19: α4-isoform knockout mice produce immotile spermatozoa incapable of (in vitro) 
HOMO            LKIPISKVDASAAKAIVVHGAELKDIQSKQLDQILQNHPEIVFARTSPQQKLIIVEGCQR 713 
PAN             LKIPISKVDASAAKAIVVHGAELKDIQSKQLDQILQNHPEIVFARTSPQQKLIIVEGCQR 713 
PONGO           LKIPISKVDASAAKAIVVHGAELKDIQSKQLDQILQNHPEIVFARTSPQQKLIIVEGCQR 693 
MACACA          LKIPISKVDASAAKAIVVHGTELKDLQSQQLDQILQNHTEIVFARTSPQQKLIIVEGCQR 713 
PAPIO           LKIPISKVDASAAKAIVVHGTELKDLQSQQLDQILQNHTEIVFARTSPQQKLIIVEGCQR 713 
CHLOROCEBUS     LKIPISKVDASAAKAIVVHGTELKDLQSKQLDLILQNHTEIVFARTSPQQKLLIVEGCQR 713 
CAVIA           RGIPVSQVNVKDAKAIVVHGSELKDMNLQQLKQIIKNHTEIVFARTSPQQKLIIVEACQE 717 
MUS             LNIPISQVNNKSVKAIVVHGSELKDMESQQLDDILKSYKEIVFARTSPQQKLIIVEGCQR 716 
MYOTIS          LKIPVDQVNSRDAKAIVIHGSKLKDLNSEQLDNILQNHTEIVFARTSPQQKLIIVEGCQR 715 
LOXODONTA       LQVPVSQINPRDVKAIVVHGSELKNLSSEQLDEILKNHSEIVFARTSPQQKLIIVEGCQR 715 
Figure 6 Sequence alignment of various mammalian α4-isoforms.
Grey-marked residues highlight the two identified amino acids across various mammalian species. HOMO: Homo 
sapiens (modern humans), PAN: Pan troglodytes (chimpanzee), PONGO: Pongo abelii (orangutan), MACACA: 
Macaca fascicularis (crab-eating macaque), PAPIO: Papio anubis (olive baboon), CHLOROCEBUS: Chlorocebus 
sabaeus (green monkey), CAVIA: Cavia porcellus (domestic guinea pig), MUS: Mus musculus (house mouse), MYOTIS: 
Myotis davidii (insectivorous bat), LOXODONTA: Loxodonta africana (African bush elephant).
A
B
Figure 7 Homology models of the four enzymatic conformations of the α2- and α4-isoform 
of human Na+,K+-ATPase.
Residues responsible for the observed ATPase activity differences highlighted in green. Under physiological 
conditions, Na+,K+-ATPase exerts its transport function by alternating between four different conformational states: 
E1, E1P, E2P, and E2. Panel A displays the localization of the two residues Met670 and Thr683 of the α2-isoform, with 
the formation of hydrogen bonds involving Thr683 in various conformations. Panel B highlights the localization of 
residues Ile679 and Pro692 of the α4-isoform, showing the formation of a hydrogen bond involving Pro692 in the E1 
conformation. Red represents the β-sheets that constitute the Rossmann-fold.
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fertilization.2 The distinct biochemical characteristics of α4β1- and α4β3-isoforms have been 
linked to a highly specialized function proposed for the α4-isoform: co-localized with the 
Na+/H+ exchanger (NHE) its role supposedly lies in maintaining a Na+ gradient that is used 
for extrusion of protons, which are released from mitochondria in the sperm cell flagellum.20 
In humans, an alternative regulator of intracellular pH in sperm is constituted by the proton-
selective channel Hv1, which is activated by membrane depolarization as well, providing an 
alternative mechanism of action for α4-mediated intracellular pH maintenance.21,22 
At the time of the discovery of the fourth isoform, its gene was shown to be physically 
linked to the α2-isoform encoding gene.23 This finding was confirmed recently by a study 
suggesting that the gene encoding the α4-isoform originated from the α2-isoform encoding 
gene.5 Previous studies have highlighted the differences between the various isoforms of rat 
Na+,K+-ATPase: whereas the apparent Na+ and ATP affinities are similar for α2β1- and α4β1-
isoforms, the apparent K+ affinity and ouabain affinity of the α4β1-isoform are decreased 
compared with the α2β1-isoform.18 Interestingly, we have observed before (unpublished 
studies) that these two isoforms exhibit different ATPase activities: the α2-isoform shows 
highest activity upon expression of all four isoforms in Sf9 insect cells, whereas the 
α4-isoform possesses lowest activity, approximately 0.1-0.2 µmol Pi mg-1 hour-1. Our goal was 
to identify the mutations that have conferred this low ATPase activity upon the α4-isoform 
in comparison with the closely related α2-isoform. The first series of chimeras resulted in 
identification of increased ATPase activity of an α4-based chimera where the αM4-αM5 
loop sequence was replaced by the corresponding amino acids from the α2-isoform. This 
showed that the low ATPase activity observed for α4-isoform wild type enzyme is not due to 
differences in amino acid sequences in any of the ten transmembrane regions or extracellular 
domains of Na+,K+-ATPase, but rather is associated with differences in either the nucleotide 
binding (N-) or phosphorylation (P-) domains, which together constitute the large cytosolic 
loop connecting αM4 and αM5. Follow-up studies based on the design of chimera 10 revealed 
that the amino acids responsible for the observed ATPase activity differences were located 
at the beginning (N-terminal) and/or end (C-terminal) part of the αM4-αM5 loop, together 
constituting the P-domain. Upon replacement of the C-terminal residues of the αM4-αM5 
loop with their corresponding α2-residues, the ATPase activity was increased dramatically 
compared with α4-isoform enzyme, highlighting the residues located within this region for 
further investigation. Eventually, we were able to narrow down the number of amino acids 
responsible for the observed effect to eight: the number of residues that are different between 
the α2- and α4-isoforms located within the 679-717 range of the α4-isoform sequence. 
Gain-of-function studies confirmed that indeed these amino acids were involved by showing 
that introduction of all eight α2-isoform derived amino acids into the α4-isoform resulted in 
a dramatic increase in ATPase activity compared with the α4-isoform wild type enzyme. Final 
experiments proved that the effect of introduction of these eight amino acids was mainly due 
to introduction of two mutations: I679M and P692T. Inclusion of two additional mutations 
(Q680T and K682E) resulted in only a minor increase in ATPase activity of α4 wild type 
enzyme, strengthening the hypothesis that I679M and P692T together are responsible for the 
observed differences in activity between the α2- and α4-isoforms.
As mentioned above, previous studies showed that the gene encoding the α4-isoform 
originates from the α2-encoding gene.5,23 Moreover, the former is hypothesized to be 
present only in therian mammals, based on analysis of evolutionary patterns of the various 
isoforms.5 Assuming that α2-isoform residues Met670 and Thr683 were mutated into isoleucine 
and proline during evolution, we studied the α4-isoform evolutionary pathway for the two 
mutations identified in the present study. Investigation of the presence of these two amino 
acids across the various human isoforms showed that Ile679 and Pro692 are both unique for the 
α4-isoform. The other three isoforms contain either a phenylalanine or methionine replacing 
the Ile679, while Pro692 appears to have originated exclusively with the emergence of the 
α4-isoform. Comparison of α4-isoform sequences between species revealed that both Ile679 and 
Pro692 are present in the sequence of all Hominidae family members including Pan troglodytes 
(chimpanzee), Gorilla gorilla (gorilla) and Homo sapiens (humans), whereas the Old World 
monkeys including Macaca fascicularis (crab-eating macaque), Papio Anubis (olive baboon), 
and Chlorocebus sabaeus (green monkey) differ in the amino acids located at these positions, 
suggesting introduction of these mutations upon the development of the great apes.
Both amino acids identified in the present study are located within the C-terminal part of the 
P-domain, the most conserved domain of Na+,K+-ATPase.24 The P-domain has a characteristic 
Rossmann-fold, a structural motif that is present in many nucleotide-binding proteins and 
in the case of Na+,K+-ATPase consisting of a central seven-stranded β-sheet flanked by 
various α-helices, including the cytoplasmic end of the fifth transmembrane domain (αM5).24 
Within this cytoplasmic site, Ile679 and Pro692 are flanking a small α-helix connecting the two 
Rossmann-fold β-sheets located at the cytoplasmic side of the protein in both the E1 and 
E2 conformations. Structural analysis did not result in identification of extensive hydrogen 
bond networks involving Pro692 in the α4-isoform (except for a minor interaction in the 
E1 conformation), excluding a direct role for these two residues in the conformational changes 
that take place during the Na+,K+-ATPase reaction cycle. Interestingly, the same hydrogen 
bond was predicted for all three conformations except the E1 conformation of the α2-isoform. 
Moreover, no significant hydrogen bonds were predicted for Ile679 or its α2-equivalent in both 
isoforms, although this residue showed the largest increase in ATPase activity in the single 
mutant studies. Located closely to the phosphorylation site of Na+,K+-ATPase, one hypothesis 
concerning the observed effect on ATPase activity might be that replacement of the two 
residues resulted in an altered orientation of the Rossmann-fold, in particular involving an 
α-helix containing a conserved lysine residue (α4 Lys694) essential for the transition to the E1P 
state by abstracting the negative charge of the Asp369 side chain and the γ-phosphate.25 
In conclusion, we have shown that replacing two α4-isoform amino acids with their α2-isoform 
counterparts (I679M and P692T) resulted in a dramatic increase in ATPase activity. These 
two amino acids are located in a short α-helix connecting two β-sheets at the cytoplasmic side 
of the Rossmann-fold present in the Na+,K+-ATPase P-domain, and were not predicted to 
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form H-bond networks based on homology modeling. Both amino acid substitutions appear 
to have been introduced upon the emergence of the great apes, since they are not found 
in other mammalian species. Possibly, the α4-isoform has emerged from the α2-isoform, 
although with a decreased need for ATPase activity, which has given rise to the two mutations 
described here.
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Introduction
Almost 60 years have passed since the discovery of Na+,K+-ATPase, and the scientific 
knowledge concerning this protein has been increasing steadily. Since 2009, when the 
project resulting in this thesis started, over 2500 articles have been published on the many 
functions of Na+,K+-ATPase. In these five years, the scientific community has taken a leap 
in understanding how this highly important protein is related to health and disease, through 
crystal structures of different conformations, newly discovered mutations in the isoforms, 
endogenous inhibitors, and an updated view on its role in signal transduction. The goal of 
the project was to investigate the various isoforms of Na+,K+-ATPase found in the human 
body. To this end a baculovirus expression system was used, taking advantage of the absence 
of endogenous Na+,K+-ATPase in insect cells used to produce different (mutant) isoforms. 
Not only was Na+,K+-ATPase itself studied, but also the effect of various inhibitors belonging 
to the ancient class of digitalis-like compounds (DLCs). Here, we discuss the results of the 
various studies published in this thesis in a broader context.
Na+,K+-ATPase and cellular signaling
Over the last ten years cellular signaling via Na+,K+-ATPase has received a lot of attention 
and is nowadays a firmly established concept. Various signaling pathways have been linked 
to Na+,K+-ATPase, including the EGFR-MAPK cascade, the PLC-γ pathway, and the PI3K 
pathway.1-3 The MAPK pathway is perhaps most extensively studied: it is thought that upon 
stabilization of the E2P-DLC conformation of Na+,K+-ATPase by binding of a DLC, the initiating 
event resulting in downstream MAPK signaling is alleviation of one of the Na+,K+-ATPase-
Src direct interactions, releasing the Src kinase domain from the Na+,K+-ATPase N-domain, 
thereby inducing Src autophosphorylation.4-6 The phosphorylated Src transmits the signal to 
downstream signaling proteins, resulting in MAPK activation, subsequently leading to effects 
on various cellular functions. Na+,K+-ATPase involved in DLC-mediated signaling resides in 
caveolae, which are small invaginations of the plasma membrane. Reportedly, approximately 
50% of total cellular Na+,K+-ATPase resides in caveolae, where the enzyme is dedicated to 
signaling and does not possess transport activity.7 However, over the last five years several 
studies have called into question the previously established view on the Na+,K+-ATPase-
EGFR-MAPK cascade and the specific role of caveolar Na+,K+-ATPase as described above. At 
first, extensive comparative studies between caveolar and noncaveolar Na+,K+-ATPase pools 
reported no distinct differences between both pools: both contain active enzyme, and more 
importantly, both pools possess active Src that cannot be further activated by ouabain, casting 
doubts over the proposed direct interaction between Src and Na+,K+-ATPase.8 This result is 
in line with our unpublished studies in LLC-PK1 cells, where we were not able to induce Src 
phosphorylation upon addition of ouabain to the culture medium. In addition, the results 
described in Chapter 2 show that Src activation is not induced by DLC-mediated inhibition 
solely, since vanadate was capable of inducing Src phosphorylation as well in a test tube set-up 
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using recombinant Src and purified Na+,K+-ATPase.9 This finding implies that Na+,K+-ATPase 
inhibition in general leads to local increases in ATP concentration, which subsequently result 
in Src autophosphorylation, a process that is inhibited when Na+,K+-ATPase is active (Fig. 1). 
This hypothesis is in sharp contrast with a study by Xie and coworkers, who reported that 
vanadate is not capable of inducing Src phosphorylation while using an similar experimental 
setup.6 This brings forward an important question: how can two similar assays result in 
such contradictory results? As mentioned above, the experimental setup used by our group 
was similar to the article by Xie and coworkers, and it is unlikely that small differences in 
experimental design led to opposite results. Our findings were recently confirmed by a study 
performed by another lab, again using a similar experimental setup, concluding as well that 
there is no evidence for a direct interaction between Src and Na+,K+-ATPase.10 This means 
that there are now two independent studies concluding that there is no biochemical evidence 
for a direct interaction between Src and Na+,K+-ATPase. Recently, the role of Src in cellular 
signaling was questioned with regard to the PI3K signaling pathway as well11, stressing the 
need for further elucidation of the molecular mechanism of DLC-mediated signaling via 
Na+,K+-ATPase. Until then, the exact role of Src and the molecular mechanism involved in 
cellular signaling remains uncertain.
Endogenous production of digitalis-like compounds
Digitalis-like compounds are highly specific inhibitors of Na+,K+-ATPase, which are well-
ATP ADP + Pi ATP ADP + Pi
Src pSrc
Extracellular
Intracellular
Figure 1 Schematic representation of the proposed mechanism of Src activation. 
Under normal conditions (left side), Na+,K+-ATPase consumes ATP at a high rate, preventing Src phosphorylation. 
However, upon binding of a Na+,K+-ATPase inhibitor (1) as depicted on the right side, the rate of ATP consumption 
by Na+,K+-ATPase decreases (2), leading to a concomitant increase of local ATP concentration (3), which can then be 
used for phosphorylation of Src (pSrc), initiating a signaling cascade (4). 
known in medical practice for their use in treatment of various heart conditions, including 
atrial fibrillation, atrial flutter and sometimes heart failure. Extracted from the leaves of 
Digitalis purpurea12 and isolated from the skin of DLC-resistant animals, these compounds 
have been used for both medicinal and hunting purposes. As mentioned in Chapter 1, 
various studies have pointed towards a role for endogenously produced DLCs in blood 
volume expansion.13-15 This has led to the identification of various endogenous DLCs, 
including ouabain16,17, dihydro-ouabain-like factor18, marinobufagenin19, telocinobufagenin20, 
19-norbufalin21, and bufalin.22 It is now widely accepted that the human body produces 
small amounts of DLCs, resulting in circulating concentrations that are too low to exert 
Na+,K+-ATPase inhibition. Therefore, a role in cellular signaling as described above has been 
suggested for these compounds. However, a recent study using ultra-performance liquid 
chromatography tandem mass spectrometry method (UPLC-MS/MS), with a lower limit of 
detection of 1.7 pM designed for the detection of endogenous ouabain, could not detect the 
compound in plasma from patients with and without heart failure.23 The authors point out 
that identification of endogenously produced ouabain using immunoassays likely suffers from 
limited specificity due to cross-reactivity with structurally similar compounds, explaining 
how previous studies have reported concentrations in the high picomolar range. This calls for 
a careful approach regarding immunoassay-based identification of endogenously produced 
DLCs, for instance by combining multiple analytical assays as well as testing for the presence 
of DLCs by performing functional assays.
DLC binding to Na+,K+-ATPase 
In recent years, the availability of crystal structures of enzymatic conformations has accelerated 
the pace of scientific developments concerning Na+,K+-ATPase. The first publication of a 
crystal structure of Na+,K+-ATPase with a DLC bound to its binding site described the low-
affinity DLC bound state E2-DLC obtained by ouabain soaking into previously formed E2 state 
crystals in the presence of K+.24 More recently, a crystal structure representing Na+,K+-ATPase 
in the E2P-DLC conformation obtained by co-crystallization of ouabain was published, 
representing the high-affinity ouabain bound state.25 This crystal structure revealed the 
presence of a magnesium ion in ion-binding site II and describes the possible involvement 
of this ion in long-range electrostatic interactions with the highly strained five-membered 
unsaturated lactone ring that is inserted deeply into the DLC binding site, 5 Å away from the 
ion-binding site. In addition, this study confirmed various previously published mutagenesis 
studies identifying key residues involved in binding of the apolar and polar sides of the steroid 
core of DLCs, strengthening the conclusions of these studies.26-30 
Although the published crystal structures have provided valuable information on binding of 
ouabain, crystal structures of Na+,K+-ATPase binding other DLCs are not available yet. At 
the same time, the decline of digoxin and ouabain use in clinical practice, due to their low 
therapeutic index, has renewed the interest in binding affinities of other DLCs, especially 
with regard to the other isoforms of Na+,K+-ATPase. This idea is based on the presence 
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of multiple isoforms in heart muscle cells where the ubiquitous α1- and more restricted 
α2- and α3-isoforms are expressed.31 Since the inotropic effect of DLCs is attributed to a direct 
increase in cardiac contractility, identification of structural compound properties that confer 
a high selectivity to the α2- and α3-isoforms over the ubiquitously expressed α1-isoform 
would be of great interest for future drug development. This goal has been approached 
from the ligand point of view by testing a variety of DLCs with regard to their binding 
affinities32-34, as well as from the receptor point of view by utilizing mutagenesis studies on 
Na+,K+-ATPase and mutants that confer increased or decreased affinities for specific DLCs.35 
Based on an observation concerning the binding affinity of dihydro-ouabain for non-gastric 
H+,K+-ATPase34, we set out to identify the interactions between hydrogenated forms of DLCs 
and amino acids present near the DLC-binding site as described in Chapter 3. Hydrogenated 
DLCs possess a fully saturated lactone ring, represented by absence of the double bond found 
in unsaturated lactone rings. Importantly, the unsaturated lactone ring was implicated in 
long-range electrostatic interactions with a magnesium ion in ion-binding site II as described 
above.25 We were able to obtain hydrogenated ouabain and digoxin by allowing ouabain and 
digoxin to react with H2 gas for 16 hours, resulting in complete hydrogenation of these two 
DLCs based on NMR measurements. Subsequently, via a series of mutagenesis studies of the 
α2-subunit we were able to link residues Met119 and Ser124 to differences in affinities between 
α1- and α2-isoforms to ouabain, dihydro-ouabain, digoxin, and dihydro-digoxin. Although 
the crystal structure representing the high-affinity bound ouabain state did not reveal the 
corresponding α1-residues to be involved in binding in this conformation, the mutagenesis 
studies clearly revealed that these two amino acids play an important role in isoform-
selectivity of these compounds. Since these two residues are located in the first extracellular 
loop linking transmembrane domains 1 and 2, their effect is most likely mediated by the 
initial binding and/or dissociation phase(s) of docking into the DLC binding pocket. We 
also observed another structural feature: the presence of a sugar moiety reduced the isoform 
selectivity. This is in contrast to a previous study, which found no such effect.32 
Na+,K+-ATPase and disease(s)
As mentioned above, four isoforms of the α-subunit are encoded by the human genome, 
each having a characteristic expression pattern. In the last five years, many studies have been 
conducted on the link between Na+,K+-ATPase isoform mutations and various diseases, 
revealing associations between various disease phenotypes and the tissue-specific roles of 
different isoforms (Table 1). The α1-isoform has been linked only to aldosterone-producing 
adenomas by somatic mutations.36 The absence of familiarly associated disease for this 
ubiquitously expressed isoform most likely reflects the absolute importance of Na+,K+-ATPase 
function for cellular life. Also, there have been no reports of mutations in the α4-isoform 
leading to disease. A promising direction for future research would be to screen subfertile 
men for mutations in the α4-isoform of Na+,K+-ATPase, since this protein is associated 
specifically with sperm motility and therefore is an interesting candidate with respect to 
subfertility-related mutations.37-41
In Chapters 4 and 5 we describe the biochemical characterization of various mutations of the 
α2-isoform leading to sporadic/familial hemiplegic migraine (SHM/FHM) type 2: a subtype 
of migraine characterized by neurological symptoms preceding the migraine attacks. In 
general, the proposed disease mechanism cause by these mutations is a loss of function of 
the α2-isoform that is expressed in astrocytes located at the synapses in the central nervous 
system. Astrocytes fuction as supporting cells, favoring the re-uptake of the neurotransmitter 
glutamate that is released upon arrival of a nerve impulse at the synaptic cleft. By uptake of 
extracellular potassium and extrusion of sodium, Na+,K+-ATPase provides the driving force 
necessary for reuptake of free glutamate via the glutamate transporter.42,43 However, there 
are still many questions that need answering regarding the pathophysiology of SHM/FHM 
type 2, including investigation of the exact sequence of events leading to a migraine attack, but 
also how specific mutations exert their effect on Na+,K+-ATPase function. Using baculovirus 
expression in insect cells, we were able to describe the biochemical characteristics regarding 
various SHM/FHM type 2 associated mutations. 
In Chapter 4 we describe the biochemical characteristics of nine mutations associated with 
SHM/FHM type 2. For six of the mutations we detected a significant loss of catalytic activity, 
providing a possible explanation for the phenotype of these mutations in line with the 
suggested role of the α2-isoform in astrocytes at the synaptic cleft: loss of Na+,K+-ATPase 
function results in loss of glutamate reuptake, leading to disturbed signal transduction 
over the synapses in the central nervous system. At the same time, a group of researchers 
from the university of Århus published an article revealing a third half-channel present in 
Na+,K+-ATPase, located in the C-terminal half of the enzyme.44 This half-channel transports 
protons to the third (IIIb) ion-binding site in the E2 conformation when potassium ions are 
bound at ion-binding sites I and II. Previous research had revealed that ion-binding sites I 
and II, located between transmembrane helices 4, 5, and 645,46, are accessible from the two 
sides of the membrane via two half-channels: one connecting these sites to the cytosol and 
the other linking the extracellular space with the core of the transmembrane region.47,48 One 
of the characteristic features of PII- and PIIIa-type ATPases is the presence of an additional 
Isoform α1 α2 α3 α4
Similarity to other isoforms ~ 90% ~ 90% ~ 90% ~ 80%
Expressed in All cells
Skeletal, Heart, and Vascular 
smooth muscle, Adipocytes, 
Astrocytes
Neurons, Ovaries, Heart 
skeletal muscle, White blood 
cells
Testis only
Associated disease(s) None (only somatic 
mutations reported)
Sporadic/familial hemiplegic 
migraine (SHM/FHM)
 type 2
Rapid-onset dystonia 
Parkinsonism (RDP), 
Alternating hemiplegia of 
childhood (AHC)
None (subfertility?)
Affected cell type (Glomerulosa cells) Astrocytes Neurons (Sperm cells)
Effect of mutation (Inappropriate depolarization) Loss of driving force for re-
uptake of glutamate
Unknown (Unknown)
Isoform studied in this thesis Chapters 2,3 Chapters 3, 4, 5 and 7 Chapter 6 Chapter 7
Table 1 Overview of the α-isoforms of Na+,K+-ATPase and their role in health and disease.
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C-terminal segment harboring four transmembrane helices.49 The aforementioned research 
group concluded from electrophysiological studies of various SHM/FHM type 2-associated 
mutations that an ion-pathway located within this C-terminal segment was affected. Our 
study included several mutations located within the region of the C-terminal half-channel 
as well, and indeed we confirmed for most of these mutants a severe loss of ATPase activity, 
whereas one mutant (R834Q) did possess a decreased ATPase activity compared with wild 
type enzyme. The work presented here and the discoveries of the Århus group provide crucial 
converging evidence for the mechanisms underlying diseases associated with SHM/FHM 
type 2-associated mutations. 
Chapter 5 describes how various SHM/FHM type 2 mutations likely affect domain interactions 
necessary for the conformational changes of the reaction cycle.50 However, for the other 
mutations that were studied we could not identify an effect on Na+,K+-ATPase functionality 
for any of the biochemical characteristics that we tested, suggesting either non-pathogenicity 
or an alternative mechanism of disease for these mutations.
Whereas SHM/FHM type 2 are associated with mutations in the α2-isoform, mutations in 
the α3-isoform of Na+,K+-ATPase have been linked to other neurological diseases, including 
rapid-onset dystonia parkinsonism (RDP) and alternating hemiplegia of childhood (AHC). 
RDP, which is characterized by an abrupt onset of symptoms including dystonia and 
parkinsonism, usually presents itself in teens and young adults51 and has been linked to a 
variety of α3-associated mutations.51-53 It was reported for the first time in the 1990’s, and 
at least 10 mutations in the gene encoding the third isoform of Na+,K+-ATPase have been 
reported until today.54 More recently, mutations in the same isoform were linked to another 
severe neurological disease: AHC55-59, which is characterized by episodes of (alternating) 
hemiplegia starting within the first year of life and associated with considerable co-morbidity. 
In contrast to RDP, AHC is characterized by seizures: symptoms usually disappear upon falling 
asleep, although attacks may last for several days. Patients may experience a high frequency of 
seizures, accounting for the devastating effects of this disease. On the other hand, the clinical 
severity of AHC cases has been reported to vary significantly.60-63 Since both RDP and AHC 
are now known to be caused by mutations in the α3-isoform of Na+,K+-ATPase and symptoms 
may overlap between both diseases, it has been suggested that both diseases represent 
different manifestations of one underlying disorder.64 In this hypothesis, AHC represents the 
more severe phenotype, whereas RDP is associated with less severe manifestations.65 One 
of the more frequently observed AHC-associated mutations (D801N)55,65 affects an amino 
acid (Asp801) that is associated with an RDP-causing mutation (D801Y) as well.52 Even more 
supportive of this hypothesis is mutation D923N, which has been detected in both RDP66,67 
and (mild) AHC patients.59,67,68 
In Chapter 6, we set out to investigate the biochemical characteristics of several frequently 
observed AHC-associated mutations because an extensive characterization was lacking and 
it became apparent that AHC showed a wide range of severity of disease. Indeed, using the 
baculovirus expression system to express six AHC-associated mutants (including D801N 
and E815K, responsible for ~ 60% of all cases), we were able to show differences in protein 
functionality, which improved our understanding of the relationship between disease severity 
and the various mutations. We showed that mutation E815K indeed resulted in a complete 
loss-of-function for the associated protein, whereas mutant D801N was able to bind ouabain 
and therefore might still function as a signaling protein, reflecting minor enzyme functionality 
for this mutation. These findings are in line with the less severe phenotype associated with the 
D801N mutation compared with the phenotype of E815K. This study is the first to describe 
the biochemical characteristics of AHC mutants in detail and provides important new 
information that might explain why the phenotypes of various mutations differ. 
The fourth isoform
Whereas the expression profile of the first three α-isoforms was known already in the 80’s69, 
it took until 1994 before it was clear that the fourth α-isoform encoding gene was expressed 
only in testis tissue.37 Until then, the role of the gene encoding this isoform (ATP1AL2, later 
renamed to ATP1A4) was unknown, although a physical link with the α2-gene had been 
established before.70 Following extensive biochemical characterization of this isoform38,71, 
further research highlighted expression mainly in germ cells of testes, with the highest 
amount of the α4-isoform present in spermatozoa, responsible for two thirds of the ATPase 
activity in gametes.72 This finding was confirmed in human tissue, where the amount of 
α4-isoform was shown to increase with sperm maturation, linking the enzyme to mature 
sperm physiology in humans.73 Moreover, the α4-isoform was shown to be localized within 
the sperm tail, predominantly in the mid-piece of the flagellum, and therefore was linked to 
sperm motility.74 The same study revealed that the human α4-isoform has a higher affinity for 
Na+ and a lower affinity for K+ and ouabain as compared to the α1-isoform also expressed in 
spermatozoa, suggesting a specialized role for the α4-isoform. More recently, sperm motility 
was shown to depend on the α4-isoform, since knock-out male mice were completely sterile 
and spermatozoa of these mice were unable to fertilize eggs in vitro.41 Together, these results 
point towards an important role for the human α4-isoform in male fertility. Unpublished 
studies by our lab had shown that ATPase activity observed for the α4β1-isoform expressed in 
insect cells was almost negligible, whereas the activity associated with the α2β1-isoform was 
the highest of all four isoforms. This led us to investigate how these two isoforms could differ 
so much in their ATPase activity. Via a series of mutagenesis studies, resulting in over 20 
chimaeras and selected single mutations of both isoforms, we were able to identify two amino 
acids responsible for the low ATPase activity of the α4-isoform. Upon replacement of these 
residues with their α2-isoform counterparts (I679M and P692T), we could induce a tenfold 
increase in ATPase activity of the α4β1 enzyme. The role for these two amino acids remains 
to be established, but this finding is of importance for future studies on the effect of mutations 
in the α4-gene. These might be associated with subfertility, and the increase in α4-isoform 
ATPase activity upon replacement of the two amino acids mentioned above facilitates a large 
window of measurement for future loss-of-function mutations.
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Conclusions and future directions
The work described in this thesis improves our understanding of Na+,K+-ATPase (patho)
physiology. We have contributed to the scientific knowledge on cellular signaling via the 
α1-isoform, questioning the proposed role of the Src protein in DLC-induced cellular 
signaling. Also, we have established an important difference in hydrogenated-DLC affinities 
between the α1- and α2-isoform and have identified two amino acids located within the first 
extracellular loop responsible for this effect. In addition, we have studied mutant proteins 
associated with either SHM/FHM type 2 (α2-isoform) and AHC (α3-isoform), providing 
important information on biochemical characteristics associated with these mutations. 
Finally, studies into the low ATPase rate observed for the α4 wild type enzyme led to the 
discovery of two amino acids responsible for this low activity as compared to the α2-isoform. 
For the future, several Na+,K+-ATPase related topics deserve further attention: (1) The 
presence of endogenously produced DLCs needs to be investigated using state-of-the-art 
mass spectrometry analyses in order to reach a decisive conclusion on their role in health 
and disease, also regarding the proposed signaling pathways initiated by these compounds; 
(2) With the advance of genomics, it is likely that future research will reveal new FHM2 type 
2- and AHC-related mutations in the α2- and α3-isoforms. Increasing our understanding of 
the effects of these and currently known mutations might help understand the role of Na+,K+-
ATPase in the phenotypical characteristics of these diseases; (3) Finally, we hypothesize that 
it is worthwhile to screen subfertile men for mutations in the gene encoding the α4-isoform. 
This isoform could be an interesting target for drug therapy since it plays a prominent role in 
sperm motility and since it is expressed exclusively in testis tissue. 
All in all, this thesis contributes to the understanding of the firstly discovered active transport 
protein, although every new answer generates new questions. Or, to use the words of the 
illustrious discoverer of the subject of this thesis, Jens Christian Skou: “Looking for the 
answer, you hunt it, you catch it, you fool yourself; the answer, is always, a step ahead.”75 
Let this thesis be a small step along the way to answering all questions regarding the many 
functions of Na+,K+-ATPase isoforms in health and disease. 
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Summary
The plasma membrane of animal cells consists of a lipid bilayer separating the intra- and 
extracellular environments, allowing for differences in the biochemical composition between 
both compartments. There are large differences across the membrane in the concentrations 
of ions, amino acids, proteins, and many other molecules. In order to fulfill its physiological 
role, each cell invests heavily in maintenance of its intracellular environment at the expense of 
cellular energy in the form of ATP. One of the prerequisites for cellular life is the presence of high 
intracellular K+ concentrations for neutralization of the negatively charged proteins present in 
the cell. The cell must employ a mechanism that ensures high intracellular K+ concentrations 
to allow proteins to function within their physiological range, while preventing swelling of the 
cell caused by the concomitant influx of water. Nature has solved this by elegantly balancing 
the influx of K+ by the efflux of another abundantly present cation: Na+. Cells go through great 
lengths in order to maintain an optimal intracellular environment, and the transport of Na+ 
and K+ across the cellular membrane is no exception. To maintain a high intracellular K+ and 
extracellular Na+ concentration the cell has to transport both cations in opposite direction 
across the membrane against their steep concentration gradients. This bidirectional transport 
is among the most energetically taxing processes that take place in the cell, accounting for 
approximately 30-40% of its ATP expenditure, or even higher percentages in certain tissues. 
In the 1950s, pioneering research by the Danish biochemist Jens Christian Skou led to the 
identification of an ATPase (ATP consuming enzyme) in the giant axons of squid tissue 
that was activated only in the simultaneous presence of Na+, K+, Mg2+, and ATP. At the time, 
the existence of active transport was still theoretical, and Skou’s discovery of what is now 
known to be Na+,K+-ATPase proved for the first time that active transporter enzymes do exist. 
Later studies showed that Na+,K+-ATPase exists as a heterodimer, consisting of a catalytic 
α-subunit that together with a β-subunit (required for proper folding and insertion into the 
membrane) forms an enzyme that translocates Na+ and K+ across the cellular membrane in 
a fixed stoichiometry (3:2, respectively) at the expense of one molecule of ATP, and that this 
process can be inhibited by digitals-like compounds (DLCs).
Nowadays, there is a wealth of information on the role of Na+,K+-ATPase within the human 
body, which is described in Chapter 1. The α-subunit is present in four different isoforms, 
and each isoform displays a tissue-specific expression pattern. This ranges from expression in 
all human cells as observed for the α1-isoform, to highly localized expression as observed for 
the α4-isoform, which is expressed solely in testis tissue. The other two α-isoforms display an 
intermediate expression pattern: whereas the α2-isoform is expressed by astrocytes located at 
the synaptic cleft (among other places), the α3-isoform is detected mainly in neurons of the 
central and peripheral nervous systems. All four α-isoforms have a physiological function 
that is reflected by their expression patterns. The α1-isoform, the most abundant of all four, 
is proposed to function as the housekeeping isoform. Present in every cell of the human 
body, it serves to maintain the essential ion gradients as discussed above. This isoform has 
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drawn renewed attention because of reports about the presence of pico- and nanomolar 
concentrations of various endogenously produced DLCs in blood plasma. Until then, DLCs 
were only known to exist in plants and certain animal species, mainly serving a protective 
role against predators. In fact, low concentrations of DLCs from plants have been used in 
medicine for the treatment of atrial fibrillation and heart failure: inhibition of Na+,K+-ATPase 
by DLCs results in inhibition of Na+ transport from the cell, eventually leading to increased 
contractility. With the discovery of endogenously produced DLCs in a concentration range 
that lies below the therapeutic range, it was hypothesized that these endogenous compounds 
are involved in cellular signaling events by inhibiting Na+,K+-ATPase only mildly. In 
Chapter 2, we investigated the role of Na+,K+-ATPase in one of the proposed DLC-induced 
signaling pathways where the enzyme is thought to be involved in a direct interaction with 
Src protein. In our experiments, we found no evidence for this proposed direct interaction. 
Using purified Na+,K+-ATPase and recombinant Src, we showed that phosphorylation 
of Src (suggested to be induced by a certain conformation of Na+,K+-ATPase) depended 
exclusively on the amount of ATP that was available in the test tube. We could induce Src 
phosphorylation not only by addition of digoxin, but also nonspecifically by depleting either 
Na+ or K+, or addition of another inhibitor, vanadate. These findings led us to conclude 
that there is not enough evidence for a mechanism of action including the proposed direct 
interaction between Na+,K+-ATPase and Src. We suggest that Src does indeed play a role in 
Na+,K+-ATPase-mediated signaling, but by means of a different mechanism, as shown by our 
findings. Recent publications from independent research groups have confirmed our findings 
regarding the role of Na+,K+-ATPase in Src-mediated signaling, which indicates that this 
pathway requires more investigation.
In Chapter 3 we also studied DLC binding to Na+,K+-ATPase, focusing on the binding affinities 
of (hydrogenated) ouabain and digoxin from both the ligand and the receptor perspective. To 
compare the various isoforms and their mutants, we made use of a baculovirus expression 
system, allowing us to obtain purified membrane fractions from insect cells that contained 
the desired (mutant) enzyme. We set out to investigate the binding affinities of various DLCs 
for the α1- and α2-isoforms. We observed that dihydro-ouabain showed a clear preference for 
the former, with an approximately tenfold difference in affinity between both isoforms. This 
was not seen for ouabain, although the structure of both DLCs only differs in a fully saturated 
(dihydro-ouabain) versus an unsaturated (ouabain) lactone ring moiety. Next, we investigated 
the specific amino acid residues responsible for the observed difference in affinity for 
dihydro-ouabain. We could identify two residues in the α2-isoform that upon conversion 
into their α1-isoform counterparts reduced the isoform selectivity that was present for 
the wild type enzymes: Met119 and Ser124 (α2-coding) reduced this difference significantly. 
The effect of hydrogenation of the lactone ring moiety was identical for digoxin and its 
hydrogenated form dihydro-digoxin: digoxin showed a preference for the α2-isoform, whereas 
dihydro-digoxin favored the α1-isoform, although the difference was less pronounced than 
observed with ouabain and dihydro-ouabain. Again, the same amino acids (Met119 and 
Ser124) appeared to play a role in the isoform selectivity. For digoxin, the preference for the 
α2-isoform could be reduced significantly upon replacement of Met119, whereas preference of 
dihydro-digoxin for the α1-isoform could be reversed by replacing Ser124. Together, these 
studies shed new light on the isoform selectivity for DLCs and their hydrogenated counterparts: 
isoform selectivity between the α1- and α2-isoforms is mediated via Met119 and Ser124.
Na+,K+-ATPase and disease
Over the last years, Na+,K+-ATPase has also received increasing attention for its involvement 
in development of disease. For instance, mutations in the α2-isoform have been linked 
to sporadic/familial hemiplegic migraine (SHM/FHM), rare subtypes of migraine with 
aura. Although the exact pathophysiological mechanism of these mutations remains to be 
determined, it is generally assumed that Na+,K+-ATPase expressed in astrocytes, located at the 
synaptic cleft as supporting cells, plays a role. Most likely, mutations in the α2-isoform hamper 
the catalytic functionality of the enzyme, thereby causing a decrease in the transmembrane 
gradients of both Na+ and K+. As a consequence, re-uptake of glutamate from the synaptic cleft 
is reduced, which contributes to the development of migraine attacks. Apparently, mutations 
associated with SHM/FHM affect the enzyme’s functionality. Therefore, we wanted to know 
what the exact biochemical effects of these mutations were. The results of our studies are 
described in Chapters 4 and 5.
Chapter 4 describes the role of nine SHM/FHM mutations in the development of disease. 
Based on assessment of one of the key parameters of Na+,K+-ATPase functionality, ATPase 
activity, we could identify six mutants with a complete loss of function: P796S, M829R, R834X, 
del 935-940 ins Ile, R937P, and D999H. All of these showed negligible amounts of ATPase 
activity. For mutant P796S, we speculated that introduction of a serine results in the formation 
of a hydrogen bond that might indirectly affect the association of the α- and β-subunits. 
Mutant M829R is suggested to have lost ATPase activity due to lack of important interactions 
stabilizing the interdomain region between the sixth and seventh transmembrane domains. 
As for the remaining four mutants showing complete loss of function, we hypothesize that 
these mutations all interfere with the integrity of a recently discovered half-channel, which 
is located within the C-terminal region of the enzyme and plays a very important role in the 
enzyme’s ion transport mechanism. Mutant T345A showed an insignificant increase in ATPase 
activity compared with α2 wild type enzyme, but this was paralleled by a minor increase in 
ouabain binding capacity. We could not provide an explanation for the role of this mutation 
in development of disease. The biochemical characteristics of mutant R879W also did not 
link to disease, and we could not identify any intramolecular interactions that might provide 
an alternative hypothesis. These two mutations could therefore constitute polymorphisms 
instead of disease causing mutations. Finally, we could identify a significantly decreased 
ATPase activity as well as maximum ouabain binding level for mutant R834Q. Although this 
mutation is also located within the C-terminal half-channel, apparently the resulting effect is 
not as detrimental as the other mutations within this region. 
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In Chapter 5 we characterized the biochemical effects of eleven additional SHM/FHM-
linked mutations. Again, we used baculovirus expression to obtain membrane fractions 
expressing mutant enzyme. We found that the effects of these mutations varied considerably. 
For instance, we could not identify any differences in biochemical properties between wild 
type enzyme and mutants Y9N, R51H, C702Y, and R879Q, suggesting that they do not play a 
role in the development of SHM/FHM. On the other hand, mutant P786L showed a complete 
loss of function, and we could not determine any ATPase activity or ouabain binding, 
which are hallmarks of Na+,K+-ATPase activity. Two mutants, R548C and R548H, showed a 
decrease in turnover rate, indicating that these mutants function at a lower speed, resulting 
in less transport of Na+ and K+, which could therefore explain their link to development of 
SHM/FHM. Turnover rates of mutants E174K and E700K were also lower, although not 
statistically different. The remaining two mutants (G900R and E902K) did not reveal any 
biochemical explanation for their role in development of disease, but both affected residues 
are considered to play an important role in interactions between the α- and β-subunits, and 
might therefore result in decreased functionality of the Na+,K+-ATPase pool present at the 
astrocyte’s plasma membrane.
Disease-causing mutations have also been linked to the α3-isoform. For instance, rapid-onset 
dystonia-parkinsonism (RDP), a severe neurological disorder, is associated with mutations 
in this isoform. More recently, it was shown that mutations located primarily in or near the 
transmembrane regions may lead to development of alternating hemiplegia of childhood 
(AHC), a disease characterized by episodes of hemi-paralysis that may occur already shortly 
after birth. Interestingly, it is hypothesized that these two different diseases (RDP and AHC) 
present two sides of a continuum of α3-isoform mutations. Chapter 6 provides an extensive 
biochemical characterization of six mutations found in AHC patients: S137Y, D220N, 
I274N, D801N, E815K, and G947R. Mutant D220N gave no changes in any of the tested 
parameters compared with the wild type enzyme, which suggests that this mutation may not 
be pathogenic, although we have not investigated protein localization. Three of the mutants 
(I274N, E815K, and G947R) lacked ATPase activity, ouabain binding, and phosphorylation, 
representative of a severe loss of function. Two mutants (S137Y and D801N) showed loss of 
ATPase activity and phosphorylation while both mutants were able to bind ouabain, suggesting 
that some protein functionality was still present. We hypothesize that the difference in 
protein functionality between mutants E815K and D801N (the two most frequently observed 
AHC-linked mutations) might reflect the difference in phenotype observed for these two 
mutations. 
Chapter 7, the last experimental chapter of this thesis, describes the difference in ATPase 
activity between the α2- and α4-isoforms. We have found previously that membrane fractions 
expressing the α2-isoform possess high ATPase activity, whereas the α4-isoform displays 
only minor activity. Since both isoforms are hypothesized to be linked evolutionarily, we set 
out to identify the amino acids involved in the difference in ATPase activity. By designing 
and producing a series of chimeric proteins aimed at identifying the region of the proteins 
responsible for this difference, we were able to show that replacement of only two amino 
acids in the α4-isoform with their α2-isoform counterparts resulted in a dramatic increase 
in ATPase activity. Both amino acids are located in the P-domain of the large cytosolic loop 
connecting the fourth and fifth transmembrane domains. Here, Ile679 and Pro692 (present in 
the α4-isoform) are located near the Rossmann-fold, which harbors the phosphorylation site 
of Na+,K+-ATPase, hypothetically affecting the ATPase activity through interference with the 
structural integrity of this region and thus leading to the significantly lower ATPase activity 
present for the α4-isoform. 
Chapter 8 describes the broader context of the studies reported in this thesis, stressing the 
crucial role of Na+,K+-ATPase in health and disease. We argue that there will be an increase in 
the amount of mutations linked to Na+,K+-ATPase isoforms, which will require biochemical 
characterization to help understand the phenotype. In addition, it is desirable to focus on 
establishing the presence of endogenous DLCs using state-of-the-art techniques that have 
recently become available. Finally, it would be very interesting to screen subfertile men for 
mutations in the α4-isoform, since this isoform is expressed solely in testis and therefore 
provides an interesting target for therapy. 
In summary, we have shown for the first time how AHC-linked mutations affect the protein’s 
various functions, and have shed new light on the proposed role of Na+,K+-ATPase in its 
proposed role in cellular signaling. We have also investigated the ouabain binding pocket with 
regard to binding of hydrogenated DLCs and have increased the knowledge on the effects of 
various SHM2/FHM2 linked mutations. Finally, we have been able to increase the ATPase 
activity of the α4-isoform upon replacing only two residues. Together, the studies reported 
here add to our understanding of the role of Na+,K+-ATPase in health and disease, illustrating 
how this enzyme plays a crucial role in the human body.
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Samenvatting
Het plasmamembraan van alle dierlijke cellen bestaat uit een dubbele lipidenlaag die de intra- 
en extracellulaire milieus scheidt, waardoor verschillen in de biochemische samenstelling van 
beide compartimenten mogelijk zijn. Zo bestaan er grote verschillen in concentraties van 
bijvoorbeeld ionen, aminozuren, eiwitten en vele andere moleculen aan weerszijden van het 
membraan. Om zijn fysiologische rol te kunnen vervullen investeert elke cel grote hoeveelheden 
energie in de vorm van ATP in het handhaven van de intracellulaire samenstelling. Eén van 
de noodzakelijke voorwaarden voor het goed functioneren van de cel is de aanwezigheid 
van een hoge cytosolaire concentratie van K+, waardoor de negatief geladen eiwitten worden 
geneutraliseerd. De cel heeft hiervoor een mechanisme nodig dat ervoor zorgt dat de 
intracellulaire concentratie van K+ hoog kan zijn, terwijl tegelijkertijd moet worden voorkomen 
dat het celvolume toeneemt door osmotische wateropname. De natuur heeft dit probleem 
opgelost door de cellulaire opname van K+ te compenseren met het uitpompen van Na+. Een 
belangrijk deel van de energie die de cel gebruikt voor het handhaven van het intracellulaire 
milieu, is nodig voor het transport van Na+ en K+ over het celmembraan. Doordat de 
extracellulaire Na+-concentratie en de intracellulaire K+-concentratie beide hoog zijn, moet de 
cel deze ionen in tegengestelde richting tegen hun concentratiegradiënt in transporteren. Dit 
is één van de meest energiekostende processen binnen de cel, dat naar schatting 30-40% van 
de totale ATP consumptie kost, terwijl dit percentage nog hoger ligt in bepaalde organen. In 
de jaren ’50 van de vorige eeuw leidde pionierswerk van de Deense biochemicus Jens Christian 
Skou tot de ontdekking van een ATPase (een ATP-verbruikend enzym) in axonen van de 
pijlinktvis dat alleen geactiveerd kon worden wanneer zowel Na+, K+, Mg2+ en ATP aanwezig 
waren. Tot dat moment was het bestaan van actief transport vooral een theoretisch concept, 
maar Skou’s ontdekking van wat tegenwoordig Na+,K+-ATPase wordt genoemd bewees voor 
de eerste keer dat er inderdaad eiwitten bestaan die actief transport verzorgen. Latere studies 
hebben aangetoond dat Na+,K+-ATPase een heterodimeer is: een eiwitcomplex dat bestaat 
uit een combinatie van een katalytische α-subeenheid en een β-subeenheid die betrokken 
is bij het vouwen, transporteren en invoegen van het enzym in het celmembraan. Na+ en K+ 
worden door het celmembraan heen getransporteerd in een vaste verhouding van 3:2 ten 
koste van één molecuul ATP, een proces dat geremd kan worden door de aanwezigheid van 
digitalis-achtige stoffen (DAS).
Tegenwoordig is er veel bekend over de functies van Na+,K+-ATPase in het menselijk 
lichaam, zoals in Hoofdstuk 1 beschreven. De α-subeenheid is aanwezig in vier verschillende 
isovormen, waarbij elke isovorm een weefselspecifiek expressiepatroon heeft. Dit varieert van 
expressie in alle cellen voor de α1-isovorm tot zeer gelokaliseerde expressie voor bijvoorbeeld 
de α4-isovorm, welke alleen aanwezig is in testisweefsel. De andere twee isovormen worden 
tot expressie gebracht in meerdere, maar niet alle organen: waarbij de α2-isovorm onder 
anderen voorkomt in astrocyten die gelokaliseerd zijn bij synapsovergangen, komt de 
α3-isovorm vooral voor in neuronen, zowel van het centrale als het perifere zenuwstelsel. Het 
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is aannemelijk dat alle vier de isovormen een rol hebben die past bij hun expressiepatroon. 
Zo duidt de aanwezigheid van de α1-isovorm in alle humane celtypen op een algemene, 
basale rol in de cellulaire fysiologie. Door de aanwezigheid van deze isovorm worden de 
essentiële ion-gradiënten tussen de intra- en extracellulaire compartimenten gehandhaafd. 
In de afgelopen decennia heeft deze isovorm echter hernieuwde aandacht gekregen, vanwege 
studies die de aanwezigheid van pico- en nanomolaire concentraties van enkele endogeen 
geproduceerde DAS aantoonden in het bloedplasma. Tot dan toe waren deze stoffen alleen 
aangetoond in planten en bepaalde diersoorten, die ze gebruiken als afweer tegen vraat en 
roofdieren. DAS verkregen uit planten werden al sinds lange tijd als geneesmiddel gebruikt 
ter behandeling van boezemfibrilleren en hartfalen: de remming van Na+,K+-ATPase door 
DAS leidt tot remming van het transport van Na+ uit de cel, wat uiteindelijk leidt tot een 
verhoogde contractiliteit van hartspiercellen. Doordat duidelijk werd dat het menselijk 
lichaam zelf ook DAS produceert, maar slechts in subtherapeutische concentraties, ontstond 
het idee dat deze stoffen mogelijk een rol spelen in cellulaire signaaltransductie door 
Na+,K+-ATPase minimaal te remmen. In Hoofdstuk 2 hebben we de rol van Na+,K+-ATPase 
in één van de mogelijke DAS-geïnduceerde signaaltransductiecascades onderzocht, waarbij 
Na+,K+-ATPase verondersteld wordt een directe interactie aan te gaan met het Src-eiwit. 
In onze experimenten vonden we echter geen bewijs voor een dergelijke interactie tussen 
beide eiwitten. Door recombinant Src en gezuiverd Na+,K+-ATPase samen te voegen in een 
reageerbuis ontdekten we dat Src-fosforylering (verondersteld veroorzaakt te worden door 
een bepaalde conformatie van Na+,K+-ATPase) direct afhankelijk was van de hoeveelheid 
ATP die aanwezig was. Zo konden we Src-fosforylering niet alleen induceren door toevoeging 
van digoxine (een DAS), maar ook door het verminderen van de Na+- of K+-concentraties 
of het toevoegen van vanadaat, een andere (niet-DAS) remstof. Deze resultaten leidden ons 
ertoe te concluderen dat er geen bewijs is voor een signaaltransductiemechanisme waarbij een 
directe interactie tussen Src en Na+,K+-ATPase betrokken is. Dit betekent niet dat Src geen 
enkele rol zou spelen in signaaltransductie via Na+,K+-ATPase, maar wel dat er waarschijnlijk 
een ander mechanisme aan ten grondslag ligt. Opvallend genoeg hebben andere laboratoria 
in recente studies onze bevindingen met betrekking tot de afwezigheid van een directe 
interactie tussen Src en Na+,K+-ATPase bevestigd. Dit betekent dat de precieze rol van Src in 
DAS-geïnduceerde signaaltransductie nog verder onderzocht dient te worden. 
In Hoofdstuk 3 bestudeerden we ook hoe DAS Na+,K+-ATPase beïnvloeden, maar met een 
ander doel. In dit hoofdstuk hebben we onderzocht hoe de affiniteiten van (gehydrogeneerde) 
DAS variëren tussen verschillende isovormen, zowel vanuit het perspectief van het ligand 
(in dit geval ouabaïne en digoxine) als van de receptor. Om de verschillende isovormen en 
mutanten van deze isovormen te kunnen bestuderen hebben we gebruik gemaakt van een 
baculovirus-expressiesysteem, waarmee we gezuiverde insectencelmembraanfracties met 
daarin aanwezig de gewenste (gemuteerde) isovormen konden verkrijgen. We richtten 
ons in deze studie op de verschillen in affiniteit van DAS voor de α1- en α2-isovormen. 
Dihydro-ouabaïne liet een duidelijke voorkeur zien voor de α1-isovorm: deze stof vertoonde 
een tienvoudig verhoogde affiniteit ten opzichte van de α2-isovorm. Dit verschil in affiniteit 
was niet aanwezig voor ouabaïne, terwijl beide stoffen slechts verschillen in de chemische 
structuur van de lactonring, namelijk de aan- (ouabaïne) of afwezigheid (dihydro-ouabaïne) 
van een dubbele binding. Vervolgens richtten we ons op het identificeren van de aminozuren 
die verantwoordelijk zijn voor het verschil in affiniteit voor dihydro-ouabaïne tussen de 
α1- en α2-isovormen. Door een serie van experimenten konden we uiteindelijk voor twee 
aminozuren in de α2-isovorm (Met119 en Ser124) aantonen dat, wanneer we deze vervingen 
door de corresponderende α1-isovorm-aminozuren, het verschil in affiniteit tussen beide 
isovormen significant kleiner werd. Het effect van de aanwezigheid van een gehydrogeneerde 
lactonring was ook aanwezig voor digoxine en de gehydrogeneerde vorm dihydro-digoxine. 
Digoxine had een hogere affiniteit voor de α2-isovorm, terwijl hydrogenatie van de lactonring 
een toename van de affiniteit voor de α1-isovorm induceerde, hoewel het effect minder 
groot was dan voor ouabaïne en dihydro-ouabaïne. Tevens werd duidelijk dat ook voor de 
isovormselectiviteit van digoxine en dihydro-digoxine Met119 en Ser124 een belangrijke rol 
spelen. De selectiviteit van digoxine voor de α2-isovorm kon significant verlaagd worden 
door Met119 te vervangen, terwijl de selectiviteit van dihydro-digoxine voor de α1-isovorm 
verminderd werd door het vervangen van Ser124. Deze resultaten dragen bij aan het begrijpen 
van de isovormselectiviteit van (gehydrogeneerde) DAS: Met119 en Ser124 zijn betrokken bij de 
selectiviteit van DAS voor de α1- en α2-isovormen.
Na+,K+-ATPase en ziekte
Gedurende de laatste jaren heeft Na+,K+-ATPase steeds meer aandacht gekregen met 
betrekking tot de rol van het enzym in verschillende ziektes. Zo is bijvoorbeeld bekend 
dat mutaties in de α2-isovorm kunnen leiden tot het ontstaan van sporadische/familiaire 
hemiplegische migraine (SHM/FHM), zeldzame vormen van migraine met aura. Alhoewel 
het exacte moleculaire mechanisme van deze mutaties nog onbekend is, wordt over het 
algemeen aangenomen dat de aanwezigheid van Na+,K+-ATPase in de astrocyten die aanwezig 
zijn als ondersteunende cellen bij de synapsen een belangrijke rol speelt. Waarschijnlijk leiden 
mutaties in Na+,K+-ATPase tot een verminderde katalytische activiteit voor het handhaven 
van ion-gradiënten van zowel Na+ als K+, beide belangrijk voor het heropnemen van glutamaat 
uit de synapsspleet, waardoor migraine kan ontstaan. Daarom hebben we de effecten van 
verschillende mutaties op de biochemische eigenschappen van Na+,K+-ATPase onderzocht. 
De resultaten van deze studies zijn beschreven in Hoofdstukken 4 en 5. 
In Hoofdstuk 4 wordt beschreven hoe negen verschillende SHM/FHM-mutaties mogelijk tot 
de ontwikkeling van deze ziekte kunnen bijdragen. Eén van de belangrijke parameters van 
Na+,K+-ATPase, de ATPase-activiteit, liet zien dat zes van deze mutaties een ernstig verlies 
van functionaliteit induceerden: P796S, M829R, R834X, del 935-940 ins Ile, R937P en D999H 
vertoonden vrijwel geen ATPase-activiteit. Voor mutant P796S lijkt met de introductie van een 
serine op deze positie ook een extra waterstofbrug te ontstaan, die mogelijk op indirecte wijze 
een effect heeft op de interactie tussen de beide subeenheden van Na+,K+-ATPase. Mutant 
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M829R lijkt een verminderde ATPase-activiteit te veroorzaken door verlies van belangrijke 
interacties die de verbinding tussen het zesde en zevende transmembraandomein stabiliseren. 
De overige vier mutaties worden verondersteld de ATPase-activiteit te verminderen doordat 
ze de structurele integriteit van een recent ontdekt half-kanaal aantasten dat gelokaliseerd 
is in het C-terminale gedeelte van Na+,K+-ATPase en dat een belangrijke rol speelt in het 
ion-transport mechanisme. Mutant T345A liet een niet-significante toename zien in de 
ATPase activiteit, maar een evenredige toename van de ouabaïne bindingscapaciteit toonde 
aan dat er geen significante verstoring van de Na+,K+-ATPase-functie is te verwachten door 
deze mutatie. Hierdoor kunnen we op grond van de gedane experimenten niet verklaren hoe 
deze mutatie dan wel tot ziekte kan leiden. Mutant R879W liet ook geen afwijkingen zien 
in de biochemische parameters zoals getest en ook kon geen verklaring worden gevonden 
in een mogelijk effect op intramoleculaire interacties. Het kan zijn dat het dan ook geen 
mutaties zijn die leiden tot ziekte, maar twee zeldzame polymorfismen. Voor mutant R834Q 
ontdekten we een significant verlaagde ATPase-activiteit en een verlaagde maximale ouabaïne 
bindingscapaciteit. Deze mutatie is tevens gelokaliseerd in het C-terminale half-kanaal zoals 
hierboven reeds beschreven, maar mogelijk is het effect van deze mutatie minder sterk dan de 
overige mutaties die dit half-kanaal aantasten. 
In Hoofdstuk 5 bestudeerden we de biochemische effecten van elf additionele SHM/FHM-
geassocieerde mutaties. Opnieuw werd gebruik gemaakt van dezelfde baculovirusgemedieerde 
expressie zodat membraanfracties konden worden verkregen met daarin de te bestuderen 
mutanten. Biochemische karakterisering van deze mutanten liet grote verschillen in de 
effecten zien. Zo konden er geen effecten worden gezien voor de mutanten Y9N, R51H, 
C702Y, R879Q, waaruit geconcludeerd kan worden dat deze mutanten mogelijk geen causale 
rol spelen in de ontwikkeling van SHM/FHM. Mutant P786L liet een verlies van functie 
zien door zowel een afwezige ATPase-activiteit alsook een minimale ouabaïne binding, 
verlies van twee zeer kenmerkende eigenschappen van Na+,K+-ATPase. Twee mutanten, 
R548C en R548H, vertoonden een lagere transportsnelheid, leidend tot minder transport 
van zowel Na+ als K+ en daardoor mogelijk een oorzaak van het ontwikkelen van migraine. 
Lagere transportsnelheden werden ook gezien bij mutanten E174K en E700K, maar deze 
afnames waren niet statistisch significant. De laatste twee mutanten (G900R en E902K) lieten 
weliswaar geen effect zien op de geteste biochemische eigenschappen, maar mogelijk spelen 
beide residuen een rol in de interactie tussen de α- en β-subeenheden, waardoor er minder 
functioneel eiwit aanwezig is in de celmembraan.
Ook mutaties in de α3-isovorm zijn geassocieerd met het ontstaan van ziekte. Een voorbeeld 
hiervan is een speciale vorm van de ziekte van Parkinson. Van meer recente aard is de 
ontdekking dat een andere neurologische ziekte ook veroorzaakt wordt door mutaties in deze 
isovorm. Deze ziekte, pediatrische alternerende hemiplegie (PAH), wordt veroorzaakt door 
mutaties gelokaliseerd in of vlakbij de transmembraandomeinen en wordt gekarakteriseerd 
door aanvallen met halfzijdige verlamming, optredend vanaf de eerste levensmaanden. 
Een interessante hypothese is het idee dat beide ziektes in elkaars verlengde liggen. 
In Hoofdstuk 6 beschrijven we uitgebreid de biochemische eigenschappen van zes frequente 
mutaties die gevonden zijn in patiënten met PAH: S137Y, D220N, I274N, D801N, E815K en 
G947R. Mutant D220N liet geen enkele afwijking zien in vergelijking met het normale Na+,K+-
ATPase, waardoor een causale rol voor deze mutatie vooralsnog onwaarschijnlijk is, alhoewel 
wij niet de lokalisatie van deze mutant hebben onderzocht. Drie mutanten (I274N, E815K 
en G947R) vertoonden geen ATPase-activiteit, konden geen ouabaïne binden en konden 
niet worden gefosforyleerd, hetgeen aantoont dat deze mutaties tot een ernstig functieverlies 
van Na+,K+-ATPase leiden. Twee mutanten (D801N en G947R) lieten geen ATPase-activiteit 
en fosforylering zien, terwijl de ouabaïne bindingscapaciteit niet verloren was gegaan, wat 
impliceert dat deze mutaties tot een minder ernstig verlies van functionaliteit leiden dan 
de andere drie mutanten. Mogelijk verklaart het verschil in biochemische eigenschappen 
tussen de mutanten D801N en E815K (de meest voorkomende mutaties) het in de literatuur 
gepubliceerde verschil met betrekking tot het fenotype. 
Hoofdstuk 7, het laatste experimentele hoofdstuk van dit proefschrift, beschrijft de resultaten 
van een serie experimenten die erop gericht was om de verschillen in ATPase-activiteit tussen 
de α2- en α4-isovormen beter te begrijpen. Eerdere studies in ons laboratorium hadden reeds 
aangetoond dat waar de α2-isovorm de hoogste ATPase-activiteit vertoonde, de α4-isovorm 
slechts in geringe mate actief was. Omdat volgens de literatuur beide isovormen evolutionair 
aan elkaar verwant zijn, bestudeerden we welke aminozuren verantwoordelijk zijn voor het 
gevonden verschil in ATPase-activiteit. Door middel van de productie van een serie chimeren 
gericht op het ontdekken van de verantwoordelijke aminozuren, konden we aantonen 
dat de vervanging van twee aminozuren in de α4-isovorm door de corresponderende 
α2-isovorm residuen de ATPase-activiteit van de α4-isovorm zeer sterk verhoogt. Beide 
residuen zijn gelokaliseerd in het P-domein dat zich bevindt in de grote cytosolaire lus tussen 
het vierde en vijfde transmembraandomein. De α4-isovormresiduen Ile679 en Pro692 bevinden 
zich hier vlakbij een zogenaamde Rossmann-structuur die ook het te fosforyleren residue 
bevat. Mogelijk dat de aanwezigheid van de twee residuen de Rossmann-structuur aantast, 
wat de lagere ATPase-activiteit van de α4-isovorm verklaart.
In Hoofdstuk 8 worden de resultaten van het onderzoek dat beschreven is in dit proefschrift 
beschouwd in een bredere context, waarmee duidelijk wordt dat Na+,K+-ATPase een belangrijke 
rol speelt in ziekte en gezondheid. Verder valt te verwachten dat in de komende jaren er 
meer mutaties zullen worden ontdekt in Na+,K+-ATPase isovormen, waarvan biochemische 
karakterisering bij zal dragen aan het begrijpen van het bijbehorende fenotype. Daarnaast is 
het wenselijk om met de nieuwste analysetechnieken de aanwezigheid van endogene DAS 
verder te onderzoeken. Een andere interessante vraag betreft de aanwezigheid van mutaties in 
de α4-isovorm bij subfertiele mannen, aangezien het expressiepatroon van deze isovorm een 
interessant therapeutisch aanknopingspunt biedt.
Samenvattend hebben we als eersten laten zien hoe PAH-geassocieerde mutaties de 
verschillende eiwitfuncties beïnvloeden en hebben we tevens laten zien dat de veronderstelde 
rol van Na+,K+-ATPase in signaaltransductie verder onderzoek behoeft. Ook hebben we de 
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ouabaïnebindingsplaats onderzocht met betrekking tot de binding van gehydrogeneerde 
DAS en hebben we SHM/FHM geassocieerde mutaties bestudeerd. Daarbij hebben we de 
ATPase-activiteit van de α4-isovorm kunnen verhogen door vervanging van slechts twee 
aminozuren. Gezamenlijk dragen de resultaten van dit proefschrift bij aan het vergroten van 
de wetenschappelijke kennis omtrent de rol van Na+,K+-ATPase in ziekte en gezondheid en ze 
onderstrepen daarmee de belangrijke rol van dit enzym binnen het menselijk lichaam.
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List of abbreviations and glossary
αM  transmembrane domain
A  alanine, nonpolar amino acid
ADP  adenosine diphosphate, formed during ATP hydrolysis
AHC  alternating hemiplegia of childhood, disease resulting from mutations in  
  ATP1A3
Ala  alanine, nonpolar amino acid
AMPK  AMP-activated protein kinase, signaling protein
ANOVA  analysis of variance, statistical tool to measure differences between groups
Arg  arginine, basic amino acid
Asn  asparagine, polar uncharged amino acid
Asp  aspartic acid, acidic amino acid
ATP  adenosine triphosphate, cellular fuel: hydrolyzed to obtain energy
ATP1A1  gene encoding the α1-subunit
ATP1A2  gene encoding the α2-subunit 
ATP1A3  gene encoding the α3-subunit
ATP1A4  gene encoding the α4-subunit
ATP1B1  gene encoding the β1-subunit
BSA  bovine serum albumin
C  cysteine, polar uncharged amino acid
CD  cytosolic domain
CG(s)  cardiac glycosides, alternative name for DLC(s)
Chimera  protein consisting of parts of multiple proteins
Ci  Curie
Conformation structural arrangement
Cys  cysteine, polar uncharged amino acid
D  aspartic acid, acidic amino acid
de novo  new/unprecedented
DLC(s)  digitalis-like compound(s), inhibitor(s) of Na+,K+-ATPase activity
E  glutamic acid, acidic amino acid
EDTA  ethylenediaminetetraacetic acid, chelating molecule
EGFR  epidermal growth factor, signaling protein
EOmax  maximum amount of ouabain binding
EP  amount of phosphorylated intermediate
ERBB2  human epidermal growth factor receptor 2
ERK  extracellular signal-related kinase, signaling protein
F  phenylalanine, nonpolar amino acid 
FGFR  fibroblast growth factor receptor
FHM  familial hemiplegic migraine, disease resulting from mutations in ATP1A2
G  glycine, polar uncharged amino acid
Gln  glutamine, polar uncharged amino acid
Glu  glutamic acid, acidic amino acid
Gly  glycine, polar uncharged amino acid
H  histidine, basic amino acid
h  hour(s)
H-bond  hydrogen-bond
His  histidine, basic amino acid
HRP  horse radish peroxidase, used to detect presence of antibody
I  isoleucine, nonpolar amino acid 
IC50  concentration at which 50% inhibition takes place
IFD  initial-fit docking
Ile  isoleucine, nonpolar amino acid
in vitro  in a test tube
in vivo  in a living organism
IP3R  inositol trisphosphate receptor, involved in Ca2+ release
K  lysine, basic amino acid
K+0.5  concentration at which half-maximal K+ mediated ATPase activity is   
  observed
Kd  dissociation constant, measure for affinity of compounds
L  leucine, nonpolar amino acid
Leu  leucine, nonpolar amino acid
LLC-PK1 pig kidney cell line
Lys  lysine, basic amino acid
M  methionine, nonpolar amino acid
MAPK  mitogen-activated protein kinase, signaling protein
Met  methionine, nonpolar amino acid
min  minute(s)
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N  asparagine, polar uncharged amino acid
n.d.  not detectable
Na+0.5  concentration at which half-maximal Na+ mediated ATPase activity is   
  observed
nH  Hill-coefficient, quantifies cooperative binding
NMDG  N-Methyl-D-Glucamine, used to compensate for loss of ionic strength
NMR  nuclear magnetic resonance
P  proline, nonpolar amino acid
PBS(-T)  phosphate buffered saline (-tween),
PCR  polymerase chain reaction
PDB  protein data bank, crystal structure repository
PDGFR  platelet-derived growth factor receptor
Phe  phenylalanine, nonpolar amino acid
Pi  phosphate, formed during ATP hydrolysis
PI3K  phosphatidylinositol-4,5-bisphosphate 3-kinase, signaling protein
PLC-γ  phosphoinositide phospholipase C-gamma, signaling protein
Pro  proline, nonpolar amino acid
Q  glutamine, polar uncharged amino acid
R  arginine, basic amino acid
RAS  rat sarcoma protein, signaling protein
RDP  rapid-onset dystonia parkinsonism, disease resulting from mutations in   
  ATP1A3
s  second(s)
S  serine, polar uncharged amino acid
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SEM  standard error of the mean, measure of variation within a group
Ser  serine, polar uncharged amino acid
SERCA  sarco/endoplasmic reticulum Ca2+-ATPase
Sf9  Spodoptera frugiperda 9, insect cell line
SH  SRC homology
SHM  sporadic hemiplegic migraine, disease resulting from mutations in ATP1A2
(p)Src  (phosphorylated) tyrosine-protein kinase Src, signaling protein
State  structural arrangement, similar to conformation
T  threonine, polar uncharged amino acid
TBS(-T)  tris buffered saline (-tween)
Thr  threonine, polar uncharged amino acid
Trp  tryptophan, nonpolar amino acid
Tyr  tyrosine, polar uncharged amino acid
V  valine, nonpolar amino acid
Vmax  maximum velocity of an enzymatic reaction
Val  valine, nonpolar amino acid
Vanadate phosphate analog, inhibits Na+,K+-ATPase nonspecifically
W  tryptophan, nonpolar amino acid
Y  tyrosine, polar uncharged amino acid
YASARA yet another scientific artificial reality application, freeware to view crystal  
  structures
YFP  yellow-fluorescent protein, used as a negative control
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VWO-diploma aan het Baudartius College te Zutphen, waarna werd begonnen met de studie 
Biomedische Wetenschappen aan de Radboud Universiteit Nijmegen. Zijn bachelorstage 
liep hij bij de afdeling Interne Geneeskunde binnen het Radboud universitair medisch 
centrum, onder begeleiding van dr. Tom Sprong, in samenwerking met het laboratorium 
Kindergeneeskunde-Infectieziekten van prof. dr. Peter Hermans. In de masterfase werd er 
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dr. Jan Koenderink. Dit onderzoek heeft geresulteerd in de publicaties die verzameld zijn in dit 
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Ineens doemt uit de verte de finishstreep van mijn promotieonderzoek op. Ook al wist ik dat 
het eraan zat te komen, het voelt toch enigszins onwennig om te beseffen dat het nog maar 
zo’n klein stukje is. Heb ik de afgelopen jaren dan als een zware tocht ervaren? Gelukkig niet, 
integendeel zelfs: het waren jaren waarin ik niet alleen onderzoek heb mogen doen naar een 
zeer interessant onderwerp, maar bovendien het geluk heb gehad daarbij omringd te zijn door 
een aangenaam reisgenootschap. 
Eén van mijn eerste herinneringen aan de start van het project is het gesprek dat gevoerd 
werd op de kamer van Frans, mijn promotor. Beste Frans, het is me altijd bijgebleven hoe jij 
me wist te overtuigen van mijn slagingskansen op dit project. Dit bleek achteraf tekenend te 
zijn voor jouw stijl van leidinggeven: je integere houding, onuitputtelijke kennis wat betreft de 
farmacologie, gekoppeld aan het altijd beschikbaar zijn voor vragen (zelfs na middernacht) en 
de rust die je uitstraalt maken je tot een kundig afdelingshoofd en promotor.
Bij datzelfde gesprek was ook Jan aanwezig, de co-promotor van dit project. Jan, jouw nuchtere 
houding in de wetenschap en het leven daarbuiten maakte dat ik makkelijk bij je binnen liep, 
en waar nodig simpelweg tijd in jouw agenda reserveerde. Volgens mij begrijpen we elkaar 
goed, waardoor niet alles uitgesproken hoeft te worden, dat is wel zo efficiënt. Alles bij elkaar 
is het een prachtig project geworden, met als kers op de taart het door jou georganiseerde 
ATPase congres in Nederland, afgelopen zomer. Leuk dat we bij de verdediging een paar die-
hard ATPase onderzoekers konden uitnodigen. Deze geven zo’n verdediging enig “cachet”, 
zoals ons voormalig afdelingshoofd Paul Smits zou zeggen.
Also, I would like to express my gratitude to our collaborators in Århus: Natasha Fedosova, 
Mette Laursen, and Poul Nissen. Thanks for all the discussions, and the purified protein, it 
was essential for chapter 2, whereas Mette’s contribution to chapter 3 was just as significant!
Het was in dezelfde kamer dat ik Herman ontmoette, die als analist op hetzelfde project was 
aangesteld, al was het officieel maar voor de helft van de tijd. Herman, het was van het begin 
af aan duidelijk dat jij de ware vakman binnen het ATPase onderzoek bent, met een oneindige 
hoeveelheid ervaring. Dank voor alles (en dat is heel wat!) wat je aan het project hebt 
bijgedragen en alle gesprekken over het doen van onderzoek, maar ook over de geschiedenis 
van het biochemisch onderzoek in Nijmegen. Misschien dat we de koelkast op de derde 
verdieping maar tot monument moeten laten verklaren? Ik denk met plezier terug aan onze 
gesprekken aan het strand van Californië en ons bezoek aan San Francisco, waar we ons rot 
zochten naar een terras.
170 171
DankwoordChapter 9
9
Julien (mon petit, Assange), qu’est-ce que je doit dire a vous? Dans les dernieres années tu es 
devenu plus qu’ un collègue. La seule chose qui manque est ton néerlandais (bien que vous 
ayez passé le test avec le veló sous la pluie), mais mon Francais sonne comme quelqun un 
peut fort bourré aussi. It was always nice to practice my French with you, and it’s a pity that 
our working spaces are now farther apart. Still, we meet regurlarly during “meatings” and 
discuss about the future. I still think we need to work on our plans for a certain TV-show with 
monsieur Schirris!  
Op het lab mocht ik mijn eerste jaar plaatsnemen aan de bench bij Rachel (Rage), al werd 
er al snel met tape een duidelijke scheiding gemaakt tussen onze werkplekken. Elkaars 
tolerantiegrens passeerden we allebei graag en daardoor zorgden we samen toch voor het 
nodige leven in de brouwerij. Daarbij was het fijn dat er iemand was om slechte filmquotes 
mee te delen. Gelukkig was het niet alleen maar onzin, we hebben ook  serieuze gesprekken 
gehad, toch?  
In hetzelfde U-tje zat ook Hanneke (Mevrouw Wittgen), die als een soort van oudere zus 
fungeerde. Zo begon haar maandagochtend met het bijpraten met het hele lab, zodat ze weer 
op de hoogte was van het wel en wee van iedereen. Hanneke, onze gesprekken aan het einde 
van de werkdag heb ik altijd zeer gewaardeerd, en moesten nog wel eens worden afgebroken 
omdat we nu echt naar huis moesten, een goed teken lijkt me. 
De laatste U-genoot van het illustere U-tje 4 was Rick. Rick, met terugwerkende kracht mijn 
excuses voor alle onzin die je hebt moeten aanhoren van mijzelf en Rachel, hopelijk heb je er 
niet teveel onder geleden. Onze taalliefde uitte zich in het adopteren van een belegen woord, 
en je farmacokinetische formules op de achterkant van een bierviltje zal ik ook niet snel meer 
vergeten! Leuk dat we onze samenwerking nog even voortzetten, en jammer dat onze tocht 
naar Groningen met de mighty Mic niet doorging, die houd je tegoed. 
De rest van mijn collega’s, niet minder gewaardeerd, wil ik graag ook nog even noemen. 
Kim(bo), dank voor je introductie in de pubquiz-wereld en de Madagascar-quotes. Rick M., 
my main man, fijn dat jij de talk-like-a-pirate-day ook buiten de officiële datum in ere houdt. 
Sanna (Ramona), wat was het fijn om iemand te hebben om op de kast te jagen wanneer 
Rachel er niet was, al merkte je ooit terecht op dat we het best vaak met elkaar eens zijn. Elnaz, 
diep respect heb ik voor hoe snel je de Nederlandse taal leerde, maar het meest heb ik genoten 
van je presentaties over DLCs en jouw uitspraak van de verschillende stofnamen in het Engels. 
Veel succes in de UK! Anita (Annies), met jou erbij was het nooit stil, en je spreektempo 
is tot nu toe ongeëvenaard. Martijn (Big Wilmer), het is altijd leuk om met jou de recente 
ontwikkelingen binnen en buiten de wetenschap te bespreken, dank voor je positief kritische 
houding! Monsieur Schirris, mocht u ooit nog normale werktijden ambiëren dan is denk 
ik het presentatorschap van “hoe heurt het eigenlijk” de enige juiste keuze! Jitske (juffrouw 
Jansen), leuk dat je erbij kwam: je droge commentaren en Achterhoekse bijzonderheden 
houden de boel een beetje luchtig. Janny P., de moeder-overste van het lab, dank voor je goede 
zorgen en je hartelijke lach. Jeroen, wanneer mag ik nou eens komen drummen? Maarten en 
Lindsey (Jip en Janneke), goed dat jullie nu als nieuwere promovendi de moleculaire biologie 
in ere houden! Ab en Petra, dank jullie wel voor jullie gezelschap na (maar ook tijdens) 
menig afdelingsuitje! Verder dank aan Roos, Marieke, Michèle, Miloš, Tom N., Ria, Esther 
(juffrouw Peters), Pedro (Mr. Gravity), alle prekliniek collega’s, en ook nog Alwin (Alwinius 
Scharstuhlus), Bas P. (Tris-Bas(e)) en Frank (Frankino) voor alle gezelligheid!
Tijdens dit project mocht ik verschillende studenten begeleiden. Merel, Julia, Karin, Chris en 
Muriël: dank jullie wel voor jullie inzet en goede vragen, ze hebben aan de basis gelegen van 
meerdere hoofdstukken van dit proefschrift!
Het is fijn om mensen om je heen te hebben die misschien wel niet de finesses van jouw 
onderzoek begrijpen, maar die je des te meer steunen op andere manieren. Bijvoorbeeld door 
het proofreaden van de inleiding, discussie en samenvatting (waarvoor dank, Mark!), maar 
ook door de vele goede gesprekken waarbij de lastiger onderwerpen niet geschuwd worden. 
Dank aan iedereen die geïnteresseerd bleef als je op de vraag hoe het mij ging een antwoord 
kreeg over de stand van zaken rondom dit proefschrift! Ik houd me voor dat ik nu meer tijd 
zal hebben voor contacten met nog meer mensen, hopelijk maak ik dat waar. 
Mijn opa leerde mij dat om goed te begrijpen waarom mensen bepaalde keuzes maken je iets 
zult moeten weten over hun geschiedenis. Mijne begint in een gezin met twee broers. Roeland 
en Victor (en Tirza!), niet alleen ben ik trots op wat jullie kunnen en doen, meer nog waardeer 
ik hoe we ons de laatste jaren hebben ontwikkeld tot volwassenen, met ongeveer dezelfde 
waarden, maar nog belangrijker: met oog voor de beweegredenen van de ander, en berusting 
in het feit dat we met hetzelfde sop overgoten zijn. 
Mijn ouders wil ik bedanken voor alles wat jullie ons hebben gegeven (en nog steeds doen), en 
de bescheiden verwachtingen voor wat betreft onze studieresultaten: als je maar je best doet. 
Het is fantastisch om zoveel mogelijkheden te krijgen en daarbij je eigen keuzes te mogen 
maken. Zie hier het resultaat van één zo’n keuze, al zijn er (gelukkig) nog belangrijker keuzes 
in het leven.
Lieve Laura, wat kan ik nog zeggen dat jij niet allang weet? Het ware thuis is daar waar je niets 
hoeft te zeggen. Dank je voor het zijn van zo’n thuis. Je bent mijn lief! In Dei Nomine Feliciter. 

